DOI	Title	Authors	Abstract	Journal	Date
10.1073/pnas.2121425119	pleistocene legacy structure variation modern seagrass ecosystem .	Duffy JE, Stachowicz JJ, Reynolds PL, Hovel KA, Jahnke M, Sotka EE, Boström C, Boyer KE, Cusson M, Eklöf J, Engelen AH, Eriksson BK, Fodrie FJ, Griffin JN, Hereu CM, Hori M, Hughes AR, Ivanov MV, Jorgensen P, Kruschel C, Lee KS, Lefcheck JS, Moksnes PO, Nakaoka M, O&#x27;Connor MI, O&#x27;Connor NE, Orth RJ, Peterson BJ, Reiss H, Reiss K, Richardson JP, Rossi F, Ruesink JL, Schultz ST, Thormar J, Tomas F, Unsworth R, Voigt E, Whalen MA, Ziegler SL, Olsen JL	distribution earth&#x27;s biome be structure match climate plant trait turn shape associate community ecosystem process service . however that climate trait match can be disrupt historical event last ecosystem impact . as earth&#x27;s environment change fast time human history critical question be whether how organismal trait ecosystem can adjust altered condition . quantify relative importance current environmental forcing versus evolutionary history shape growth form stature biomass associate community eelgrass zostera marina widespread foundation plant marine ecosystem northern hemisphere coastline experience major shift distribution genetic composition pleistocene . find that eelgrass stature biomass retain legacy pleistocene colonization atlantic ancestral pacific range more recent basin bottleneck genetic differentiation . evolutionary legacy turn influence biomass associated algae invertebrate fuel coastal food webs effect comparable strong effect current environmental forcing . such historical lag phenotypic acclimatization may constrain ecosystem adjustment rapid anthropogenic climate change thus alter prediction future functioning ecosystem .	Proceedings of the National Academy of Sciences of the United States of America	09/08/2022
10.3390/jimaging10080192	railtrack davit vision transformer base approach automated railway track	Phaphuangwittayakul A, Harnpornchai N, Ying F, Zhang J	railway track defect pose significant safety risk can lead accident economic loss loss life . traditional manual inspection method be time consume costly prone human error . paper propose railtrack davit novel vision transformer base approach railway track defect classification . leverage dual attention vision transformer davit architecture railtrack davit effectively capture global local information enable accurate defect detection . model be train evaluate multiple dataset include rail fastener fishplate multi fault thairailtrack . comprehensive analysis model&#x27;s performance be provide include confusion matrix training visualization classification metric . railtrack davit demonstrate superior performance compare state art cnn base method achieve high accuracy 96.9 rail dataset 98.9 fastener fishplate dataset 98.8 multi faults dataset . moreover railtrack davit outperform baseline thairailtrack dataset 99.2 accuracy quickly adapt unseen image show well model stability fine tuning . capability can significantly reduce time consumption when apply model novel dataset practical application .	Journal of imaging	07/08/2024
10.3390/jimaging10090227	leverage perspective transformation enhanced pothole detection	Abu-Raddaha A, El-Shair ZA, Rawashdeh S	road condition often degrade insufficient maintenance adverse weather significantly contribute accident exacerbate limited human reaction time sudden hazard like pothole . early detection distant pothole be crucial timely corrective action such reduce speed avoid obstacle to mitigate vehicle damage accident . paper introduce novel approach utilize perspective transformation to enhance pothole detection different distance focus particularly distant pothole . perspective transformation improve visibility clarity pothole virtually bring close enlarge feature be particularly beneficial give fix size input requirement object detection network typically significantly small raw image resolution capture camera . method automatically identify region interest roi)-the road area calculate corner point to generate perspective transformation matrix . matrix be apply image correspond bounding box label enhance representation pothole dataset . approach significantly boost detection performance when use yolov5 small achieve 43 improvement average precision ap metric intersection union threshold 0.5 0.95 single class evaluation notable improvement 34 63 194 near medium far pothole respectively categorize base distance . good knowledge work be first to employ perspective transformation specifically enhance detection distant pothole .	Journal of imaging	14/09/2024
10.1016/j.cell.2025.02.022	meningeal lymphatics microglia axis regulate synaptic physiology .	Kim K, Abramishvili D, Du S, Papadopoulos Z, Cao J, Herz J, Smirnov I, Thomas JL, Colonna M, Kipnis J	meningeal lymphatic serve outlet cerebrospinal fluid dysfunction be associate various neurodegenerative condition . previous study have demonstrate that dysfunctional meningeal lymphatic evoke behavioral change neural mechanism underlie change have remain elusive . here show that prolonged impairment meningeal lymphatic alter balance cortical excitatory inhibitory synaptic input accompany deficit memory task . synaptic behavioral alteration induce lymphatic dysfunction be mediate microglia lead increase expression interleukin 6 gene il6 . il-6 drive inhibitory synapse phenotype combination trans- classical il-6 signal . restore meningeal lymphatic function aged mouse reverse age associate synaptic behavioral alteration . finding suggest that dysfunctional meningeal lymphatic adversely impact cortical circuitry il-6 dependent mechanism identify potential target treat aging associate cognitive decline .	Cell	14/03/2025
10.3390/jimaging10080197	multi scale target detection method use improved faster region	Chen Q, Li M, Lai Z, Zhu J, Guan L	currently exist deep learning method exhibit many limitation multi target detection such low accuracy high rate false detection miss detection . paper propose improved faster r cnn algorithm aim to enhance algorithm&#x27;s capability detect multi scale target . algorithm have three improvement base faster r cnn . firstly new algorithm use resnet101 network feature extraction detection image achieve strong feature extraction capability . secondly new algorithm integrate online hard example mining ohem soft non maximum suppression soft nms distance intersection union diou module improve positive negative sample imbalance problem small target be easily miss model training . finally region proposal network rpn be simplify to achieve fast detection speed low miss rate . multi scale training mst strategy be also use to train improved faster r cnn to achieve balance detection accuracy efficiency . compare other detection model improve faster r cnn demonstrate significant advantage term map@0.5 f1 score log average miss rate lamr . model propose paper provide valuable insight inspiration many field such smart agriculture medical diagnosis face recognition .	Journal of imaging	13/08/2024
10.3390/jimaging10090215	concrete crack detection segregation feature fusion crack isolation	Swarna RA, Hossain MM, Khatun MR, Rahman MM, Munir A	scientific knowledge image base crack detection method be limit understand performance diverse crack size type environmental condition . builder engineer often face difficulty image resolution detect fine crack differentiate structural non structural issue . enhanced algorithm analysis technique be need more accurate assessment . hence research aim to generate intelligent scheme can recognize presence crack visualize percentage crack image explanation . propose method fuse feature concrete surface image resnet-50 convolutional neural network cnn curvelet transform handcraft hc method optimize linear discriminant analysis lda extreme gradient boost xgb classifier then use feature to recognize crack . study evaluate several cnn model include vgg-16 vgg-19 inception v3 resnet-50 various hc technique such wavelet transform counterlet transform curvelet transform feature extraction . principal component analysis pca lda be assess feature optimization . classification xgb random forest rf adaptive boost adaboost category boost catboost be test . to isolate quantify crack region research combine image thresholding morphological operation contour detection convex hull method form novel algorithm . two explainable ai xai tool local interpretable model agnostic explanation lime gradient weighted class activation mapping++ grad cam++ be integrate propose method to enhance result clarity . research introduce novel feature fusion approach enhance crack detection accuracy interpretability . method demonstrate superior performance achieve 99.93 99.69 accuracy two exist dataset outperform state art method . additionally development algorithm isolate quantify crack region represent significant advancement image processing structural analysis . propose approach provide robust reliable tool real time crack detection assessment concrete structure facilitate timely maintenance improve structural safety . offer detailed explanation model&#x27;s decision research address critical need transparency ai application thus increase trust adoption engineering practice .	Journal of imaging	31/08/2024
10.1182/blood.2024027620	daratumumab bortezomib thalidomide dexamethasone newly diagnose myeloma	Corre J, Vincent L, Moreau P, Hebraud B, Hulin C, Béné MC, Broijl A, Caillot D, Delforge M, Dejoie T, Facon T, Lambert J, Leleu X, Macro M Dr, Perrot A, Zweegman S, Filleron T, Cabarrou B, van de Donk NWCJ, Mahéo S, Hua W, Wang J, Krevvata M, Vanquickelberghe V, de Boer C, Tuozzo A, Borgsten F, Rowe M, Carson R, Wuilleme S, Sonneveld P	previous result cassiopeia nct02541383 demonstrate superior progression free survival pfs minimal residual disease mrd negativity addition daratumumab bortezomib thalidomide dexamethasone vtd induction consolidation daratumumab maintenance versus observation transplant eligible newly diagnose multiple myeloma ndmm . here present long term mrd status pfs outcome 80.1 month median follow up . patient be randomly assign 1:1 daratumumab plus vtd d vtd vtd induction consolidation patient remain study be re randomized daratumumab maintenance observation £ 2 year . mrd status be assess pre define timepoint study phase . d vtd improve overall mrd negativity rate 10 5 post induction 34.6 vs 23.1 p&lt;0.0001 post consolidation 63.7 vs 43.7 p&lt;0.0001 provide pfs benefit regardless post induction mrd status versus vtd alone . daratumumab maintenance improve overall mrd negativity rate observation regardless induction consolidation treatment d vtd daratumumab vs d vtd observation 10 5 77.3 vs 70.7 p=0.0417 10 6 60.7 vs 52.0 p=0.0365 vtd daratumumab vs vtd observation 10 5 70.9 vs 51.2 p&lt;0.0001 10 6 48.4 vs 30.7 p&lt;0.0001 improve mrd negativity rate regardless risk status as define cytogenetic abnormality revise international staging system score . far daratumumab maintenance provide pfs benefit versus observation regardless induction consolidation treatment post consolidation mrd status . d vtd follow daratumumab maintenance consistently produce high landmark accumulative sustain mrd negativity rate 10 5 10 6 translate superior long term pfs outcome . result demonstrate that daratumumab base induction consolidation follow daratumumab maintenance result deep most durable mrd negativity lead superior pfs outcome .	Blood	24/03/2025
10.7554/eLife.101973	ormdl3 restrain type interferon signal anti tumor immunity promote	Zeng Q, Yao C, Zhang S, Mao Y, Wang J, Wang Z, Sheng C, Chen S	mounting evidence have demonstrate genetic association ormdl sphingolipid biosynthesis regulator 3 ormdl3 gene polymorphism bronchial asthma diverse set inflammatory disorder . however role type interferon type ifn signal remain poorly define . herein report that ormdl3 be negative modulator type ifn signal interact mitochondrial antiviral signal protein mavs subsequently promote proteasome mediate degradation retinoic acid inducible gene rig i . immunoprecipitation couple mass spectrometry ip ms assay uncover that ormdl3 bind ubiquitin specific protease 10 usp10 form complex stabilize rig decrease k48 link ubiquitination . ormdl3 thus disrupt interaction usp10 rig thereby promote rig degradation . additionally subcutaneous syngeneic tumor model c57bl/6 mouse reveal that inhibition ormdl3 enhance anti tumor efficacy augment proportion cytotoxic cd8 positive t cell ifn production tumor microenvironment tme . collectively finding reveal pivotal role ormdl3 maintain antiviral innate immune response anti tumor immunity .	eLife	24/03/2025
10.3390/jimaging10090208	task adaptive angle selection computed tomography base defect detection .	Wang T, Florian V, Schielein R, Kretzer C, Kasperl S, Lucka F, van Leeuwen T	sparse angle x ray computed tomography ct play vital role industrial quality control lead inherent trade off scan time reconstruction quality . adaptive angle selection strategy try to improve upon base idea that geometry object investigation lead uneven distribution information content projection angle . deep reinforcement learning drl have emerge effective approach adaptive angle selection x ray ct . while previous study focus optimize generic image quality measure use fix number angle work extend consider specific downstream task namely image base defect detection introduce flexibility number angle use . leverage prior knowledge typical defect characteristic task adaptive angle selection method adaptable term angle count enable easy detection defect reconstructed image .	Journal of imaging	23/08/2024
10.1001/jama.2025.3579	microultrasonography guided vs mri guide biopsy prostate cancer diagnosis	Kinnaird A, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF, Pavlovich CP, Brito J, Shore ND, Struck JP, Schostak M, Harland N, Rodriguez-Socarrás M, Brisbane WG, Lughezzani G, Toledano H, Ouertani MS, Macek P, Fung C, Tu W, Gusenleitner A, Günzel K, Incze PF, George AK, Pereira JG, Jansen R, Renzulli J 2nd, Klotz L	importance high resolution microultrasonography guide biopsy be alternative mri fusion guide biopsy prostate cancer diagnosis . objective to compare microultrasonography guide mri fusion guide biopsy . design setting participant multicenter international open label randomize noninferiority trial biopsy naive man 20 center 8 country clinical suspicion prostate cancer elevated prostate specific antigen psa and/or abnormal digital rectal examination finding december 2021 september 2024 . intervention participant be assign to receive microultrasonography guide biopsy n   =   121 microultrasonography mri fusion guide biopsy microultrasonography mri n   =   226 microultrasonography biopsy be perform prior unblinde mri mri conventional us fusion guide biopsy mri conventional ultrasonography n   =   331 . participant receive synchronous systematic biopsy . main outcomes measures primary outcome be difference detection gleason grade group 2 high cancer use microultrasonography plus systematic biopsy vs mri conventional ultrasonography plus systematic biopsy . secondary outcome be difference detection gleason grade group 2 high cancer find use microultrasonography mri plus systematic biopsy vs mri conventional ultrasonography plus systematic biopsy . noninferiority margin be set 10 . result total 802 man undergo randomization 678 underwent biopsy . median iqr age be 65 59 70 year prostate specific antigen level be 6.9 5.2 9.8 ng ml 83 self identify white . gleason grade group 2 high cancer be detect 57 participant 47.1 microultrasonography group 141 42.6 mri conventional ultrasonography group 106 46.9 microultrasonography mri group . microultrasonography guide biopsy be noninferior mri fusion guide biopsy difference 3.52 95 ci -3.95 to 10.92 noninferiority p   lt   .001 . combine biopsy microultrasonography mri be also noninferior mri conventional ultrasonography software assist mri fusion biopsy use conventional ultrasonography device difference 4.29 95 ci -4.06 to 12.63 noninferiority p   lt   .001 . rate gleason grade group 2 high cancer diagnose target biopsy only be 38.0 microultrasonography group 34.1 mri conventional ultrasonography group 40.3 microultrasonography mri group difference be not significant . conclusion relevance use microultrasonography guide biopsy be noninferior mri conventional ultrasonography fusion guide biopsy detection gleason grade group 2 high prostate cancer biopsy naive man . microultrasonography may provide alternative mri image guide prostate biopsy . trial registration clinicaltrials.gov identifier nct05220501 .	JAMA	23/03/2025
10.1038/s41467-025-57879-3	association 2923 plasma protein incident inflammatory bowel disease	Zhang X, Zhao H, Wan M, Man J, Zhang T, Yang X, Lu M	prospective relationship proteomic inflammatory bowel disease ibd remain largely underexplored present potential therapeutic intervention . use datum 48,800 ibd free participant uk biobank pharma proteomics project ukb ppp assess association 2923 plasma protein incident ibd risk use cox analysis . mendelian randomization mr meta analysis integrate cis protein quantitative trait loci datum ukb ppp ibd genome wide association study datum international inflammatory bowel disease genetics consortium finngen study identify causal protein . colocalization analysis strengthen evidence share common causal variant . cohort study reveal association 673 295 125 protein risk ibd crohn&#x27;s disease cd ulcerative colitis uc respectively . mr colocalization analysis prioritize il12b cd6 mxra8 cxcl9 ifng ccn3 rspo3 il18 have causal high colocalization evidence ibd subtype . finding advance understanding ibd&#x27;s molecular etiology highlight potential therapeutic target .	Nature communications	21/03/2025
10.1038/s41586-025-08732-6	vdac2 loss elicit tumour destruction inflammation cancer therapy .	Yuan S, Sun R, Shi H, Chapman NM, Hu H, Guy C, Rankin S, Kc A, Palacios G, Meng X, Sun X, Zhou P, Yang X, Gottschalk S, Chi H	tumour cell often evade immune pressure exert cd8(+ t cell immunotherapy mechanism be largely unclear(1,2 . here use complementary vivo vitro crispr cas9 genetic screen to target metabolic factor establish voltage dependent anion channel 2 vdac2 immune   signal dependent checkpoint curtail interferon γ ifnγ)-mediated tumour destruction inflammatory reprogramme tumour microenvironment . target vdac2 tumour cell enable ifnγ induce cell death cgas sting activation markedly improve anti tumour effect immunotherapeutic response . use genome scale genetic interaction screen identify bak mediator vdac2 deficiency induce effect . mechanistically ifnγ stimulation increase bim bid bak expression vdac2 deficiency elicit uncontrolled ifnγ induce bak activation mitochondrial damage . consequently mitochondrial dna be aberrantly release cytosol trigger robust activation cgas sting signal type   ifn response . importantly co deletion sting signal component dampen therapeutic effect vdac2 depletion tumour cell suggest that target vdac2 integrate cd8(+ t cell- ifnγ mediate adaptive immunity tumour intrinsic innate   immune like response . together finding reveal vdac2 dual action target to overcome tumour immune evasion establish importance coordinately destruct inflame tumour to enable efficacious cancer immunotherapy .	Nature	19/03/2025
10.1016/j.cmet.2025.02.007	dietary timing enhance exercise modulate fat muscle crosstalk adipocyte	Chen J, Xiang J, Zhou M, Huang R, Zhang J, Cui Y, Jiang X, Li Y, Zhou R, Xin H, Li J, Li L, Lam SM, Zhu J, Chen Y, Yang Q, Xie Z, Shui G, Deng F, Zhang Z, Li MD	feed rhythm regulate exercise performance muscle energy metabolism . however mechanism regulate adipocyte function remain unclear . here use multi omics analysis involve phospho-)proteomic lipidomic find day restrict feeding drf regulate diurnal rhythm mitochondrial proteome neutral lipidome nutrient sense pathway mouse gonadal white adipose tissue gwat . adipocyte specific knockdown prkaa2 gene encode ampkα2 impairs physical endurance . defect be associate altered rhythmicity acyl coenzyme a coa metabolism relate gene loss rhythmicity gwat lipidome circadian remodeling serum metabolite particular lactate succinate . also find that adipocyte prkaa2 regulate muscle clock gene drf . notably oral administration ampk activator c29 increase endurance muscle function time day manner require intact adipocyte ampkα2 signaling . collectively work define adipocyte ampkα2 signal critical regulator circadian metabolic coordination fat muscle thereby enhance exercise performance .	Cell metabolism	12/03/2025
10.1016/S0140-6736(24)02840-X	global regional national burden household air pollution 1990 2021		background despite substantial reduction use solid fuel cook worldwide exposure household air pollution hap remain lead global risk factor contribute considerably burden disease . present comprehensive analysis spatial pattern temporal trend exposure attributable disease 1990 2021 feature substantial methodological update compare previous iteration global burden diseases injuries risk factors study include improved exposure estimation account specific fuel type . method estimate hap exposure trend attributable burden cataract chronic obstructive pulmonary disease ischaemic heart disease low respiratory infection tracheal cancer bronchus cancer lung cancer stroke type 2 diabetes cause mediate adverse reproductive outcome 204 country territory 1990 2021 . first estimate mean fuel type specific concentration μg m(3 fine particulate matter pm(2·5 pollution to individual use solid fuel cooking be expose categorise fuel type location year age sex . use systematic review epidemiological literature newly develop meta regression tool meta regression bayesian regularise trimmed derive disease specific non parametric exposure response curve to estimate relative risk function pm(2·5 concentration . combine exposure estimate relative risk to estimate population attributable fraction attributable burden cause sex age location year . finding 2021 2·67 billion 95 uncertainty interval ui 2·63 2·71 people 33·8 95 ui 33·2 34·3 global population be expose hap source mean concentration 84·2 μg m(3 . although figure show notable reduction percentage global population expose 1990 56·7 56·4 57·1 absolute term have be only decline 0·35 billion 10 3·02 billion people expose hap 1990 . 2021 111 million 95 ui 75·1 164 global disability adjust life year daly be attributable hap account 3·9 95 ui 2·6 5·7 daly . rate global hap attributable daly 2021 be 1500·3 95 ui 1028·4 2195·6 age standardise daly 100   000 population decline 63·8 since 1990 when hap attributable dalys comprise 4147·7 3101·4 5104·6 age standardise daly 100   000 population . hap attributable burden remain high sub saharan africa south asia 4044·1 3103·4 5219·7 3213·5 2165·4 4409·4 age standardise daly 100   000 population respectively . rate hap attributable daly be high male 1530·5 1023·4 2263·6 female 1318·5 866·1 1977·2 . approximately one third hap attributable burden 518·1 410·1 641·7 be mediate short gestation low birthweight . decomposition trend driver change hap attributable burden highlight that decline exposure be counteract population growth most region world especially sub saharan africa . interpretation although burden attributable hap have decrease considerably hap remain substantial risk factor especially sub saharan africa south asia . comprehensive estimate hap exposure attributable burden offer robust reliable resource health policy maker practitioner to precisely target tailor health intervention . give persistent substantial impact hap many region country be imperative to accelerate effort to transition under resource community clean household energy source . such initiative be crucial mitigate health risk promote sustainable development ultimately improve quality life health outcome million people . funding bill amp melinda gates foundation .	Lancet (London, England)	18/03/2025
10.1016/j.cell.2025.02.014	ligand induce ubiquitination unleash lag3 immune checkpoint function	Jiang Y, Dai A, Huang Y, Li H, Cui J, Yang H, Si L, Jiao T, Ren Z, Zhang Z, Mou S, Zhu H, Guo W, Huang Q, Li Y, Xue M, Jiang J, Wang F, Li L, Zhong Q, Wang K, Liu B, Wang J, Fan G, Guo J, Chen L, Workman CJ, Shen Z, Kong Y, Vignali DAA, Xu C, Wang H	lymphocyte activation gene 3 lag3 have emerge promising cancer immunotherapy target mechanism underlie lag3 activation upon ligand engagement remain elusive . here lag3 be find to undergo robust non k48 link polyubiquitination upon ligand engagement promote lag3&#x27;s inhibitory function instead cause degradation . ubiquitination could be trigger engagement major histocompatibility complex class ii mhc class ii membrane bind not soluble fibrinogen like protein 1 fgl1 . lag3 ubiquitination mediate redundantly e3 ligase c cbl cbl b disrupt membrane binding juxtamembrane basic residue rich sequence thereby stabilize lag3 cytoplasmic tail membrane dissociate conformation enable signaling . furthermore lag3 ubiquitination be crucial lag3 mediate suppression antitumor immunity   vivo . consistently lag3 therapeutic antibodie repress lag3 ubiquitination correlate checkpoint blockade effect . moreover patient cohort analysis suggest that lag3 cbl coexpression could serve biomarker response lag3 blockade . collectively study reveal immune checkpoint trigger mechanism translational potential cancer immunotherapy .	Cell	06/03/2025
10.1126/sciimmunol.adm8251	dnmt1 inhibition reprogram t cell nk like cell potent antitumor	Li Y, Wang J, Zhou L, Gu W, Qin L, Peng D, Li S, Zheng D, Wu Q, Long Y, Yao Y, Lin S, Sun M, Zhang X, Wang J, Liu P, Kong X, Li P	inactivation transcription factor bcl11b reprogram t cell induce t nk cell itnk . however remain unclear how bcl11b suppresse natural killer nk cell transcriptional program . here identify that dna methyltransferase dnmt1 physically interact bcl11b increase bcl11b stability fidelity dna methylation maintenance nk cell relate gene thereby repress expression . moreover dnmt1 maintain epigenetic silencing distinct subset nk cell relate gene independent bcl11b. dnmt1 inhibition depletion reprogram t cell chimeric antigen receptor car)-t cell nk like cell exhibit more robust antitumor effect bcl11b deficient itnk parental car t cell . moreover h3k27me3 trimethylation histone 3 lysine 27 synergize dna methylation to repress nk cell relate pathway combine ezh2 enhancer zeste homolog 2 dnmt1 inhibition potentiate reprogramming cytotoxicity nk like cell . finding uncover molecular mechanism safeguard t cell identity provide rationale derive nk like cell epigenetic inhibitor cancer immunotherapy .	Science immunology	21/03/2025
10.1007/s13304-025-02111-6	protective ileostomy creation anterior resection rectum picarr	Balla A, Saraceno F, Rullo M, Morales-Conde S, Targarona Soler EM, Di Saverio S, Guerrieri M, Lepiane P, Di Lorenzo N, Adamina M, Alarcón I, Arezzo A, Bollo Rodriguez J, Boni L, Biondo S, Carrano FM, Chand M, Jenkins JT, Davies J, Delgado Rivilla S, Delrio P, Elmore U, Espin-Basany E, Fichera A, Lorente BF, Francis N, Gómez Ruiz M, Hahnloser D, Licardie E, Martinez C, Ortenzi M, Panis Y, Pastor Idoate C, Paganini AM, Pera M, Perinotti R, Popowich DA, Rockall T, Rosati R, Sartori A, Scoglio D, Shalaby M, Simó Fernández V, Smart NJ, Spinelli A, Sylla P, Tanis PJ, Valdes Hernandez J, Wexner SD, Sileri P	previous survey expert surgeon&#x27;s decision make process dmp protective ileostomy pi creation anterior resection be investigate . base previous datum multiple choice questionnaire have be develop . aim be to perform quantitative analysis result obtain international survey to describe clinical practice worldwide . ten question be relate participants&#x27 demographic 20 question 17 likert scale question investigate dmp regard pi creation . to evaluate tendency answer likert type question mean answer obtain be compare mean point likert scale . survey be complete 1019 physician . neoadjuvant chemoradiotherapy distance anastomosis anal verge   ≤   10   cm be consider alone sufficient to justify creation pi statistically significant difference comparison mean point scale p   =    lt   0.0001 case . total mesorectal excision alone be not consider factor sufficient to create pi p   =   0.416 . most participant agree to define approach to create pi quot;tailored&quot patients&#x27 risk factor p   =    lt   0.0001 quot;influence experience&quot case patient low moderate risk anastomotic leakage p   =    lt   0.0001 . study provide useful insight worldwide clinical practice regard creation pi follow anterior resection . give lack standardization evidence base guideline analysis may be helpful to assist surgeons&#x27 practice .	Updates in surgery	23/03/2025
10.1016/j.ahj.2025.03.009	association vasopressin administration mortality patient	Sarma D, Smith R, Padkins M, Rali AS, Vallabhajosyula S, Khanna AK, Kashani K, Hibbert B, Jentzer JC	background utility vasopressin adjunctive catecholamine spare vasopressor cardiogenic shock cs have not be widely examine . method include consecutive adult patient admit diagnosis cs require vasopressor . high dose vasopressor hdv be define ≥0.3 mcg kg min norepinephrine equivalent . multivariable logistic regression propensity analysis be use to calculate odd ratio or 95 confidence interval ci value hospital mortality before adjustment relevant covariate . result include 721 cs patient include hdv 32.5 . vasopressin be administer 207 29 patient first 24 hour . hospital mortality occur 38.1 be high hdv group 56.8 vs. 29.2 . vasopressin be associate low propensity adjust hospital mortality adjust 0.59 95 ci 0.35 0.99 p   =   0.05 . vasopressin use be also associate low mortality hdv group unadjusted 0.54 95 ci 0.32 0.92 p   =   0.02 . conclusion vasopressin use first 24 hour be associate low adjust mortality patient cs particularly require hdv . use vasopressin cs merit dedicate prospective evaluation .	American heart journal	20/03/2025
10.1186/s12967-025-06357-x	explore protective effect metformin sarcopenia insight	Hu Y, Lu S, Xue C, Hu Z, Wang Y, Zhang W, Wang D, Wang J, Ding G, Yu J, Hu Y, Liu Y	background impact metformin sarcopenia remain uncertain . study aim to investigate whether metformin influence sarcopenia risk evaluate effect potential drug target sarcopenia trait . methods analyze datum national health nutrition examination survey nhanes n   =   3549 to assess association metformin use sarcopenia risk elderly patient type 2 diabetes . mendelian randomization mr analysis use genome wide association study gwas uk biobank n   =   1,366,167 finngen n   =   218,007 expression quantitative trait loci eqtl instrumental variable examine causal effect metformin relate target sarcopenia trait while molecular docking explore interaction metformin drug target . result metformin use be associate increase grip strength   =   2.46 95 ci 1.49 2.38 skeletal muscle mass   =   1.24 95 ci 0.20 2.28 as well reduce mortality hr   =   0.62 95 ci 0.54 0.71 . mr analysis suggest possible link gdf15 gene expression sarcopenia trait evidence genetic confounding . molecular docking indicate stable binding metformin gdf15 . conclusion study suggest that metformin may lower sarcopenia risk particularly elderly patient type 2 diabetes gdf15 identify promising target sarcopenia treatment .	Journal of translational medicine	21/03/2025
10.1038/s41586-025-08717-5	oncolytic virus vg161 refractory hepatocellular carcinoma .	Shen Y, Bai X, Zhang Q, Liang X, Jin X, Zhao Z, Song W, Tan Q, Zhao R, Jia W, Gu S, Shi G, Zheng Z, Wei G, Wang Y, Fang T, Li Y, Wang Z, Yang Z, Guo S, Lin D, Wei F, Wang L, Sun X, Qin A, Xie L, Qiu Y, Bao W, Rahimian S, Singh M, Murad Y, Shang J, Chu M, Huang M, Ding J, Chen W, Ye Y, Chen Y, Li X, Liang T	hepatocellular carcinoma remain life threaten malignancy limited therapeutic option follow failure second line treatments(1,2 . oncolytic virus selectively replicate lyse cancer cell release neoantigen stimulate systemic antitumour immunity(3 offer potential therapeutic option . here present result multicentre phase 1 clinical trial evaluate vg161 engineer oncolytic herpe simplex virus express il-12 il-15 il-15rα pd-1 pd l1 block fusion protein(4 safety efficacy patient advanced liver cancer . vg161 be well   tolerate dose limit toxicity observe demonstrate promise efficacy reshape tumour immune microenvironment re sensitizing tumour be previously resistant systemic treatment . notably also find that patient have previously be sensitive to checkpoint inhibitor therapy show enhanced efficacy vg161 treatment . furthermore develop efficacy prediction model base differentially express gene successfully identify patient be likely to benefit vg161 predict prolong overall survival . finding position vg161 promising third line therapeutic option refractory hepatocellular carcinoma . provide new avenue treatment advance field oncolytic virus base immunotherapy . clinicaltrials.gov registration nct04806464 .	Nature	19/03/2025
10.1016/j.cell.2025.02.021	turnover atla proteome phosphoproteome mouse tissue brain	Li W, Dasgupta A, Yang K, Wang S, Hemandhar-Kumar N, Chepyala SR, Yarbro JM, Hu Z, Salovska B, Fornasiero EF, Peng J, Liu Y	understand how protein different mammalian tissue be regulate be central biology . protein abundance turnover post translational modification such phosphorylation be key factor determine tissue specific proteome property . however property be challenge to study tissue remain poorly understand . here present turnover ppt comprehensive resource mapping abundance lifetime 11,000 protein 40,000 phosphosite eight mouse tissue various brain region use advanced proteomic stable isotope labeling . reveal tissue specific short- long live protein strong correlation interact protein lifetime distinct impact phosphorylation protein turnover . notably discover remarkable pattern turnover change peroxisome protein specific tissue phosphorylation regulate stability neurodegeneration relate protein such tau α synuclein . thus turnover ppt provide fundamental insight protein stability tissue dynamic proteotype functional protein phosphorylation be accessible interactive web base portal https://yslproteomics.shinyapps.io/tissueppt .	Cell	14/03/2025
10.1016/j.cmet.2025.02.009	remote limb ischemic conditioning alleviate steatohepatitis extracellular	Zhao Y, Gao L, Chen J, Wei J, Lin G, Hu K, Zhao W, Wei W, Huang W, Gao L, Yuan A, Qian K, Chen AF, Pu J	metabolic dysfunction associate steatohepatitis mash be advanced form liver disease adverse outcome . manipulate interorgan communication be consider promising strategy manage metabolic disease include steatohepatitis . here report that remote limb ischemic conditioning ric clinically validate therapy distant organ protection transient muscle ischemia significantly alleviate steatohepatitis different mouse model . beneficial effect limb ischemic conditioning be mediate muscle liver transfer small extracellular vesicle sevs cargo micrornas lead elevation mir-181d-5p liver . hepatic mir-181d-5p overexpression faithfully mirror molecular histological benefit limb ischemic conditioning suppress nuclear receptor 4a3 nr4a3 . furthermore circulate ev human volunteer undergo limb ischemic conditioning improve steatohepatitis transcriptomic perturbation primary human hepatocyte animal model . datum underscore translational potential limb ischemic conditioning steatohepatitis management extend understanding muscle liver crosstalk .	Cell metabolism	18/03/2025
10.1038/s41586-025-08741-5	matrix produce neutrophil populate shield skin .	Vicanolo T, Özcan A, Li JL, Huerta-López C, Ballesteros I, Rubio-Ponce A, Dumitru AC, Nicolás-Ávila JÁ, Molina-Moreno M, Reyes-Gutierrez P, Johnston AD, Martone C, Greto E, Quílez-Alvarez A, Calvo E, Bonzon-Kulichenko E, Álvarez-Velez R, Chooi MY, Kwok I, González-Bermúdez B, Malleret B, Espinosa FM, Zhang M, Wang YL, Sun D, Zhen Chong S, El-Armouche A, Kim KK, Udalova IA, Greco V, Garcia R, Vázquez J, Dopazo A, Plaza GR, Alegre-Cebollada J, Uderhardt S, Ng LG, Hidalgo A	defence environmental threat be provide physical barrier confer mechanical protection prevent entry microorganisms(1 . if microorganism overcome barrier however innate immune cell use toxic chemical to kill invade cells(2,3 . here examine immune diversity tissue identify population neutrophil skin express broad repertoire protein enzyme need to build extracellular matrix . naive skin matrix produce neutrophil contribute composition structure extracellular matrix reinforce mechanical property promote barrier function . injury neutrophil build x27;rings&#x27 matrix wound shield foreign molecule bacteria . structural program rely tgfβ signal disable tgfβ receptor neutrophil impair ring formation wound facilitate bacterial invasion . infer that innate immune system have evolve diverse strategy defence include one physically shield host outside world .	Nature	19/03/2025
10.1016/j.placenta.2004.10.002	human placental explant culture approach assessment .	Miller RK, Genbacev O, Turner MA, Aplin JD, Caniggia I, Huppertz B	placental explant culture vitro be useful study tissue function include cellular uptake production release secretory component cell interaction proliferation growth differentiation gene delivery pharmacology toxicology disease process . variety culture condition be require to mimic utero environment different time gestation include differ oxygen partial pressure extracellular matrix culture medium . optimization explant method be examine first third trimester human placental tissue biological process investigation .	Placenta	01/07/2005
10.1161/CIRCULATIONAHA.124.072226	natural history clinical outcome patients dsg2 dsc2 variant relate	Chen L, Hu Y, Saguner AM, Bauce B, Liu Y, Shi A, Guan F, Chen Z, Bueno Marinas M, Wu L, Foltran D, Hermida A, Fressart V, Pinci S, Celeghin R, Chen Z, Zhang B, Yubi L, Liu X, Cason M, Martini M, Rigato I, Brunckhorst C, Biller R, Basso C, Yang B, Zhao X, Cadrin-Tourigny J, Gasperetti A, James CA, Zhou X, Gandjbakhch E, Pilichou K, Duru F, Hu S	background genetic variant desmosomal cadherin desmoglein 2 dsg2 desmocollin 2 dsc2 cause distinct form arrhythmogenic right ventricular cardiomyopathy arvc remains poorly report . study aim to provide comprehensive description phenotypic expression natural history clinical outcome patient arvc subset . methods genetic clinical datum dsg2 dsc2 variant carrier be collect 5 country europe asia . assess phenotypic profile patient clinical outcome focus heart failure ventricular arrhythmia event . result overall 271 subject 254 dsg2 variant be include study median age 38 year interquartile range 25 52 62.7 male . 165 be proband 200 be diagnose definite arvc . total 181 66.8 individual carry missense variant mainly distribute extracellular domain . notably include 78 28.8 individual multiple variant . 200 case diagnose arvc 41 20.5 experience premature cardiac death age 65 . 81 individual leave ventricular ejection fraction right ventricular fractional area change datum be available presentation 29 35.8 have isolate right ventricular dysfunction 16 19.8 have biventricular dysfunction . single variant carrier engage intense physical exercise be young disease onset compare do not p=0.001 . compare single variant carrier multiple variant be more likely to be diagnose arvc 96.2 versus 64.8 p&lt;0.001 exhibit more severe left ventricular dysfunction 44.4 versus 22.1 p=0.001 right ventricular dilation 88.9 versus 55.8 p&lt;0.001 . multiple variant carrier be significantly young arvc diagnosis compare single variant carrier 33 18 49 year versus 42 27 54 year p&lt;0.001 . follow up end stage heart failure p&lt;0.001 malignant ventricular arrhythmia p=0.004 be significantly more frequent multiple variant compare single variant carrier . compare pkp2 patient dsg2 dsc2 patient exhibit significantly high risk end stage heart failure p&lt;0.001 . conclusion arvc attributable variant desmosomal cadherin mostly present right ventricular biventricular disease . multiple variant be common patient be associate more frequent clinical penetrance early onset disease adverse clinical outcome .	Circulation	24/03/2025
10.1016/j.molcel.2025.02.022	β hydroxybutyrate facilitate mitochondrial derive vesicle biogenesis	Tang M, Tu Y, Gong Y, Yang Q, Wang J, Zhang Z, Qin J, Niu S, Yi J, Shang Z, Chen H, Tang Y, Huang Q, Liu Y, Billadeau DD, Liu X, Dai L, Jia D	mitochondrial dynamic metabolite reciprocally influence other . mitochondrial derive vesicle mdvs transport damage mitochondrial component to lysosome extracellular space . while many metabolite be know to modulate mitochondrial dynamic be largely unclear whether be involve mdv generation . here discover that major component ketone body β hydroxybutyrate bhb improve mitochondrial function facilitate biogenesis mdvs . mechanistically bhb drive specific lysine β hydroxybutyrylation kbhb sort nexin-9 snx9 key regulator mdv biogenesis . kbhb increase snx9 interaction inner mitochondrial membrane imm)/matrix protein promote formation imm matrix mdvs . snx9 kbhb be not only critical maintain mitochondrial homeostasis cell also protect mouse alcohol induce liver injury . altogether research uncover fact that metabolite influence formation mdvs directly engage post translational modification key protein machinery establish framework understand how metabolite regulate mitochondrial function .	Molecular cell	14/03/2025
10.1073/pnas.2409325122	trans synaptic modulation cholinergic circuit tune opioid reinforcement .	Zucca S, Brunori G, Dunn HA, Lankford CK, Sutton LP, Algibez Flores B, Maza NA, Sial O, Crynen G, Luján R, Martemyanov KA	opioid trigger structural functional neural adaptation reward circuit lead dependence . synaptic cell adhesion molecule cam play pivotal role circuit organization present prime candidate orchestrate remodeling neural connection response drug exposure . however contribution cam opioid induce rewiring reward circuit have not be explore . here use unbiased molecular profiling to identify cam nucleus accumben nac modulate morphine administration . find that opioid exposure induce expression elfn1 cam selectively express cholinergic interneuron nac . determine that elfn1 act tran synaptically to modulate strength plasticity glutamatergic input cholinergic neuron recruitment presynaptic metabotropic glutamate receptor 4 mglu4 . disruption elfn1 diminish morphine reward intake self administer mouse . together finding identify key molecular factor responsible adjust strength opioid effect modulate configuration striatal circuitry experience dependent fashion unveil potential therapeutic target combat opioid abuse .	Proceedings of the National Academy of Sciences of the United States of America	25/03/2025
10.1126/science.ads8738	cell architecture mitochondrial respiratory chain .	Waltz F, Righetto RD, Lamm L, Salinas-Giegé T, Kelley R, Zhang X, Obr M, Khavnekar S, Kotecha A, Engel BD	mitochondria regenerate adenosine triphosphate atp oxidative phosphorylation . process be carry five membrane bind complex collectively know respiratory chain work concert to transfer electron pump proton . precise organization complex native cell be debate . use situ cryo electron tomography to visualize native structure organization several major mitochondrial complex chlamydomonas reinhardtii cell . atp synthase respiratory complex segregate curved flat crista membrane domain respectively . respiratory complex iii iv assemble respirasome supercomplex determine native 5 angstrom å resolution structure show binding electron carrier cytochrome c. combine single particle cryo electron microscopy 2.4 å resolution model how respiratory complex organize inside native mitochondria .	Science (New York, N.Y.)	21/03/2025
10.1016/j.cell.2025.02.018	genetic protection type 1 diabete result accelerated insulin mrna	van Tienhoven R, O&#x27;Meally D, Scott TA, Morris KV, Williams JC, Kaddis JS, Zaldumbide A, Roep BO	insulin gene ins variation beta cell stress be associate risk development type 1 diabetes t1d autoimmunity insulin . unfolded protein response alleviate endoplasmic reticulum er stress involve activation inositol require enzyme 1α ire1α impede translation mrna decay . discover that ire1α digestion motif be present insulin mrna carry snp rs3842752 g&gt;a . snp 3&#x27 untranslated region ins associate protection t1d ins(p . er stress beta cell ins(p lead to accelerate insulin mrna decay compare susceptible ins variant ins(s . human islet ins(p show improved vitality function reversed diabete more rapidly when transplant diabetic mouse islet carry ins(s only . surrogate beta cell ins(p express less er stress ins drip neoantigen . explanation genetic protection t1d may act instead concert previously propose mechanism attribute ins promoter polymorphism .	Cell	11/03/2025
10.1186/s12933-025-02693-w	association triglyceride glucose body mass index trajectory	Tang H, Huang J, Zhang X, Chen X, Yang Q, Luo N, Lin H, Hong J, Wu S, Tian C, Lin M, Tang J, Wen J, Chen P, Jiang L, Zhang Y, Yi K, Tan X, Chen Y	background although study have examine association triglyceride glucose body mass index tyg bmi cardiovascular outcome cardio renal metabolic crm background none have explore role progression crm multimorbidity . addition prior research be limit small sample size failure to account competitive effect other crm disease . method study datum obtain large scale prospective uk biobank cohort be use . crm multimorbidity be define new onset ischemic heart disease type 2 diabete mellitus chronic kidney disease follow up . multivariable cox regression be use to analyse independent association tyg bmi crm multimorbidity first double triple crm disease . c statistic be calculate model restrict cubic spline be apply to assess dose response relationship . multi state model be use to investigate association tyg bmi trajectory crm multimorbidity baseline crm disease first crm disease first crm disease double disease double disease triple disease disease specific analysis . result study include 349,974 participant mean age 56.05 standard deviation sd 8.08 55.93 be female . median follow up approximately 14   year 56,659 16.19 participant baseline crm disease develop least one crm disease include 8451 14.92 progress double crm disease 789 9.34 far develop triple crm disease . crude model sd increase tyg bmi be associate 47 high risk first crm disease 72 high risk double crm disease 95 high risk triple crm disease c statistic 0.625 0.694 0.764 respectively . multi state model analysis show 32 increase risk new crm disease 24 increase risk progression double crm disease 23 increase risk further progression double crm disease . tyg bmi be significantly associate onset individual first crm disease except stroke transition double crm disease . significant interaction be also observe tyg bmi remained significantly associate crm multimorbidity subgroup . sensitivity analysis include vary time interval enter state expand crm definition include atrial fibrillation heart failure peripheral vascular disease obesity dyslipidaemia confirm finding . conclusion tyg bmi remarkably influence onset progression crm multimorbidity . incorporate crm multimorbidity prevention management could have important public health implication .	Cardiovascular diabetology	21/03/2025
10.1016/S1474-4422(25)00024-9	safety efficacy long term gantenerumab treatment dominantly inherit	Bateman RJ, Li Y, McDade EM, Llibre-Guerra JJ, Clifford DB, Atri A, Mills SL, Santacruz AM, Wang G, Supnet C, Benzinger TLS, Gordon BA, Ibanez L, Klein G, Baudler M, Doody RS, Delmar P, Kerchner GA, Bittner T, Wojtowicz J, Bonni A, Fontoura P, Hofmann C, Kulic L, Hassenstab J, Aschenbrenner AJ, Perrin RJ, Cruchaga C, Renton AE, Xiong C, Goate AA, Morris JC, Holtzman DM, Snider BJ, Mummery C, Brooks WS, Wallon D, Berman SB, Roberson E, Masters CL, Galasko DR, Jayadev S, Sanchez-Valle R, Pariente J, Kinsella J, van Dyck CH, Gauthier S, Hsiung GR, Masellis M, Dubois B, Honig LS, Jack CR, Daniels A, Aguillón D, Allegri R, Chhatwal J, Day G, Fox NC, Huey E, Ikeuchi T, Jucker M, Lee JH, Levey AI, Levin J, Lopera F, Roh J, Rosa-Neto P, Schofield PR	background amyloid plaque removal monoclonal antibody therapy slow clinical progression symptomatic alzheimer&#x27;s disease however potential delay onset clinical symptom asymptomatic people be unknown . dominantly inherited alzheimer network trials unit dian tu be ongoing platform trial assess safety efficacy multiple investigational product participant dominantly inherit alzheimer&#x27;s disease diad . base finding amyloid removal downstream biological effect gantenerumab group platform trial continue 3 year open label extension ole study to assess safety efficacy long term treatment high dose gantenerumab . methods randomised placebo control double blind phase 2/3 multi arm trial dian tu-001 assess solanezumab gantenerumab versus placebo participant be 15 year before 10 year estimate year to symptom onset have clinical dementia rating cdr global score 0 cognitively normal 1 mild dementia . study be follow ole study gantenerumab treatment conduct 18 study site australia canada france ireland puerto rico spain uk usa . inclusion ole participant risk diad have participate double blind period dian tu-001 be require to know mutation status . investigate increase dose subcutaneous gantenerumab 1500 mg 2 week . lack regulatory path gantenerumab study be stop early prespecifie interim analysis when most participant have complete 2 year treatment clinical measure cdr sum boxes cdr sb . primary outcome final analysis be amyloid plaque measure 11)c pittsburgh compound b positron emission tomography pib pet standardise uptake value ratio suvr pib pet suvr 3 year assess modify intention treat group mitt define participant receive gantenerumab treatment post ole baseline have at least one pib pet suvr assessment gantenerumab treatment post baseline assessment . participant receive at least one dose study drug ole be include safety analysis . dian tu-001 nct01760005 ole nct06424236 be register clinicaltrials.gov . finding 74 participant be recruit ole study june 3 2020 april 22 2021 73 be enrol receive gantenerumab treatment . 47 64 stop dose early termination study sponsor 13 18 prematurely discontinue study other reason 13 people complete 3 year treatment . mitt group primary analysis comprise 55 participant . interim analysis hazard ratio clinical decline cdr sb asymptomatic mutation carrier be 0·79 n=53 95 ci 0·47 1·32 participant be treat gantenerumab double blind ole period gant 0·53 n=22 0·27 to 1·03 participant be treat gantenerumab long longest gant . final analysis adjusted mean change ole baseline to year 3 pib pet suvr be -0·71 suvr 95 ci -0·88 to -0·53 p&lt;0·0001 . amyloid relate imaging abnormality occur 53 39 73 participant 47 34 73 microhaemorrhage 30 22 73 oedema 6 five 73 be associate superficial siderosis . treatment associate macrohaemorrhage death occur . interpretation partial short term amyloid removal do not show significant clinical effect . however long term full amyloid removal potentially delay symptom onset dementia progression . conclusion be limit ole design use external control need to be confirm long term trial . funding national institute aging alzheimer&#x27;s association ghr foundation f hoffmann la roche genentech .	The Lancet. Neurology	01/04/2025
10.1093/ckj/sfaf057	causal relationship immune cell phenotype primary glomerular	Tang W, Li Q, Yang X, Yang H	background primary glomerular disease pgds include nephrotic syndrome ns membranous nephropathy mn iga nephropathy igan be complex renal condition influence immune system dysregulation . although association immune cell phenotype pgd have be observe precise causal relationship have not be fully elucidate . method utilize genetic association datum genome wide association study gwas investigate 731 immunophenotype relation pgd . bidirectional two sample mendelian randomization mr approach primarily employ inverse variance weighting ivw be conduct to establish causality . mr egger weight median simple mode weight mode be use complementary method to reinforce robustness validity result . sensitivity analysis far validate sensitivity stability result . result identify 38 immunophenotype suggestively relate igan 20 risk factor 18 protective effect . six immunophenotype remain significant bonferroni correction percentage cd25hi t cell percentage cd25hi cd45ra(- cd4 not t regulatory treg t cell percentage cd25hi cd45ra(- cd4 not treg cd4(+ t cell population cx3cr1 expression monocyte cd40 expression monocyte cd64 expression cd14(+ cd16(- monocyte . validation analysis igan cd3 expression effector memory cd4(+ t cell far confirm predispose risk role effector memory t cell development igan . additionally mr analysis demonstrate suggestive association 25 immunophenotype mn 8 risk factor 17 protective factor as well 22 immunophenotype ns 10 risk factor 12 protective factor . last intersect immunophenotype show suggestive association pgd identify two common immunophenotype share igan mn three igan ns one mn ns . conclusion genetic level investigation uncover causal association immunophenotype pgd provide valuable insight immunological underpinning pgd . finding suggest potential target treatment strategy thereby facilitate more personalized effective therapeutic approach pgd management .	Clinical kidney journal	01/03/2025
10.1007/978-1-0716-3854-5_2	use 3 dimensional cultures to propagate genetically modified lung organoids .	Chen F, Naughton KJ, Lee JH, Brainson CF	transformed lung organoid have extensive application lung cancer modeling drug screening . traditional two dimensional 2d culture fail to propagate large subpopulation murine primary tumor vitro . however three dimensional 3d air liquid interface ali culture be employ to grow normal lung organoid can be use to efficiently culture cancerous lung tumor cell . here detail procedure cultivate genetically modify lung organoid 3d ali culture . protocol contain two part . first part describe how to transduce lung epithelial cell be freshly sort lung actively grow murine organoid virus order to modify gene expression . target lung cell be incubate virus 1 2   h transduction . then transduce cell be thoroughly wash mix stromal support cell matrigel be load transwell insert culture validate genetic modification downstream assay . second part describe how to isolate tumor cell grow orthotopically genetically engineer mouse model to produce organoid cell line can be use ex vivo drug discovery assay . protocol tumor be isolate lung mouse finely chop wash . then tumor chunk be mix matrigel 3d ali culture . finally organoid bud tumor chunk be trypsinize passage to establish organoid line . together two protocol provide promising platform to study genesis progression treatment lung cancer .	Methods in molecular biology (Clifton, N.J.)	01/01/2024
10.1038/s41590-025-02103-z	enhance human nk cell antitumor function knock smad4 to counteract	Rea A, Santana-Hernández S, Villanueva J, Sanvicente-García M, Cabo M, Suarez-Olmos J, Quimis F, Qin M, Llorens E, Blasco-Benito S, Torralba-Raga L, Perez L, Bhattarai B, Alari-Pahissa E, Georgoudaki AM, Balaguer F, Juan M, Pardo J, Celià-Terrassa T, Rovira A, Möker N, Zhang C, Colonna M, Spanholtz J, Malmberg KJ, Montagut C, Albanell J, Güell M, López-Botet M, Muntasell A	transform growth factor beta tgfβ activin suppress natural killer nk cell function proliferation limit efficacy adoptive nk cell therapy . inspire partial resistance tgfβ nk cell smad4 haploinsufficiency use crispr cas9 knockout smad4 human nk cell . here show that smad4(ko nk cell be resistant tgfβ activin inhibition retain cytotoxicity cytokine secretion interleukin-2 interleukin-15 drive proliferation . show enhanced tumor penetration tumor growth control monotherapy combination tumor target therapeutic antibody . notably smad4(ko nk cell outperform control nk cell treat tgfβ inhibitor underscore benefit maintain smad4 independent tgfβ signal . smad4(ko confer tgfβ resistance diverse nk cell platform include cd19 car nk cell stem cell derive nk cell adapt nk cell . finding position smad4 knockout versatile compelling strategy to enhance nk cell antitumor activity provide new avenue improve nk cell base cancer immunotherapy .	Nature immunology	21/03/2025
10.2337/dc24-2535	association diabetes anemia evidence nhanes uk biobank .	Wang D, Morton JI, Salim A, Shaw JE, Magliano DJ	objective to explore association diabete anemia . research design method include 9,026 389,616 participant u.s. national health nutrition examination surveys uk biobank study ukb respectively . multivariable logistic regression be use to examine cross sectional association diabete anemia as define hemoglobin measurement . ukb follow up multivariable cox proportional hazard regression be perform to estimate hazard ratio hrs 95 ci incident anemia as define hemoglobin level diagnosis record relation diabetes . far assess impact inflammation renal dysfunction medication use association population . result white people age 40 69 year u.s. u.k. adjust odd study participant diagnose diabete also have anemia be two to four time high normal glycemia . median follow up 13.6 year ukb 42,354 people develop anemia . adjusted hrs incident anemia compare diagnose diabete normal glycemia be 3.05 95 ci 2.90 3.21 iron deficiency anemia 3.02 95 ci 2.51 3.63 anemia chronic disease 4.88 95 ci 4.23 5.63 vitamin b12 deficiency anemia . further adjustment inflammation renal dysfunction medication use partially attenuate association remain strong significant . conclusion diabetes be associate several major type anemia . further study be warrant to identify mechanism .	Diabetes care	21/03/2025
10.1016/j.cmet.2025.02.008	pyruvate metabolism enzyme dlat promote tumorigenesis suppress leucine	Wang N, Lu S, Cao Z, Li H, Xu J, Zhou Q, Yin H, Qian Q, Zhang X, Tao M, Jiang Q, Zhou P, Zheng L, Han L, Li H, Yin L, Gu Y, Dou X, Sun H, Wang W, Piao HL, Li F, Xu Y, Yang W, Chen S, Liu J	pyruvate branch chain amino acid bcaa metabolism be pivotal pathway tumor progression intricate interplay implication tumor progression remain elusive . research reveal that dihydrolipoamide s acetyltransferase dlat pyruvate metabolism enzyme promote leucine accumulation sustain mammalian target rapamycin mtor complex activation hepatocellular carcinoma hcc . mechanistically dlat directly acetylate k109 residue au rna bind methylglutaconyl coenzyme a coa hydratase auh critical enzyme leucine catabolism inhibit activity lead to leucine accumulation . notably dlat upregulation correlate poor prognosis patient hcc . therefore develop auh(k109r)-mrna lipid nanoparticle lnp therapeutic strategy effectively inhibit tumor growth restore leucine catabolism inhibit mtor activation   vivo . summary finding uncover dlat&#x27;s unexpected role acetyltransferase auh suppress leucine catabolism . restore leucine catabolism auh(k109r)-mrna lnp effectively inhibit hcc development highlight novel direction cancer research .	Cell metabolism	13/03/2025
10.1038/s41591-025-03592-z	single cell profiling human endometrium polycystic ovary syndrome .	Eriksson G, Li C, Sparovec TG, Dekanski A, Torstensson S, Risal S, Ohlsson C, Hirschberg AL, Petropoulos S, Deng Q, Stener-Victorin E	polycystic ovary syndrome pcos have negative effect receptivity endometrium to embryo implantation increase risk miscarriage endometrial cancer . cellular molecular heterogeneity endometrium woman pcos have not be well study . study present comprehensive cellular atla endometrium proliferative phase woman pcos characterize overweight obesity hyperandrogenism insulin resistance compare control similar age weight body mass index . analysis 247,791 isolate endometrial nucleus 27 biopsy 5 control 12 pcos case baseline 7 16 week metformin 3 lifestyle intervention reveal cell type specific disease signature variation cellular composition localization . sample take 16   week metformin treatment lifestyle management show extensive recovery disease specific endometrial signature . link specific role cell type clinical feature such hyperandrogenism insulin resistance specific cell type to risk endometrial metabolic disease . addition potential therapeutic target such integrin inhibitor be identify role metformin restore endometrial health patient pcos be highlight . finding lie groundwork to significantly advance understanding pcos specific endometrial dysfunction future target therapy .	Nature medicine	20/03/2025
10.1016/j.cell.2025.02.017	asian diversity human immune cell .	Kock KH, Tan LM, Han KY, Ando Y, Jevapatarakul D, Chatterjee A, Lin QXX, Buyamin EV, Sonthalia R, Rajagopalan D, Tomofuji Y, Sankaran S, Park MS, Abe M, Chantaraamporn J, Furukawa S, Ghosh S, Inoue G, Kojima M, Kouno T, Lim J, Myouzen K, Nguantad S, Oh JM, Rayan NA, Sarkar S, Suzuki A, Thungsatianpun N, Venkatesh PN, Moody J, Nakano M, Chen Z, Tian C, Zhang Y, Tong Y, Tan CTY, Tizazu AM, Loh M, Hwang YY, Ho RC, Larbi A, Ng TP, Won HH, Wright FA, Villani AC, Park JE, Choi M, Liu B, Maitra A, Pithukpakorn M, Suktitipat B, Ishigaki K, Okada Y, Yamamoto K, Carninci P, Chambers JC, Hon CC, Matangkasombut P, Charoensawan V, Majumder PP, Shin JW, Park WY, Prabhakar S	relationship human diversity biomedical phenotype be pervasive yet remain understudied particularly single cell genomic context . here present asian immune diversity atlas aida multi national single cell rna sequence scrna seq healthy reference atlas human immune cell . aida comprise 1,265,624 circulate immune cell 619 donor span 7 population group 5 asian country 6 control . though population group be frequently compare continental level find that sub continental diversity age sex pervasively impact cellular molecular property immune cell . include differential abundance cell neighborhood as well cell population gene relevant to disease risk pathogenesis diagnostic . discover functional genetic variant influence cell type specific gene expression be under represent non asian population help contextualize disease associate variant . aida enable analysis multi ancestry disease dataset facilitate development precision medicine effort asia .	Cell	18/03/2025
10.1136/gutjnl-2024-333638	endothelial like cancer associate fibroblast facilitate pancreatic cancer	Sun X, Cai W, Li H, Gao C, Ma X, Guo Y, Fu D, Xiao D, Zhang Z, Wang Y, Yang S, Feng Y, Zhao T, Hao J	background cancer associate fibroblast cafs be highly heterogeneous progression pancreatic ductal adenocarcinoma pdac vasculogenic mimicry vm refer phenomenon cancer cell adopt endothelial like characteristic . objective to identify novel protumoural caf subtype undertake vm . design use single cell rna sequencing mihc to identify fapα(+)cd144(+ endothelial like caf endocafs combine prospective retrospective analysis to assess clinical outcome . tube formation proliferation invasion assay be conduct cell line organoid orthotopic tumour model lsl kras(g12d/+ lsl trp53(r172h/+ pdx1 cre kpc mouse model . mechanically perform cytokine array assay rna sequence ip mass spectrometry chip luciferase analysis . importantly sirna delivery nanosystem be develop to precisely target fapα(+)cd144(+)endocafs vivo . result fapα(+)cd144(+)endocaf be present tumour microenvironment pdac patient high cd144(+)cafs proportion display poor prognosis pdac . fapα(+)cd144(+)endocaf not only acquire vm phenotype to provide metastatic conduit also promote proliferation invasion tumour cell situ paracrine signalling thereby actively facilitate metastasis tumour cell . cd144 β catenin stat3 signal axis be activate cd144 downstream secrete cytokine be transcriptionally upregulated to maintain dual role endocafs . caf target sirna delivery nanosystem load fapα sicd144 be administer to precisely target fapα(+)cd144(+ endocafs substantially inhibit protumoural role vivo . conclusion fapα(+)cd144(+)endocaf can promote metastasis pdac undertake vm paracrine activation cd144 β catenin stat3 signal axis . caf target sirna delivery nanosystem can inhibit tumour progression precisely target fapα(+)cd144(+)endocafs .	Gut	23/03/2025
10.1038/s41422-025-01098-4	nociceptor neuron promote pdac progression cancer pain interaction	Wang K, Ni B, Xie Y, Li Z, Yuan L, Meng C, Zhao T, Gao S, Huang C, Wang H, Ma Y, Zhou T, Feng Y, Chang A, Yang C, Yu J, Yu W, Zang F, Zhang Y, Ji RR, Wang X, Hao J	emerge field cancer neuroscience have demonstrate great progress reveal crucial role nervous system cancer initiation progression . pancreatic ductal adenocarcinoma pdac be characterize perineural invasion modulate autonomic sympathetic parasympathetic sensory innervation . here far demonstrate that tumor microenvironment pdac nociceptor neuron interact cancer associate fibroblast cafs calcitonin gene relate peptide cgrp nerve growth factor ngf . interaction lead inhibition interleukin-15 expression cafs suppress infiltration cytotoxic function natural killer nk cell thereby promote pdac progression cancer pain . pdac patient nociceptive innervation tumor tissue be negatively correlate infiltration nk cell while positively correlate pain intensity . association serve independent prognostic factor overall survival relapse free survival pdac patient . finding highlight crucial regulation nk cell nociceptor neuron interaction caf development pdac . also propose that target nociceptor neuron cgrp signal may offer promising therapy pdac cancer pain .	Cell research	24/03/2025
10.1186/s12967-025-06375-9	global burden biomarker cardiovascular disease attributable	Tang H, Huang J, Lin H, Zhang X, Yang Q, Luo N, Lin M, Tian C, Wu S, Hong J, Wen J, Jiang L, Chen P, Chen X, Tang J, Zhang Y, Yi K, Tan X, Chen Y	background understand evolve pattern cardiovascular disease cvd burden attributable ambient particulate matter pollution apmp be essential . furthermore research underlie mechanism have mostly be limit laboratory animal model few large scale population base study . methods use datum global burden disease study gbd 2021 analyze disability adjust life year mortality for cvd attributable apmp measure particulate matter pm](2.5 1990 2021 . examine shift burden apmp household air pollution hap regional disparity socio demographic index sdi predict trend use bayesian age period cohort model . additionally use uk biobank ukb datum metabolomic 230,000   +   participant proteomic 50,000   + to identify biomarker mediate association pm(2.5 exposure cvd outcome far analyze biological role . metabolic proteomic signature be construct use regression elastic net model predictive performance assess time dependent receiver operate characteristic analysis . life expectancy be evaluate use flexible parametric survival model . subgroup analysis be conduct age sex lifestyle socioeconomic status genetic susceptibility . result 2021 global cvd absolute burden attributable apmp be more double 1990 significant regional disparity . burden shift hap apmp 15 cvd case globally attribute apmp . cvd burden attributable apmp increase age be project to rise 2030 . ukb approximately 30 metabolite include albumin mediate association pm(2.5 exposure cvd outcome primarily involve lipid fatty acids metabolism . 60 protein include growth differentiation factor-15 trefoil factor 2 mediate association cvd outcome enrich cytokine receptor interaction leukocyte migration pathway . metabolic proteomic signature outperform pm(2.5 alone predict 1- 5- 10 year cvd outcome . participant low decile pm(2.5 exposure metabolic proteomic signature have long life expectancy high decile . conclusion cvd burden attributable apmp remain critical public health concern . study present novel approach identify manage susceptible population metabolomic proteomic perspective .	Journal of translational medicine	22/03/2025
10.1097/ALN.0000000000005460	suzetrigine non opioid nav1.8 inhibitor treatment moderate severe	Bertoch T, D&#x27;Aunno D, McCoun J, Solanki D, Taber L, Urban J, Oswald J, Swisher MW, Tian S, Miao X, Correll DJ, Negulescu P, Bozic C, Weiner SG	background opioid be effective treat acute pain have safety tolerability addiction concern while non opioid analgesic have limited efficacy . suzetrigine oral non opioid small molecule selectively inhibit voltage gate sodium channel 1.8 nav1.8 have potential to provide efficacious safe relief acute pain addiction concern . method to evaluate suzetrigine treatment acute pain conduct two phase 3 randomize double blind placebo- active control trial adult moderate severe acute pain verbal categorical rating scale ≥4 numeric pain rating scale nprs abdominoplasty n=1118 bunionectomy n=1073 . surgery participant be randomize suzetrigine 100 mg then 50 mg 12hrs hydrocodone bitartrate acetaminophen hb apap 5/325 mg 6hrs placebo 48 hour . primary endpoint be time weight sum pain intensity difference nprs 0 48hrs spid48 versus placebo . key secondary endpoint be spid48 versus hb apap time ≥2 point reduction nprs baseline versus placebo . result primary endpoint be achieve trial suzetrigine demonstrate statistically significant clinically meaningful reduction pain versus placebo . least square mean difference spid48 suzetrigine placebo be 48.4 95%ci:33.6,63.1;p&lt;0.0001 abdominoplasty 29.3 95%ci:14.0,44.6 p=0.0002 bunionectomy . trial achieve first key secondary endpoint superiority suzetrigine versus hb apap spid48 . second key secondary endpoint time ≥2 point reduction nprs suzetrigine have more rapid onset clinically meaningful pain relief versus placebo abdominoplasty 119min versus 480mins nominal p&lt;0.0001 bunionectomy 240min versus 480mins nominal p=0.0016).adverse event aes be similar see post surgical setting . conclusion as compare placebo suzetrigine reduce moderate severe acute pain 48 hour abdominoplasty bunionectomy . pain reduction suzetrigine be similar hb apap . suzetrigine be associate adverse event be mild to moderate severity . clinicaltrialsgov registration nct05558410 nct05553366 .	Anesthesiology	21/03/2025
10.1016/S2468-2667(25)00044-1	three decade population health change japan 1990 2021 subnational		background give japan&#x27;s rapidly age demographic structure comprehensive long term evaluation national subnational health progress be important to inform public health policy . study aim to assess japan&#x27;s population health use global burden diseases injuries risk factors study gbd 2021 to analyse country&#x27;s evolve disease pattern . methods gbd 2021 use japanese datum 1474 source cover 371 disease include covid-19 88 risk factor . analysis include estimate life expectancy mortality disability adjust life year daly . estimate be generate use standardised gbd methodology incorporate various data source statistical modelling include cause death ensemble model mortality bayesian meta regression disease model non fatal outcome risk factor estimation framework to quantify attributable burden . life expectancy decomposition cause death annualise rate change age standardise mortality daly be calculate 1990 2005 2005 15 2015 21 . finding 1990 2021 life expectancy japan rise 79·4 year 95 uncertainty interval 79·3 79·4 85·2 year 85·1 85·2 prefecture level disparity widen . gain be primarily drive reduce mortality stroke add 1·5 year life expectancy ischaemic heart disease 1·0 year neoplasm particularly stomach cancer 0·5 year variation prefecture . lead cause death 2021 be alzheimer&#x27; disease other dementia 135·3 death 39·5 312·3 100   000 population stroke 114·9 89·8 129·3 100   000 ischaemic heart disease 96·5 77·7 106·7 100   000 lung cancer 72·1 61·8 77·5 100   000 . age standardise mortality major non communicable disease decline pace decline have slow . cause annualise rate change mortality rate decrease -1·6 2005 15 to -1·1 2015 21 . age standardise covid-19 mortality rate be 0·8 death 0·7 0·9 100   000 population account 0·3 death 2020 3·0 2·5 3·7 100   000 population 2021 1·0 death . age standardise daly rate diabete worsen annualise rate change increase 0·1 2005 15 to 2·2 2015 21 . change parallel worsen trend major risk factor particularly high fast plasma glucose annualise rate change attributable daly -0·8 2005 15 0·8 2015 21 high bmi 0·2 1·4 respectively . age standardise daly attributable other major risk factor continue to decrease albeit slow . interpretation japan&#x27;s health gain past 30 year be now stall rise regional disparity . increase burden alzheimer&#x27;s disease other dementia diabetes alongside high fast plasma glucose high bmi highlight area need focused attention action . funding gates foundation .	The Lancet. Public health	20/03/2025
10.1016/S1470-2045(25)00027-0	neoadjuvant chemoradiotherapy follow active surveillance versus standard	van der Wilk BJ, Eyck BM, Wijnhoven BPL, Lagarde SM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, van Klaveren D, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB	background substantial proportion individual oesophageal cancer have pathological complete response neoadjuvant chemoradiotherapy oesophagectomy . aim to investigate whether active surveillance could be alternative individual clinical complete response neoadjuvant chemoradiotherapy . methods perform multicentre step wedge cluster randomise non inferiority phase 3 trial 12 dutch hospital . individual locally advanced oesophageal cancer clinical complete response neoadjuvant chemoradiotherapy ie tumour detect endoscopic biopsy ultrasound pet ct undergo active surveillance standard surgery ie oesophagectomy 2 week reach clinical complete response . be inclusion restriction regard comorbiditie performance status participant have carcinoma be age 18 year old be treat curative intent . randomisation hospital be perform use computer generate sequence stratification method initial phase hospital perform standard surgery . primary endpoint be overall survival analyse accord modify intention treat principle allow crossover time clinical complete response intention to treat principle . non inferiority be define 2 year survival rate active surveillance 15 less standard surgery . trial be register netherlands trial register ntr-6803 inclusion phase have be complete . finding nov 8 2017 jan 17 2021 1115 individual be screen 309 be include . 198 undergo active surveillance 111 underwent standard surgery . 242 78 participant be male 67 22 be female . median follow up be 38 month iqr 32 48 . 2 year overall survival active surveillance 74 95 ci 69 78 be non inferior standard surgery 71 62 78 modify intention to treat analysis one side 95 boundary 7 low . remain non inferior intention to treat analysis 75 68 80 vs 70 63 77 one side 95 boundary 6 low . be significant difference overall survival accord modify intention to treat analysis hazard ratio 1·14 two side 95 ci 0·74 1·78 intention to treat analysis 0·83 0·53 1·31 . frequency postoperative complication postoperative mortality standard surgery postpone surgery after active surveillance be similar group . interpretation overall survival active surveillance oesophageal cancer be non inferior compare standard surgery 2 year . long term efficacy active surveillance extend follow up be require . result present trial could be use patient counselling share decision making . funding dutch cancer society kwf netherlands organisation health research development zonmw .	The Lancet. Oncology	17/03/2025
10.1053/j.gastro.2025.03.014	rifaximin do not increase rate 30 day mortality patient	Silvey S, Patel N, Khoruts A, Bajaj JS	nan	Gastroenterology	21/03/2025
10.1126/sciadv.adn8402	ampk dependent parkin activation suppress macrophage antigen presentation	Wang X, Li Y, Li Y, Wang X, Song H, Wang Y, Huang C, Mao C, Wang L, Zhong C, Yu D, Xia Z, Feng Y, Duan J, Liu Y, Ou J, Luo C, Mai W, Hong H, Cai W, Zheng L, Trempe JF, Fon EA, Liao J, Yi W, Chen J	constrained cross talk myeloid cell t cell tumor immune microenvironment time restrict cancer immunotherapy efficacy whereas underlying mechanism remain elusive . parkin e3 ubiquitin ligase renowne mitochondrial quality control have emerge regulator immune response . here show that systemic macrophage specific ablation parkin mouse lead attenuate tumor progression prolonged mouse survival . single cell rna seq flow cytometry demonstrate that parkin deficiency reshape time activate innate adaptive immunity to control tumor progression recurrence . mechanistically parkin activation amp activate protein kinase rather pten induce kinase 1 mediate major histocompatibility complex regulation macrophage autophagy relate 5 dependent autophagy . furthermore parkin deletion synergize immune checkpoint blockade treatment park2(-/- signature aid predict prognosis patient solid tumor . finding uncover parkin&#x27;s involvement suppress macrophage antigen presentation coordinate cross talk macrophage t cell .	Science advances	21/03/2025
10.1038/s41586-025-08757-x	spatially resolve mapping cell associate human complex trait .	Song L, Chen W, Hou J, Guo M, Yang J	depict spatial distribution disease relevant cell be crucial understand disease pathology(1,2 . here present genetically inform spatial mapping cell complex trait gsmap method integrate spatial transcriptomic datum summary statistic genome wide association study to map cell human complex trait include disease spatially resolve manner . use embryonic spatial transcriptomic dataset cover 25 organ benchmarke gsmap simulation corroborate know trait associate cell region various organ . apply gsmap to brain spatial transcriptomic datum reveal that spatial distribution glutamatergic neuron associate schizophrenia more closely resemble cognitive trait mood trait such depression . schizophrenia associate glutamatergic neuron be distribute near dorsal hippocampus upregulated expression calcium signal regulation gene whereas depression associate glutamatergic neuron be distribute near deep medial prefrontal cortex upregulated expression neuroplasticity psychiatric drug target gene . study provide method spatially resolve mapping trait associate cell demonstrate gain biological insight such spatial distribution trait relevant cell related signature gene map .	Nature	19/03/2025
10.1038/s41467-025-58189-4	mitochondria transplantation transiently rescue cerebellar neurodegeneration	Li SJ, Zheng QW, Zheng J, Zhang JB, Liu H, Tie JJ, Zhang KL, Wu FF, Li XD, Zhang S, Sun X, Yang YL, Wang YY	cerebellar ataxia be primary manifestation cerebellar degenerative disease mitochondrial dysfunction purkinje cell pc play critical role disease progression . study investigate feasibility mitochondria transplantation potential therapeutic approach to rescue cerebellar neurodegeneration elucidate associate mechanism . construct conditional drp1 knockout model pc pcko mouse characterize progressive ataxia . drp1 knockout result pervasive progressive apoptosis pc significant activation surround glial cell . mitochondrial dysfunction trigger mitophagy be key pathogenic factor contribute morphological functional damage pc . transplant liver derive mitochondria cerebellum 1 month old pcko mouse improve mitochondrial function reduce mitophagy delayed apoptosis pc alleviate cerebellar ataxia to 3 week . finding demonstrate that mitochondria transplantation hold promise therapeutic approach cerebellar degenerative disease .	Nature communications	22/03/2025
10.1158/0008-5472.CAN-24-0747	colorectal tumors diverse patient populations feature spectrum somatic	Matejcic M, Teer JK, Hoehn HJ, Diaz DB, Shankar K, Gong J, Nguyen NT, Loroña NC, Coppola D, Fulmer CG, Saglam O, Jiang K, Cress WD, Muñoz-Antonia T, Flores I, Gordián ER, Oliveras Torres JA, Felder SI, Sanchez J, Fleming JB, Siegel EM, Freedman JA, Dutil J, Stern MC, Fridley BL, Figueiredo JC, Schmit SL	ancestrally diverse admixed population include hispanic latino a x e community be underrepresented cancer genetic genomic study . leverage latino colorectal cancer consortium lc3 other exist dataset analyze whole exome sequence datum tumor normal pair 718 individual colorectal cancer to map somatic mutational feature ethnicity genetic similarity . global proportion african asian european native american genetic ancestry be estimate use admixture . association proportion somatic mutational feature be examine use logistic regression . apc tp53 kras be top three mutate gene participant subset latino individual lc3 . analysis examine recurrently mutate gene tumor patient latino ethnicity have few kras pik3ca mutation compare tumor non latino patient . genetic ancestry overall be associate cdc27 mutation status african genetic ancestry be associate smad2 mutation status . exome wide analysis african genetic ancestry be significantly associate high odd mutation kncn tmem184b. native american genetic ancestry be associate low frequency microsatellite instability high msi h tumor . sbs11 mutational signature be associate native american genetic ancestry as well latino ethnicity . independent replication dataset msk impact estimate association be largely consistent direction non significant . meta analysis lc3 msk impact show that african genetic ancestry be significantly associate kras mutation status msi status . work facilitate precision medicine initiative provide insight contribution genetic ancestry molecular feature colorectal tumor .	Cancer research	24/03/2025
10.1080/13691058.2014.894206	basic deprivation involvement risky sexual behaviour out school	Kunnuji M	research have show that country such nigeria many urban dweller live state squalour lack basic necessity food clothing shelter . present study set to examine association form basic deprivation such food deprivation high occupancy ratio form shelter deprivation inadequate clothing two sexual outcome timing onset penetrative sex involvement multiple sexual partnership . study use survey datum sample 480 girl resident iwaya community . survival analysis timing onset sex regression model involvement multiple sexual partnership reveal that form deprivation explore food deprivation be only significant predictor timing onset sex involvement multiple sexual partnership . study conclude that sexual activity poor out school girl be partly explain desire to overcome food deprivation recommend government non governmental organisation programme work young people should address problem basic deprivation adolescent girl .	Culture, health &amp; sexuality	01/01/2014
10.1016/j.cell.2025.02.020	transcend life death ultimate cargo aged neutrophil .	Ng LG, Kwok I	neutrophil secrete variety mediator lifespan be mostly associate pro inflammatory function . issue cell hsu et   al . describe new class extracellular vesicle produce solely aged neutrophil elicit anti inflammatory effect extend neutrophil lifespan .	Cell	20/03/2025
10.1038/s41586-025-08678-9	polyene macrolide target phospholipid fungal cell membrane .	Deng Q, Li Y, He W, Chen T, Liu N, Ma L, Qiu Z, Shang Z, Wang Z	global spread multidrug resistant pathogenic fungi present serious threat human health necessitate discovery antifungal unique mode action(1 . however conventional activity base screening previously undescribe antibiotic have be hamper high frequency rediscovery know compound lack new antifungal targets(2 . here report discovery polyene antifungal antibiotic mandimycin use phylogeny guide natural product discovery platform . mandimycin be biosynthesize mand gene cluster have evolve distinct manner known polyene macrolide antibiotic be modify three deoxy sugar . have demonstrate potent broad spectrum fungicidal activity wide range multidrug resistant fungal pathogen vitro vivo setting . contrast know polyene macrolide antibiotic target ergosterol mandimycin have unique mode action involve target various phospholipid fungal cell membrane result release essential ion fungal cell . unique ability to bind multiple target give robust fungicidal activity as well capability to evade resistance . identification mandimycin use phylogeny guide natural product discovery strategy represent important advancement uncover antimicrobial compound distinct mode action could be develop to combat multidrug resistant fungal pathogen .	Nature	19/03/2025
10.1002/jcsm.13744	novel definition grading diagnostic criteria tumour type specific	Hu C, Cong M, Song C, Xu H, Guo Z, Zhou F, Zhou L, Weng M, Rao B, Deng L, Yu K, Chen Y, Wang Z, Ruan G, Yang M, Liu C, Cui J, Li W, Wang K, Li Z, Liu M, Li T, Chen J, von Haehling S, Barazzoni R, Shi H	background exist diagnostic criterion cancer cachexia do not meet clinical need . aim to establish novel comprehensive evaluation scale cachexia specific patient solid tumour . methods study include 12   651 patient male 6793 53.7 female 5858 46.3 medium age 58 interquartile range:50/66 year medium follow duration 24.16 13.32/44.84 month 4271 33.8 patient die mean survival 55.53 95 confidence interval 54.87/56.10 month 3344 26.4 4184 33.1 5123 40.5 patient stage i ii iii iv tumour respectively derivation set 10022 validation set 2629 patient 14 type solid tumour include lung gastric liver breast oesophageal cervical bladder pancreatic prostate ovarian colorectal cancer nasopharyngeal endometrial carcinoma cholangiocarcinoma open ongoing multicentre cohort study china . risk factor cachexia include tumour characteristic nutritional parameter be examine to develop diagnostic scale use cox proportional hazard model kaplan meier analysis . result ten nutrition item body mass index weight loss intake reduction physical activity function fatigue handgrip strength anorexia albumin level albumin globulin ratio neutrophil lymphocyte ratio different weighted score be identify to construct nutrition weight scoring scale nwss nutrition risk . tumour type tumour burden status tumour node metastasis stage radical non radical tumour be determined to construct disease weight scoring scale dwss disease risk . lump scale 5   ×   5 matrix establish use five grade classification nutrition disease risk be use to determine five grade classification comprehensive cachexia risk a cachexia risk reference low disease nutrition risk b cachexia risk hazard ratio hr   =   4.517 4.033/5.058 c pre cachexia hr   =   9.755 8.73/10.901 medium survival   =   21.21   month d cachexia hr   =   16.901 14.995/19.049 medium survival   =   11.61   month e refractory cachexia hr   =   31.879 28.244/35.981 medium survival   =   4.83   month high disease nutrition risk p   lt   0.001 . patient categories a d benefit nutrition therapy anti tumour treatment vary degree . patient category e be clinically refractory nutrition therapy prolonged survival compare patient nutrition therapy medium survival pre hospitalization nutrition therapy vs. hospitalization nutrition therapy vs. nutrition therapy 2.89 1.91/3.88 vs. 4.04 3.21/4.88 vs. 5.89 4.73/7.04 month p   =   0.015 anti tumour treatment prolonged survival compare patient receive palliative care medium survival radical anti tumour treatment vs. adjuvant anti tumour treatment vs. palliative anti tumour treatment vs. palliative care 6.48 4.42/8.53 vs. 6.48 3.23/9.73 vs. 4.83 4.22/5.44 vs. 2.70 1.09/4.30 month p   =   0.263 . conclusion systematically develop novel definition grade diagnostic criterion tumour type specific comprehensive cancer cachexia risk .	Journal of cachexia, sarcopenia and muscle	01/04/2025
10.1136/bmj-2023-078226	how to use direct acyclic graph guide clinical researcher .	Feeney T, Hartwig FP, Davies NM	nan	BMJ (Clinical research ed.)	21/03/2025
10.1002/ctm2.70244	hif-1α induce long noncoding rna linc02776 promote drug resistance ovarian	Wu Y, Zeng Y, Wu Y, Ha X, Feng Z, Liu C, Liu Z, Wang J, Ju X, Huang S, Liang L, Zheng B, Yang L, Wang J, Wu X, Li S, Wen H	background chemoresistance remain major hurdle ovarian cancer oc treatment as many patient eventually develop resistance platinum base chemotherapy and/or parp inhibitor parpi . methods perform transcriptome wide analysis rna sequence rna seq datum platinum resistant -sensitive oc tissue . demonstrate role linc02776 platinum resistance oc cell mice model patient derive organoid pdo model . result identify long noncoding rna linc02776 critical factor platinum resistance . elevated expression linc02776 be observe platinum resistant oc serve independent prognostic factor oc patient . functionally silence linc02776 reduce proliferation dna damage repair oc cell thereby enhance sensitivity platinum parpi xenograft mouse model patient derive organoid pdo model acquire chemoresistance . mechanistically linc02776 bind catalytic domain poly adp ribose polymerase 1 parp1 promote parp1 dependent polyadp ribosylation parylation facilitate homologous recombination hr restoration . additionally high hif-1α expression platinum resistant tissue further stimulate linc02776 transcription . conclusion finding suggest that target linc02776 represent promising therapeutic strategy oc patient have develop resistance platinum parpi . key point linc02776 promote oc cell proliferation regulate dna damage apoptosis signal pathway . linc02776 bind parp1 to promote dna damage trigger parylation oc cell . linc02776 mediate cisplatin olaparib resistance oc cell enhance parp1 mediate parylation activity regulate parp1 mediate hr pathway . high expression linc02776 be induce hif-1α platinum resistant oc cell tissue .	Clinical and translational medicine	01/03/2025
10.1093/cid/ciaf132	paucibacillary tuberculosis drive low positive predictive value xpert	Cuella-Martin I, Hakizayezu F, Ahmed A, Runyambo D, Niyompano H, Keysers J, De Rijk WB, Mulders W, Mitchell EMH, Decroo T, Habimana YM, Migambi P, Muvunyi CM, de Jong BC, Rigouts L, Ngabonziza JCS	background xpert mtb rif ultra ultra aim to improve specificity identify rifampicin resistant tuberculosis rr tb compare xpert mtb rif . methods nationwide study rwanda patient diagnose rr tb ultra december 2021 january 2024 underwent repeat ultra testing complement rpob gene sequence phenotypic drug susceptibility testing pdst serve reference test . result 129 patient initially diagnose rr tb ultra only 41 32 have concordant rifampicin result upon repeat ultra testing . remain 88 patient 68 have unconfirme resistance repeat ultra . reference testing be available 40 98 41 confirm case verify true rr tb . 88 unconfirmed case reference testing be available 61 69 with seven 11 confirm true rr tb while 54 89 be find to have rifampicin susceptible tb . notably 89 55 patient very low bacillary load initial ultra have false rr tb result significantly high risk false resistance compare other bacillary load category combine risk ratio 8.20 95 ci 3.56 18.85 p&lt;0.001 . consequently 53 54/101 initial rr patient available reference testing receive unnecessary rr tb treatment . conclusion ultra represent valuable tool rapid rr tb detection however low prevalence setting low positive predictive value rr detection be largely drive sample very low bacillary load . as program expand active case finding early detection asymptomatic disease proportion tb detect very low bacillary load will increase . diagnostic algorithm require adjustment to prevent unnecessary rr tb treatment .	Clinical infectious diseases : an official publication of the Infectious Diseases	22/03/2025
10.1016/j.neuron.2025.02.017	apoe genotype determine cell type specific pathological landscape alzheimer&#x27;s	Li Z, Martens YA, Ren Y, Jin Y, Sekiya H, Doss SV, Kouri N, Castanedes-Casey M, Christensen TA, Miller Nevalainen LB, Takegami N, Chen K, Liu CC, Soto-Beasley A, Boon BDC, Labuzan SA, Ikezu TC, Chen Y, Bartkowiak AD, Xhafkollari G, Wetmore AM, Bennett DA, Reichard RR, Petersen RC, Kanekiyo T, Ross OA, Murray ME, Dickson DW, Bu G, Zhao N	apolipoprotein e apoe gene be strong genetic risk modifier alzheimer&#x27;s disease ad apoe4 allele increase risk apoe2 decrease compare common apoe3 allele . use single nucleus rna sequence temporal cortex apoe2 carrier apoe3 homozygote apoe4 carrier find that ad associate transcriptomic change be highly apoe genotype dependent . compare ad control apoe2 carrier show upregulated synaptic myelination relate pathway preserve synapsis myelination protein level . conversely pathway be downregulate apoe3 homozygote result reduce synaptic myelination protein . apoe4 carrier excitatory neuron display reduce synaptic pathway similar apoe3 oligodendrocyte show upregulated myelination pathway like apoe2 . however synaptic myelination protein level remain unchanged increase . apoe4 carrier also show increase pro inflammatory signature microglia reduce response amyloid β pathology . finding reveal apoe genotype specific molecular alteration ad cell type .	Neuron	11/03/2025
10.1053/j.gastro.2025.02.035	machine learning artificial intelligence multi omics approach gut	Rozera T, Pasolli E, Segata N, Ianiro G	gut microbiome be involve human health disease comprehensive understanding be necessary to exploit diagnostic therapeutic tool . multi omics approach include metagenomic metatranscriptomic metabolomic metaproteomic enable depict complexity gut microbial ecosystem . however tool generate large datum stream integration be need to produce clinically useful readout turn might be difficult to carry conventional statistical method . artificial intelligence machine learning have be increasingly apply multi omics dataset several condition associate microbiome disruption chronic disorder cancer . such tool show potential clinical implementation include discovery microbial biomarker disease classification prediction prediction response specific treatment fine tuning microbiome modulate therapy . here discuss state art potential limit artificial intelligence machine learning multi omics approach gut microbiome .	Gastroenterology	19/03/2025
10.1186/s12887-025-05592-x	validity reliability european health literacy child form turkish	Altunoz I, Aygun O	purpose objective study be to assess validity reliability european health literacy scale child form turkish child to examine instrument&#x27;s psychometric property . design method total 843 student age 9 11 year primary secondary school be include scale adaptation study . validity analysis health literacy scale child form turkish form hls child q15 tr language content validity be use to determine cultural compatibility exploratory confirmatory factor analysis be use structural analysis . reliability be investigate examine internal consistency test retest reliability . result content validity hls child q15 tr be find to be high . model fit value confirmatory factor analysis result three factor model consist health care disease prevention health promotion dimension hls child q15 tr be find to be satisfactory x2 df   =   2.68 cfi   =   0.945 gfi   =   0.965 rmsea   =   0.045 . hls child q15 tr item total correlation be 0.30 cronbach&#x27;s alpha coefficient be 0.831 . test ret correlation coefficient hls child q15 tr be 0.98 stable time . conclusion hls child q15 tr be valid reliable turkish child age 9 11 year . be recommend that valid reliable hls child q15 tr be use to measure health literacy level turkish child 12 year age . practice implication hls child q15 tr valid reliable instrument use turkish child age 9 11 year . hls chıld q15 tr will make important contribution turkish culture evaluate health literacy level child 9 11 year age turkey .	BMC pediatrics	22/03/2025
10.1016/j.arr.2025.102739	fluid base biomarker neurodegenerative disease .	Cao Y, Xu Y, Cao M, Chen N, Zeng Q, Lai MKP, Fan D, Sethi G, Cao Y	neurodegenerative disease such alzheimer&#x27;s disease ad multiple sclerosis ms parkinson&#x27;s disease pd amyotrophic lateral sclerosis als be increasingly prevalent global population age . fluid biomarker derive cerebrospinal fluid csf blood saliva urine exosome offer promising solution early diagnosis prognosis disease monitoring . biomarker can reflect critical pathological process like amyloid beta aβ deposition tau protein hyperphosphorylation α syn misfolding tdp-43 mislocalization aggregation neuronal damage enable detection long before clinical symptom emerge . recent advance blood base biomarker particularly plasma aβ phosphorylate tau tdp-43 have show diagnostic accuracy equivalent csf biomarker offer more accessible testing option . review discuss current challenge fluid biomarker research include variability standardization sensitivity issue explore how combine multiple biomarker clinical symptom improve diagnostic reliability . ethical consideration future direction involve extracellular vehicle evs integration artificial intelligence ai be also highlight . continue research effort will be key overcome obstacle enable fluid biomarker to become crucial tool personalized medicine neurodegenerative disease .	Ageing research reviews	21/03/2025
10.1016/j.ccell.2025.02.027	small molecule rna therapeutic to target prostate cancer .	Kuzuoglu-Ozturk D, Nguyen HG, Xue L, Figueredo E, Subramanyam V, Liu I, Bonitto K, Noronha A, Dabrowska A, Cowan JE, Oses-Prieto JA, Burlingame AL, Worland ST, Carroll PR, Ruggero D	tune protein expression target rna structure use small molecule be unexplored avenue cancer treatment . to understand whether vulnerability could be therapeutically target most lethal form prostate cancer castration resistant prostate cancer crpc use clinical small molecule zotatifin target rna helicase translation factor eukaryotic initiation factor 4a eif4a . zotatifin repress tumorigenesis patient derive xenograft model prolonged survival   vivo alongside hormone therapy . genome wide transcriptome translatome proteomic analysis reveal two important translational target androgen receptor ar key oncogene crpc hypoxia inducible factor 1a hif1a essential cancer modulator hypoxia . solve structure 5&#x27 utrs oncogenic mrnas strikingly observe complex structural remodeling select mrnas small molecule . remarkably tumor treat zotatifin become more sensitive anti androgen therapy radiotherapy . therefore quot;translatome therapy&quot provide additional strategy to treat deadly cancer .	Cancer cell	18/03/2025
10.1002/rcm.8668	quantification glyphosate aminomethylphosphonic acid microbiome	Fritz-Wallace K, Engelmann B, Krause JL, Schäpe SS, Pöppe J, Herberth G, Rösler U, Jehmlich N, von Bergen M, Rolle-Kampczyk U	rationale glyphosate be one most widely use herbicide be suspect to affect intestinal microbiota inhibition aromatic amino acid synthesis shikimate pathway . vitro microbiome bioreactor be increasingly use model system to investigate effect intestinal microbiota consequently method quantitation glyphosate degradation product aminomethylphosphonic acid ampa microbiome model system be require . methods optimize protocol enable analysis glyphosate ampa simple extraction methanol acetonitrile water 2:3:1 further enrichment step . glyphosate ampa be separate liquid chromatography amide column identify quantify target tandem mass spectrometry method use qtrap 5500 system ab sciex . result method have limit detection lod extract water sample lt;2   ng ml glyphosate ampa . complex intestinal medium lod be 2 5   ng ml glyphosate ampa respectively . lod allow measurement exposure relevant concentration . glyphosate level bioreactor model porcine colon be determine consequently be verify whether ampa be produce porcine gut microbiota . conclusion method present here allow quantitation glyphosate ampa complex bioreactor fluid thus enable study impact glyphosate metabolism intestinal microbiota . addition extraction protocol be compatible untargeted metabolomic analysis thus allow to look other perturbation cause glyphosate same sample .	Rapid communications in mass spectrometry : RCM	15/04/2020
10.1016/S0140-6736(25)00109-6	calcitonin gene relate peptide target therapy migraine current role	Versijpt J, Paemeleire K, Reuter U, MaassenVanDenBrink A	almost 40 year ago discovery vasoactive neuropeptide calcitonin gene relate peptide cgrp role migraine pathophysiology usher new era migraine treatment . since 2018 monoclonal antibody mabs target cgrp pathway be available migraine prevention . approval drug mark pioneer development as be first pharmacological agent specifically tailor migraine prevention . introduction agent contrast historical reliance traditional preventive medication initially formulate other indication later repurpose migraine therapy . although emergence evidence efficacy safety cgrp target mabs have raise bar treatment success migraine efficacy other headache entity such cluster headache be low to moderate . small molecule cgrp receptor antagonist call gepant have also be prove to be effective acute preventive migraine treatment . furthermore agent have bridge traditional category acute preventive treatment strategy . short term prevention treatment prodromal phase migraine represent emerge strategy enable clinician to develop treatment approach design to meet change patient need however strategy still require more formal evidence . although solid datum have be gather further research concern efficacy long term safety drug target cgrp pathway robust pharmacoeconomic evaluation be need . finally randomise withdrawal switch study would facilitate formulation evidence base guidance discontinuation switch drug target cgrp pathway .	Lancet (London, England)	22/03/2025
10.1126/science.ado8316	synaptic architecture memory engram mouse hippocampus .	Uytiepo M, Zhu Y, Bushong E, Chou K, Polli FS, Zhao E, Kim KY, Luu D, Chang L, Yang D, Ma TC, Kim M, Zhang Y, Walton G, Quach T, Haberl M, Patapoutian L, Shahbazi A, Zhang Y, Beutter E, Zhang W, Dong B, Khoury A, Gu A, McCue E, Stowers L, Ellisman M, Maximov A	memory engram be form experience dependent plasticity neural circuit detailed architecture remain unresolved . use three dimensional electron microscopy perform nanoscale reconstruction hippocampal ca3 ca1 pathway chemogenetic labeling cellular ensemble recruit associative learning . neuron remote history activity coincide memory acquisition show strong preference wiring other . instead connectome expand multisynaptic bouton independently coactivation state postsynaptic partner . rewiring ensemble represent initial engram be accompany input specific spatially restrict upscaling individual synapsis as well remodeling mitochondria smooth endoplasmic reticulum interaction astrocyte . finding elucidate physical hallmark long term memory offer structural basis cellular flexibility information coding .	Science (New York, N.Y.)	21/03/2025
10.1016/j.immuni.2025.02.023	particle uptake macrophage trigger bifurcated transcriptional pathway that	Cobo I, Murillo J, Alishala M, Calderon S, Coras R, Hemming B, Inkum F, Rosas F, Takei R, Spann N, Prohaska TA, Alabarse PVG, Jeong SJ, Nickl CK, Cheng A, Li B, Vogel A, Weichhart T, Fuster JJ, Le T, Bradstreet TR, Webber AM, Edelson BT, Razani B, Ebert BL, Taneja R, Terkeltaub R, Bryan RL, Guma M, Glass CK	exposure particle be driver several inflammatory disease . here investigate macrophage response monosodium urate crystal calcium pyrophosphate crystal aluminum salt silica nanoparticle . while particle induce distinct gene expression pattern identify common inflammatory signature acute activation lysosomal acidification gene . use monosodium urate crystal model demonstrate that lysosomal gene program be regulate 5&#x27;-prime amp activate protein kinase ampk)-dependent transcriptional network include tfeb tfe3 epigenetic regulator dna methyl transferase 3a dnmt3a dot1l. lysosomal acidification program operate parallel largely independently jnk ap-1 dependent network drive crystal induce chemokine cytokine expression . finding reveal bifurcation pathway govern inflammatory lysosomal response offer insight treat particle associate disease .	Immunity	19/03/2025
10.1161/JAHA.124.039751	impact dna methylation age acceleration long term mortality us adult	Wu S, Zhu J, Lyu S, Wang J, Shao X, Zhang H, Zhong Z, Liu H, Zheng L, Chen Y	background association dna methylation age acceleration dnamaa cardiovascular kidney metabolic ckm syndrome stage long term mortality population ckm syndrome remain unclear . methods result cohort study include 1889 participant national health nutrition examination survey 1999 2002 ckm stage dna methylation age datum . dnamaa be calculate residual regression dna methylation age chronological age . primary outcome be all cause mortality cardiovascular noncardiovascular mortality secondary outcome . proportional odd model assess association dnamaas ckm stage cox proportional hazard regression model estimate association dnamaas mortality . significant association be find dnamaas advanced ckm stage particularly grimage2mort acceleration grimaa odd ratio or 1.547 95 ci 1.316 1.819 . average follow up 14   year 1015 death occur . 5 unit increase grimaa be associate 50 increase cause mortality 95 ci 1.39 1.63 77 increase cardiovascular mortality 95 ci 1.46 2.15 42 increase noncardiovascular mortality 95 ci 1.27 1.59 . low grimaa tertile reference high grimaa tertile show hazard ratio 1.95 95 ci 1.56 2.45 cause mortality 3.06 95 ci 2.13 4.40 cardiovascular mortality 1.65 95 ci 1.20 2.29 noncardiovascular mortality . mediation analysis indicate that grimaa mediate association various exposure include physical activity healthy eating index-2015 score hemoglobin a1c etc . mortality . conclusion grimaa may serve valuable biomarker assess ckm stage mortality risk individual ckm syndrome thereby inform personalize management strategy .	Journal of the American Heart Association	21/03/2025
10.1016/j.xcrm.2025.102031	cerebrospinal fluid proteomic identification biomarker amyloid tau	Wang Z, Chen Y, Gong K, Zhao B, Ning Y, Chen M, Li Y, Ali M, Timsina J, Liu M, Cruchaga C, Jia J	accurate staging alzheimer&#x27;s disease ad pathology be crucial therapeutic trial prognosis exist fluid biomarker lack specificity especially assess tau deposition severity amyloid beta aβ)-positive patient . analyze cerebrospinal fluid csf sample 136 participant alzheimer&#x27;s disease neuroimaging initiative use more 6,000 protein . apply machine learning to predict ad pathological stage define amyloid tau positron emission tomography pet . identify two distinct protein panel 16 protein include neurofilament heavy chain nefh sparc relate modular calcium bind protein 1 smoc1 distinguish aβ negative tau negative a t- a+ individual nine protein such hcls1 associate protein x-1 hax1 glucose-6 phosphate isomerase gpi differentiate a+t+ a+t- stage . signature outperform established csf biomarker area curve auc 0.92 versus 0.67 0.70 accurately predict disease progression decade . finding be validate internal external cohort . result underscore potential proteomic base signature to refine ad diagnostic criterion improve patient stratification clinical trial .	Cell reports. Medicine	12/03/2025
10.1001/jamanetworkopen.2025.1320	discontinuation oral anticoagulation successful atrial fibrillation	Iwawaki T, Yanagisawa S, Inden Y, Hiramatsu K, Yamauchi R, Miyamae K, Miyazawa H, Goto T, Kondo S, Tachi M, Shimojo M, Tsuji Y, Murohara T	importance be clear consensus regard discontinuation oral anticoagulant oacs catheter ablation ca atrial fibrillation af . objective to evaluate thromboembolic major bleed event cause death follow oac discontinuation characteristic associate patient prognosis successful ca . design setting participant retrospective cohort study include patient af recurrence adverse event 12 month ca undergo first ca january 1 2006 december 31 2021 . study population be divide group accord continuation discontinuation oacs landmark period 12 month ca . follow datum be acquire december 31 2023 study analysis be conduct january april 2024 . exposures oac discontinuation . main outcomes measures primary outcome be thromboembolic major bleed event cause death 12 month . inverse probability treatment weighting iptw propensity score match analysis be use to adjust baseline characteristic . result study include 1821 patient mean sd age 63.6 11.7 year 1339 man 73.5 . overall 922 patient 50.6 continue oac 12 month whereas 899 49.4 discontinue oac . mean sd follow up 4.8 4.0 year thromboembolic event major bleed event death occur 43 2.4 41 2.3 71 3.9 patient respectively . iptw adjustment oac discontinuation group demonstrate significantly high incidence thromboembolism incidence rate 0.86 95 ci 0.45 1.35 vs 0.37 95 ci 0.22 0.54 100 person year log rank p   =   .04 low incidence major bleeding incidence rate 0.10 95 ci 0.02 0.19 vs 0.65 95 ci 0.43 0.90 100 person year log rank p   lt   .001 continuation group . subgroup analysis oac discontinuation be associate high risk thromboembolism patient asymptomatic af leave ventricular ejection fraction less 60 leave atrial diameter 45 mm great . contrast oac discontinuation be beneficial reduce major bleed risk patient has bled score 2 great . outcome be similar propensity score match analysis use 1100 pair match patient except insignificant difference thromboembolic event . difference mortality 2 group be not statistically significant . conclusion relevance retrospective cohort study discontinuation oacs after successful ca be associate increase thromboembolic event decrease bleed event . benefit discontinue oac be stratify accord specific characteristic pende future prospective randomized study .	JAMA network open	03/03/2025
10.1016/j.xgen.2025.100810	cross ancestry analysis chinese european population reveal insight	Lin C, Xia M, Dai Y, Huang Q, Sun Z, Zhang G, Luo R, Peng Q, Li J, Wang X, Lin H, Gao X, Tang H, Shen X, Wang S, Jin L, Hao X, Zheng Y	differential susceptibility various disease correspond metabolite variation have be document diverse ethnic population genetic determinant disparity remain unclear . here perform large scale genome wide association study 171 directly quantifiable metabolite nuclear magnetic resonance base metabolomic platform 10,792 han chinese individual . identify 15 variant metabolite association eight be successfully replicate independent chinese population n   = 4,480 . cross ancestry meta analysis integrate 213,397 european individual uk biobank identify 228 additional variant metabolite association improve fine mapping precision . moreover two sample mendelian randomization analysis reveal evidence that genetically predict level triglyceride high density lipoprotein be associate high risk coronary artery disease glycine low risk heart failure ancestry . finding enhance understanding shared specific genetic architecture metabolite as well role complex disease population .	Cell genomics	19/03/2025
10.1016/j.cell.2025.02.027	microtubule asgard archaea .	Wollweber F, Xu J, Ponce-Toledo RI, Marxer F, Rodrigues-Oliveira T, Pössnecker A, Luo ZH, Malit JJL, Kokhanovska A, Wieczorek M, Schleper C, Pilhofer M	microtubule be hallmark eukaryote . archaeal bacterial homolog tubulin typically form homopolymer non tubular superstructure . origin heterodimeric tubulin assemble microtubule remain unclear . here report discovery microtubule form tubulin asgard archaea close know relative eukaryote . asgard tubulin atuba b be closely relate eukaryotic α β tubulin enigmatic bacterial tubulin btuba b. proteomics candidatus lokiarchaeum ossiferum show that atuba b be highly express . cryoelectron microscopy structure demonstrate that atuba b form eukaryote like heterodimer assemble 5 protofilament bona fide microtubule   vitro . additional paralog atubb2 lack nucleotide bind site competitively displace atubb. atuba b2 heterodimer polymerize 7 protofilament non canonical microtubule . sub population ca . lokiarchaeum ossiferum cell cryo tomography reveal tubular structure while expansion microscopy identify atuba b cytoskeletal assembly . finding suggest pre eukaryotic origin microtubule provide framework understand fundamental principle microtubule assembly .	Cell	19/03/2025
10.1038/s41467-025-58186-7	serum vegf a biomarker addition bevacizumab to	Tanaka K, Sugisaka J, Shiraishi Y, Watanabe Y, Daga H, Azuma K, Nishino K, Mori M, Ota T, Saito H, Hata A, Sakaguchi T, Kozuki T, Akamatsu H, Matsumoto H, Tachihara M, Wakuda K, Sato Y, Ozaki T, Tsuchiya-Kawano Y, Yamamoto N, Nakagawa K, Okamoto I	anti vascular endothelial growth factor vegf agent combination immunotherapy have improve outcome cancer patient predictive biomarker have not be elucidate . report here preplanne analysis previously report apple study phase 3 trial evaluate efficacy bevacizumab combination atezolizumab plus platinum chemotherapy metastatic nonsquamous non small cell lung cancer nsclc . investigate correlation serum vegf a isoform baseline treatment response use enzyme link immunosorbent assay . reveal that addition bevacizumab significantly improve progression free survival patient low vegf a level . result demonstrate that measure serum vegf a isoform may identify nsclc patient be likely to benefit addition bevacizumab to immunotherapy . assay be easy to measure have significant potential further clinical development .	Nature communications	22/03/2025
10.1038/s43018-025-00937-y	palmitoylation gpx4 targetable zdhhc8 determine ferroptosis	Zhou L, Lian G, Zhou T, Cai Z, Yang S, Li W, Cheng L, Ye Y, He M, Lu J, Deng Q, Huang B, Zhou X, Lu D, Zhi F, Cui J	ferroptosis be closely link various pathophysiological process include aging neurodegeneration ischemia reperfusion injury viral infection notably cancer progression however post translational regulatory mechanism remain incompletely understood . here reveal crucial role s palmitoylation regulate ferroptosis glutathione peroxidase 4 gpx4 pivotal enzyme that mitigate lipid peroxidation . identify zinc finger dhhc domain contain protein 8 zdhhc8 s acyltransferase be highly express multiple tumor palmitoylate gpx4 cys75 . small molecule drug screening identify pf-670462 zdhhc8 specific inhibitor promote degradation zdhhc8 consequently attenuate gpx4 palmitoylation enhance ferroptosis sensitivity . pf-670462 inhibition zdhhc8 facilitate cd8(+ cytotoxic t cell induce ferroptosis tumor cell thereby improve efficacy cancer immunotherapy b16 f10 xenograft model . finding reveal prominent role zdhhc8 gpx4 axis regulate ferroptosis highlight potential application zdhhc8 inhibitor anticancer therapy .	Nature cancer	19/03/2025
10.1055/s-2007-971124	physiological effect variation spontaneously choose crank rate	Marais G, Weissland T, Robin H, Vanvelcenaher JM, Lavoie JM, Pelayo P	aim present study be to compare physiological response when crank rate be choose spontaneously ts set + 10 t-10 t+10 freely choose rate two upper body exercise i sub maximal test t(sub intensity range 50 to 80 118.4 + 10.2 to 189.5 + 16.3 watt maximal power mp ii supramaximal test t(supra power output be set 110 120 260.5 + 22.4 284.2 + 24.4 watt mp . eight nationally internationally rank kayaker age 20 + 2 year perform test power output be normalise relation maximal power output determine t(mp . t(sub+10 oxygen uptake ventilation be significantly p&lt 0.05 high t(subxs . t(sub+10 t(sub-10 energy expenditure be significantly p&lt;0.05 high gross net efficiency low t(subxs . t(supra-10 when power output be set 110 mp time exhaustion be significantly high p&lt;0.05 t(supraxs . finding present study suggest that upper body exercise perform ergocycle should be conduct use freely spontaneously choose crank rate .	International journal of sports medicine	01/05/1999
10.1186/s13073-025-01456-2	rare damaging ccr2 variant be associate low lifetime cardiovascular	Georgakis MK, Malik R, Bounkari OE, Hasbani NR, Li J, Huffman JE, Shakt G, Tack RWP, Kimball TN, Asare Y, Morrison AC, Tsao NL, Judy R, Mitchell BD, Xu H, Montasser ME, Do R, Kenny EE, Loos RJF, Terry JG, Carr JJ, Bis JC, Psaty BM, Longstreth WT, Young KA, Lutz SM, Cho MH, Broome J, Khan AT, Wang FF, Heard-Costa N, Seshadri S, Vasan RS, Palmer ND, Freedman BI, Bowden DW, Yanek LR, Kral BG, Becker LC, Peyser PA, Bielak LF, Ammous F, Carson AP, Hall ME, Raffield LM, Rich SS, Post WS, Tracy RP, Taylor KD, Guo X, Mahaney MC, Curran JE, Blangero J, Clarke SL, Haessler JW, Hu Y, Assimes TL, Kooperberg C, Bernhagen J, Anderson CD, Damrauer SM, Zand R, Rotter JI, de Vries PS, Dichgans M	background previous work have show role ccl2 key chemokine govern monocyte trafficking atherosclerosis . however remain unknown whether target ccr2 cognate receptor ccl2 provide protection human atherosclerotic cardiovascular disease . methods computationally predict damaging loss function revel   gt   0.5 variant ccr2 be detect whole exome sequence datum 454,775 uk biobank participant test association cardiovascular endpoint gene burden test . give key role ccr2 monocyte mobilization variant associate low monocyte count be prioritize experimental validation . response ccl2 human cell transfecte variant be test migration camp assay . validate damaging variant be test association cardiovascular endpoint atherosclerosis burden vascular risk factor . significant association be replicate six independent dataset n   =   1,062,595 . result carrier 45 predict damaging loss function ccr2 variant n   =   787 individual be low risk myocardial infarction coronary artery disease . one variant m249 k n   =   585 0.15 european ancestry individual be associate low monocyte count decrease downstream signaling chemoattraction response ccl2 . while m249 k show association conventional vascular risk factor be consistently associate low risk myocardial infarction odd ratio or 0.66 95 confidence interval ci 0.54 0.81 p   =   6.1   ×   10(-5 coronary artery disease 0.74 95%ci 0.63 0.87 p   =   2.9   ×   10(-4 uk biobank six replication cohort . phenome wide association study be evidence high risk infection m249 k carrier . conclusion carrier experimentally confirm damage ccr2 variant be low lifetime risk myocardial infarction coronary artery disease carry high risk infection . finding provide genetic support translational potential ccr2 targeting atheroprotective approach .	Genome medicine	21/03/2025
10.1186/s12889-025-22231-3	explore nonlinear association cardiometabolic index	Zhou H, Mao Y, Ye M, Zuo Z	background hypertension be prevalent chronic disease affect 1.2 billion people worldwide represent major modifiable risk factor cardiovascular disease . waist height ratio whtr triglyceride high density lipoprotein cholesterol tg hdl c ratio be establish metabolic indicator link risk cardiovascular metabolic disease . recently cardiometabolic index cmi combine whtr tg hdl c ratio have be propose to provide comprehensive assessment metabolic health . study investigate association cmi hypertension use datum national health nutrition examination survey nhanes . methods study utilize nhanes datum nine cycle span 2001 2018 encompass 20,049 participant age 20 . exclusion be make individual incomplete cmi hypertension datum pregnant woman . cmi be calculate multiply whtr tg hdl c ratio . hypertension be define accord american heart association guideline . relationship cmi hypertension be evaluate use multivariate logistic regression analysis additional subgroup analysis conduct base demographic factor . nonlinear relationship be analyze use smoothing curve fitting technique . result study identify significant positive correlation cmi hypertension risk increase one unit cmi associate 9 heighten risk hypertension 1.09 95 ci 1.05 1.13 . association remain significant various demographic subgroup . nonlinear relationship be observe critical cmi threshold 2.64 . threshold high cmi value be associate progressively high prevalence hypertension whereas threshold further increase cmi do not significantly correlate elevated risk hypertension . conclusion study demonstrate that cmi be significantly associate hypertension risk may serve valuable tool early screening risk assessment particularly identify individual high risk reach critical cmi threshold . result underscore importance address metabolic health prevention management hypertension . future research should focus longitudinal study to establish causality explore clinical utility cmi hypertension screening examine applicability diverse population .	BMC public health	21/03/2025
10.1016/j.stem.2025.02.013	human skeletal development regeneration be shape functional diversity	Ambrosi TH, Taheri S, Chen K, Sinha R, Wang Y, Hunt EJ, Goodnough LH, Murphy MP, Steininger HM, Hoover MY, Felix F, Weldon KC, Koepke LS, Sokol J, Liu DD, Zhao L, Conley SD, Lu WJ, Morri M, Neff NF, Van Rysselberghe NL, Wheeler EE, Wang Y, Leach JK, Saiz A, Wang A, Yang GP, Goodman S, Bishop JA, Gardner MJ, Wan DC, Weissman IL, Longaker MT, Sahoo D, Chan CKF	skeleton be one most structurally compositionally diverse organ system human body depend unique cellular dynamism . here integrate prospective isolation human skeletal stem cell hsscs cd45(-)cd235a(-)tie2(-)cd31(-)cd146(-)pdpn(+)cd73(+)cd164(+ ten skeletal site functional assay single cell rna sequence scrna seq analysis to identify chondrogenic osteogenic stromal fibrogenic subtype hsscs development linkage skeletal phenotype . map distinct composition hssc subtype multiple skeletal site demonstrate unique   vivo clonal dynamic . find that age relate change bone formation regeneration disorder stem pathological fibroblastic shift hssc pool . utilize boolean algorithm uncover gene regulatory network dictate difference ability hsscs to generate specific skeletal tissue . importantly hssc lineage dynamic be pharmacologically malleable provide new strategy to treat aberrant hssc diversity central age skeletal malady .	Cell stem cell	19/03/2025
10.1016/S1474-4422(25)00033-X	advance diagnosis classification management pain parkinson&#x27;s	Tinazzi M, Gandolfi M, Artusi CA, Bannister K, Rukavina K, Brefel-Courbon C, de Andrade DC, Perez-Lloret S, Mylius V	10 million people affect worldwide parkinson&#x27;s disease be fast grow neurological disorder . more two third people parkinson&#x27;s disease live chronic pain can manifest various stage disease substantially affect daily activity quality life . parkinson&#x27;s disease pain classification system overcome limitation previous classification system distinguish pain relate parkinson&#x27;s disease unrelated pain while also incorporate clinical pathophysiological mechanistic descriptor such nociceptive neuropathic nociplastic pain . system provide framework accurate diagnosis mechanism base therapy . alongside appropriate classification pain consideration treatment approach include non invasive pharmacological non pharmacological invasive strategy tailor specific type pain will refine inform research trial clinical practice when come treat pain parkinson&#x27;s disease .	The Lancet. Neurology	01/04/2025
10.1016/j.cell.2025.02.019	small molecule hypoxia therapy mitochondrial disease .	Falk MJ	issue   cell blume et   al . provide compelling rationale   pursue pharmacologic optimization   small molecule   quot;hypoxystat,&quot   leave shift oxyhemoglobin dissociation curve red blood cell attempt to induce   effective sustained reduction chronic tissue hyperoxia primary mitochondrial disease pmd be well tolerate effective pre symptomatic advanced disease treatment to extend survival improve neurologic outcome mouse model leigh syndrome spectrum .	Cell	20/03/2025
10.1055/a-2529-5025	management epithelial precancerous condition early neoplasia	Dinis-Ribeiro M, Libânio D, Uchima H, Spaander MCW, Bornschein J, Matysiak-Budnik T, Tziatzios G, Santos-Antunes J, Areia M, Chapelle N, Esposito G, Fernandez-Esparrach G, Kunovsky L, Garrido M, Tacheci I, Link A, Marcos P, Marcos-Pinto R, Moreira L, Pereira AC, Pimentel-Nunes P, Romanczyk M, Fontes F, Hassan C, Bisschops R, Feakins R, Schulz C, Triantafyllou K, Carneiro F, Kuipers EJ	population level european society gastrointestinal endoscopy esge european helicobacter microbiota study group ehmsg european society pathology esp suggest endoscopic screening gastric cancer precancerous condition high risk region age standardize rate asr gt   20 100   000 person year 2 to 3 year if cost effectiveness have be prove intermediate risk region asr 10 20 100   000 person year 5 year not low risk region asr lt   10).esge ehmsg esp recommend that irrespective country origin individual gastric risk assessment stratification precancerous condition be recommend first time gastroscopy . esge ehmsg esp suggest that gastric cancer screening surveillance asymptomatic individual 80 should be discontinue not start patients&#x27 comorbiditie should be consider when treatment superficial lesion be plan . esge ehmsg esp recommend that high quality endoscopy include use virtual chromoendoscopy vce proper training be perform screening diagnosis staging precancerous condition atrophy intestinal metaplasia lesion dysplasia cancer as well endoscopic therapy . vce should be use to guide sampling site biopsy case suspect neoplastic lesion as well to guide biopsy diagnosis staging gastric precancerous condition random biopsy to be take absence endoscopically suspect change . when be suspect early gastric neoplastic lesion should be properly describe location size paris classification vascular mucosal pattern photodocumente two target biopsy take . esge ehmsg esp do not recommend routine performance endoscopic ultrasonography eus computed tomography ct magnetic resonance imaging mri positron emission tomography pet)-ct prior endoscopic resection unless be sign deep submucosal invasion if lesion be not consider suitable endoscopic resection . esge ehmsg esp recommend endoscopic submucosal dissection esd differentiated gastric lesion clinically stage dysplastic low grade high grade intramucosal carcinoma size if not ulcerated ≤   30   mm if ulcerated emr be alternative paris 0 iia lesion size ≤   10   mm low likelihood malignancy . esge ehmsg esp suggest that decision esd can be consider malignant lesion clinically stage have minimal submucosal invasion if differentiate ≤   30 mm malignant lesion clinically stage intramucosal undifferentiated   ≤   20 mm case ulcerative finding . esge ehmsg esp recommend patient management base follow histological risk endoscopic resection curative very low risk resection lymph node metastasis lnm risk lt   0.5   -1   en bloc r0 resection dysplastic pt1a differentiate lesion lymphovascular invasion independent size if ulceration ≤   30   mm if ulcerated . further stage procedure treatment be recommend . curative low risk resection lnm risk lt   3   en bloc r0 resection lesion lymphovascular invasion a pt1b invasion ≤   500   µm differentiate size ≤   30   mm b pt1a undifferentiated size ≤   20   mm ulceration . staging should be complete further treatment be generally not necessary multidisciplinary discussion be require . local risk resection very low risk lnm increase risk local persistence recurrence piecemeal resection tumor positive horizontal margin lesion otherwise meet curative very low risk criterion meet low risk criterion provide that be submucosal invasive tumor resection margin case piecemeal resection tumor positive horizontal margin pt1b lesion invasion ≤   500 µm well differentiate size ≤   30   mm vm0 . endoscopic surveillance re treatment be recommend rather other additional treatment . high risk resection noncurative lesion following a positive vertical margin if carcinoma lymphovascular invasion deep submucosal invasion gt   500   µm muscularis mucosae b poorly differentiate lesion if ulceration size gt   20   mm c pt1b differentiate lesion submucosal invasion ≤   500   µm size gt   30   mm d intramucosal ulcerative lesion size gt   30   mm . complete staging strong consideration additional treatment surgery multidisciplinary discussion . esge ehmsg esp suggest use validate endoscopic classification atrophy e.   g. kimura takemoto intestinal metaplasia e.   g. endoscopic grading gastric intestinal metaplasia eggim to endoscopically stage precancerous condition stratify risk gastric cancer . esge ehmsg esp recommend that biopsy should be take at least two topographic site 2 biopsy antrum incisura 2 corpus guide vce two separate clearly label vial . additional biopsy incisura be optional . esge ehmsg esp recommend that patient extensive endoscopic change kimura c3   + eggim 5   + advance histological stage atrophic gastritis severe atrophic change intestinal metaplasia change antrum corpus operative link gastritis assessment operative link gastric intestinal metaplasia olga olgim iii iv should be follow high quality endoscopy 3 year irrespective individual&#x27;s country origin . esge ehmsg esp recommend that surveillance be propose for patient mild to moderate atrophy intestinal metaplasia restrict antrum absence endoscopic sign extensive lesion other risk factor family history incomplete intestinal metaplasia persistent h. pylori infection . group constitute most individual find clinical practice . esge ehmsg esp recommend h. pylori eradication patient precancerous condition endoscopic surgical therapy . esge ehmsg esp recommend that patient should be advise to stop smoking low dose daily aspirin use may be consider prevention gastric cancer select individual high risk cardiovascular event .	Endoscopy	20/03/2025
10.1182/blood.2024027767	complement cd20 antibodies&#x27 effector function .	Leusen J, Valerius T	nan	Blood	20/03/2025
10.1186/s12967-025-06378-6	chi3l1 mediate radiation resistance colorectal cancer inhibit	Jin M, Liu H, Zheng Z, Fang S, Xi Y, Liu K	background radiotherapy be key treatment colorectal cancer crc particularly rectal cancer however many patient be resistant radiation . while have be show chi3l1 be associate crc progression specific function regulatory mechanism radiation resistance remain unclear . method level chi3l1 crc normal tissue sample be obtain cancer genome atlas tcga gene expression omnibus geo dataset . to assess effect chi3l1 crc cell proliferative migratory invasive capacity cell counting kit-8 cck-8 transwell assay be perform . radiation resistance crc cell vary chi3l1 expression level be evaluate colony formation assay . western blot immunofluorescence analysis be conduct to explore correlation chi3l1 p53 expression level . ferroptosis be assess determine reactive oxygen specie ros malondialdehyde mda glutathione gsh concentration cell different chi3l1 expression level xenograft mouse model be use to identify molecular mechanism ferroptosis vivo . result significant chi3l1 upregulate be observe crc tissue be associate promotion malignant cell behavior . number colony chi3l1 overexpresse group be significantly great control group follow radiation indicate increase radiation resistance former group . furthermore chi3l1 overexpression be associate p53 downregulation elevated p53 ubiquitination . notably chi3l1 inhibit ferroptosis crc cell suppress p53 expression p53 slc7a11 signal pathway . conclusion chi3l1 overexpression promote proliferation migration invasion radiation resistance crc cell . elevated chi3l1 expression be associate increase p53 ubiquitination slc7a11 upregulation . chi3l1 promote radiation resistance suppress ferroptosis crc cell p53 slc7a11 axis .	Journal of translational medicine	21/03/2025
10.1038/s41392-025-02176-0	bcl2 family apoptosis mechanism new advance targeted therapy .	Vogler M, Braun Y, Smith VM, Westhoff MA, Pereira RS, Pieper NM, Anders M, Callens M, Vervliet T, Abbas M, Macip S, Schmid R, Bultynck G, Dyer MJ	b cell lymphoma 2 bcl2 protein family critically control apoptosis regulate release cytochrome c mitochondria . cutting edge review summarize basic biology regulate bcl2 family include canonical non canonical function highlight milestone basic research clinical application cancer other pathophysiological condition . review laboratory clinical development bh3 mimetic as well more recent approach include proteolysis target chimera protacs antibody drug conjugate adcs tool target bh4 domain bcl2 . first bcl2 selective bh3 mimetic venetoclax show remarkable efficacy manageable toxicity have transform treatment several hematologic malignancy . follow success several chemically similar bcl2 inhibitor such sonrotoclax lisaftoclax be currently clinical evaluation alone combination . genetic analysis highlight importance bcl x(l mcl1 different cancer type possible utility bh3 mimetic target protein . however development bh3 mimetic target bcl x(l mcl1 have be more challenging target toxicity include thrombocytopenia bcl x(l cardiac toxicity mcl1 inhibitor preclude clinical development . tumor specific bcl x(l mcl1 inhibition may be achieve novel target approach use protac selective drug delivery strategy would be transformational many subtype malignancy . take together envision that targeting bcl2 protein while already success story translational research may foreseeable future have broad clinical applicability improve treatment multiple disease .	Signal transduction and targeted therapy	21/03/2025
10.1182/blood.2024026236	clonal hematopoiesis be clonally unrelated multiple myeloma be associate	Lionetti M, Scopetti M, Matera A, Maeda A, Marella A, Lazzaroni F, Castellano G, Fabris S, Pioggia S, Lonati S, Marchetti A, Cattaneo A, Tornese M, Neri A Dr, Leoni C, Pettine L, Traini V, Silvestris I, Barbieri M, Fabbiano G, Ronchetti D, Taiana E, De Magistris C, Da Via&#x27; MC, Passamonti F, Bolli N	multiple myeloma mm initiation be dictate genomic event . however progression asymptomatic stage aggressive disease ultimately fail to respond treatment be also dependent change tumor microenvironment tme . clonal hematopoiesis indeterminate potential chip be prevalent clonal condition hematopoietic stem cell presence be causally link more inflame microenvironment . here show 106 patient mm that chip be frequently co exist mm diagnosis associate more advanced r iss stage high age show non significant trend low median hemoglobin . cohort two condition do not share clonal origin . single cell rna sequence 16 mm patient highlight significant tme change when chip be present decrease naïve t cell pro inflammatory tme decrease antigen present function dendritic cell expression exhaustion marker cd8 cell . inferred interaction cell type chip positive tme suggest that especially monocyte t cell clonal plasma cell may have prominent role mediate inflammation immune evasion pro survival signal favor mm cell . altogether datum show that presence chip tme mm diagnosis be significantly disrupt line usually see more advanced disease potential translational implication . datum highlight relevance association prompt further study modifi role chip mm tme .	Blood	20/03/2025
10.1016/j.ymthe.2025.03.029	combined aav mediate specific gjb2 expression restore hear dfnb1 mouse	Sun Q, Tan F, Zhang L, Lu Y, Wei H, Li N, Jiang L, Zhou Y, Chen T, Lu L, Li GL, Qi J, Yang S, Chai R	pathogenic mutation gjb2 gene encode connexin 26 be lead cause autosomal recessive hereditary deafness . gene therapy hold significant promise treat . adeno associate virus aav mediate therapeutic gene delivery have be show to be safe effective restore hearing animal model human patient . however gjb2 gene therapy have be hinder limited specificity efficiency available aav vector . study screen aav serotype find that co administration aav1 aav ie could effectively target gjb2 express cell . however ectopic gjb2 expression hair cell induce aav could cause ototoxicity be address employ specific promoter scpro . co injection aav1 aav ie carry exogenous gjb2 drive scpro effectively restore hearing function gjb2 deficient mouse . moreover combine aav system can transduce cochleae bama miniature pig aav administration inner ear cynomolgus monkey do not impair hearing show negligible systemic toxicity indicate efficiency safety gene therapy large animal . thus study provide strategy gjb2 gene therapy lay foundation future clinical application .	Molecular therapy : the journal of the American Society of Gene Therapy	21/03/2025
10.1016/j.ajcnut.2025.03.012	kangaroo care mother infant dyad skin skin contact increase human	Wells JCK	nan	The American journal of clinical nutrition	18/03/2025
10.1016/j.xcrm.2025.102033	combined quot;eat don&#x27;t eat me&quot strategy base exosome acute liver injury	Du W, Chen C, Liu Y, Quan H, Xu M, Liu J, Song P, Fang Z, Yue Z, Xu H, Ling Y, Duan J, He F, Wang L	drug induce liver injury dili involve multifaceted pathogenesis necessitate effective therapeutic strategy . wnt2 secrete liver sinusoidal endothelial cell lsec activate wnt β catenin signal pathway to promote hepatocyte proliferation injury . to address dual challenge target delivery phagocytosis evasion develop combined quot;eat don&#x27;t eat me&quot strategy . rltrkrglk rltr peptide functionalize exosome be engineer insert dmpe peg2000 crltrkrglk lipid membrane exosome derive bend.3 cell . surface display rltr mediate exosomal enrichment lsec while cd47 engineering reduce macrophage clearance   quot;don&#x27;t eat me&quot   signal . then lentiviral transfection enable stable encapsulation functional wnt2 mrna exo(cd47 designate wnt2@exo(cd47 . acetaminophen apap dimethylnitrosamine dmn)-induce murine liver injury model rltr wnt2@exo(cd47 demonstrate lsec specific targeting significant hepatoprotection . engineer exosome platform provide therapeutic strategy dili .	Cell reports. Medicine	14/03/2025
10.1016/j.canlet.2025.217636	lactate accumulation drive hepatocellular carcinoma metastasis	Jiang C, He X, Chen X, Huang J, Liu Y, Zhang J, Chen H, Sui X, Lv X, Zhao X, Xiao C, Xiao J, Zhang J, Lu T, Chen H, Li H, Wang H, Lv G, Ye L, Li R, Zheng J, Yao J, Kang Y, Wang T, Li H, Wang J, Zhang Y, Chen G, Cai J, Xiang AP, Yang Y	previous study have demonstrate that lactate accumulation common hallmark metabolic deprivation solid tumor could actively drive tumor invasion metastasis . however whether lactate influence biogenesis tumor derive exosome tdes prerequisite distant metastasis formation remain unknown . here demonstrate that extracellular lactate after take tumor cell lactate transporter mct1 drive release tde mainly facilitate multivesicular body mvb trafficking plasma membrane instead lysosome . mechanistically lactate promote p300 mediate rab7a lactylation hereafter inhibit gtpase activity promote mvb docking plasma membrane . moreover lactate administration enrich integrin β4 ecm remodeling relate protein tde cargo promote pulmonary pre metastatic niche formation . combinatorial inhibition mct1 p300 significantly abrogate hcc metastasis clinical relevant pdx model . summary demonstrate that lactate promote tde biogenesis hcc pulmonary metastasis propose potential clinical strategy target tde to prevent hcc metastasis .	Cancer letters	20/03/2025
10.1210/clinem/dgaf187	continuous glucose monitoring improve detection glycemic excursion	Galindo RJ, Moazzami B, Gerges A, Flores I, Arevalo G, Peng L, Tuttle KR, Umpierrez GE	background optimal glucose management individual type 2 diabetes t2d end stage kidney disease eskd hemodialysis be challenge . compare detection glycemic excursion continuous glucose monitoring cgm capillary glucose testing cbg population . method prospective observational study insulin treat adult t2d hemodialysis ≥90 day wear dexcom g6 pro cgm . participant be instruct to perform cbg to 4 time daily . compare difference glucose metric describe cgm pattern relation dialysis session . result 59 participant age 57 . 7±9year hba1c 7.09 mean glucose measure cbg cgm be 165.7 ± 41.8 188.9 ± 45.0 time range tir 68%±23 51%±26 respectively p lt 0.001 . cgm detect that participant have hyperglycemic episode 180mg dl time range tar 180mg dl 47.8%±27 90 have episode gt;250mg dl tar gt;250mg dl 20.9%±21.7 . cgm detect high rate hypoglycemia lt;70mg dl 47 vs. 25 p=0.005 lt;54mg dl 25 vs. 12 p=0.08 cbg testing . nocturnal prolonged hypoglycemia lt;70mg dl be only detect cgm 29 12 respectively . cgm show pattern improved glucose level pre dialysis day low glucose level hemodialysis rapid rise post dialysis period . conclusion participant t2d eskd hemodialysis cgm improve detection hyperglycemic hypoglycemic event particularly nocturnal prolonged episode . cgm reveal distinct glycemic pattern relate dialysis session potentially enable more personalized management .	The Journal of clinical endocrinology and metabolism	22/03/2025
10.1186/s13195-024-01657-8	accelerometer derive quot;weekend warrior&quot physical activity sedentary behavior	Ning Y, Chen M, Yang H, Jia J	background research have show sedentary behavior sb may increase dementia risk remain unclear whether concentrated moderate vigorous physical activity mvpa can compensate such negative effect . study aim to explore association different mvpa pattern combine sb time risk dementia . method prospective study use datum uk biobank cohort provide accelerometer base physical activity datum full week february 2013 december 2015 . participant be categorize quot;weekend warrior ww)&quot group engage more 50 mvpa ≥   150   min week 1 to 2 day inactive group total mvpa   lt   150   min week regular group meet recommend mvpa ≥   150   min week not ww . participant be far divide six group base sb duration ≥   8.52   h day lt   8.52   h day . multivariable cox model be use to assess relationship pattern risk dementia adjust age gender ethnicity townsend deprivation index education level employment status alcohol consumption smoking bmi baseline comorbiditie include cardiovascular disease hypertension diabetes . result include 91,948 participant dementia baseline . median follow up 7.93 year 736 participant develop cause dementia . when mvpa threshold be set 150   min week 16,149 participant 17.5 be classify ww long sb 19,055 20.7 as regular long sb 21,909 23.8 inactive long sb . compare inactive long sb time ww group show reduction dementia risk ww long sb time hr   =   0.69 95 ci 0.54 0.87 p   =   0.002 ww short sb time hr   =   0.74 95 ci 0.56 0.97 p   =   0.029 . regular group short sb time be associate low dementia risk hr   =   0.75 95 ci 0.59 0.96 p   =   0.021 not group long sb time . conclusion ww pattern may help mitigate dementia risk associate prolong sb suggest that quality intensity physical activity be also important factor .	Alzheimer&#x27;s research &amp; therapy	22/03/2025
10.1016/j.eururo.2025.02.023	european association urology guidelines upper urinary tract urothelial	Masson-Lecomte A, Birtle A, Pradere B, Capoun O, Compérat E, Domínguez-Escrig JL, Liedberg F, Makaroff L, Mariappan P, Moschini M, Rai BP, van Rhijn BWG, Shariat SF, Smith EJ, Teoh JYC, Soukup V, Wood R, Xylinas EN, Soria F, Seisen T, Gontero P	background objective present summary 2025 update european association urology eau guideline upper urinary tract urothelial carcinoma utuc . aim be to provide practical recommendation clinical management utuc focus diagnosis treatment follow up . method 2025 guideline utuc new relevant evidence be identify collate appraise structured assessment literature . database search include medline embase cochrane libraries . recommendation guideline be develop panel to prioritise clinically important care decision . strength recommendation be determine accord balance desirable undesirable consequence alternative management strategy quality evidence include certainty estimate nature variability patient value preference . key finding limitation key recommendation emphasise importance thorough diagnosis treatment follow up patient utuc . guideline stress importance appropriate treatment take account patient value preference . key update 2025 utuc guideline include significant change recommendation utuc diagnosis complete revision section address risk stratification ureteroscopy surgical approach radical nephroureterectomy addition four new recommendation two relate kidney spare management localise low risk utuc further two relate management high risk nonmetastatic utuc review adaptation recommendation utuc follow up addition new section address quality indicator utuc management . conclusions clinical implication overview 2025 eau guideline utuc offer valuable insight risk factor diagnosis classification treatment follow up utuc . guideline contain information management individual patient accord current good evidence be design effective integration clinical practice .	European urology	07/03/2025
10.1038/s41467-025-57988-z	dynamic ctdna track stratifie relapse risk triple negative breast cancer	Li S, Li Y, Wei W, Gong C, Wang T, Li G, Yao F, Ou JH, Xu Y, Wu W, Jin L, Rao N, Nie Y, Yu F, Jia W, Li XR, Zhang J, Yang HW, Yang Y, Wu M, Li Q, Li F, Gong Y, Yi X, Liu Q	early triple negative breast cancer etnbc be subtype bad outcome . circulate tumor dna ctdna be show to predict prognosis breast cancer utility etnbc remain unclear . 130 stage ii iii female etnbc patient receive neoadjuvant chemotherapy nac have be enrol prospectively subject ctdna analysis . ctdna post nac pre surgery post surgery not baseline be associate bad prognosis . threshold 1.1 maximum variant allele frequency baseline stratifie patient different relapse risk be validate internally externally . systemic tumor burden model integrate baseline post surgery ctdna be independently prognostic p   =   0.022 . combine systemic tumor burden pathologic response identify highly curable subgroup subgroup high risk etnbc patient . ctdna surveillance follow identifie patient high relapse risk . conclusion systemic ctdna analysis demonstrate utility systemic tumor burden model ctdna risk stratification etnbc patient may guide future treatment escalation de escalation trial .	Nature communications	21/03/2025
No	physical medicine rehabilitation .	Nan D, Liao W	nan	Zhonghua yi xue za zhi	25/12/2002
10.1186/s12883-025-04132-5	effect very early exercise inflammatory marker clinical outcome	Ademoyegun AB, Awotidebe TO, Odetunde MO, Inaolaji SO, Bakare SO, Azeez FW, Olayemi O	background apart limited evidence effect very early exercise vee clinical outcome cos stroke well knowledge be require to understand cellular action induce vee . study investigate effect vee inflammatory marker ims co . far evaluate association acute change ims co follow up individual first ever mild moderate ischaemic stroke . method prospective single center single blind randomize control trial retrospectively register pactr202406755848901 10 06 2024 be conduct . forty eight patient randomize 1:1 vee group veeg usual care group ucg complete follow up . 24   h stroke onset patient veeg undergo 45   min vee twice daily amount 1.5   h d seven day while patient ucg receive regular turning positioning . level im include interleukin-6 il-6 fibrinogen leucocyte neutrophil lymphocyte monocyte be assess baseline 4th 7th day group . thereafter patient receive 90 min follow up physiotherapy twice weekly three month . motor impairment physical disability functional independence anxiety depression cognition be evaluate 1st 3rd month follow up . result 4th 7th day patient veeg show trend low level il-6 leucocyte neutrophil monocyte high level lymphocyte . however non linear effect vee plasma fibrinogen be observe compare uc . furthermore well improvement motor impairment physical disability functional independence anxiety depression cognition be observe veeg . positive modulation ims vee be associate co time include association change il-6 day 4 7 3 month functional independence r(s   =   -0.33 p   =   0.019 r(s   =   -0.33 p   =   0.021 day 7 3 month motor impairment r(s   =   0.30 p   =   0.039 . conclusion initiate moderate intensity exercise 24   h appear beneficial positively modulate im include il-6 acute stage improve physical motor cognitive affective function 1 3 month follow up . association exercise induce acute change ims improve co time highlight potential role moderate intensity vee enhance stroke recovery positive inflammatory modulation .	BMC neurology	21/03/2025
10.1186/s12933-025-02687-8	association triglyceride glucose index trajectory risk worsen	Lai Y, Lin C, Liu X, Liu Y, Cai H, Zhao N, Gao Y, Yi Z, Huang J, Li M, Xu L	background triglyceride glucose index serve dependable biomarker gauge insulin resistance link cardiovascular disease . study be design to investigate how trajectory triglyceride glucose index relate risk worsen heart failure overall mortality patient age 60   year old chronic heart failure type 2 diabetes . method study enrol 466 patient have   ≥   3 medical exam . formula calculate triglyceride glucose index be ln fast triglyceride mg dl   ×   fast blood glucose mg dl]/2 . trajectory triglyceride glucose index longitudinal analysis be analyze linear mixed model . relationship trajectory tyg index risk worsen heart failure overall mortality be analyze compete cox regression analysis mixed effect cox regression analysis . result variable adjustment compare first quartile group adjusted hazard ratio worsen heart failure top quartile group be 2.40 1.35 3.28 10 year follow up 2.09 1.22 3.58 overall follow up duration . adjusted hazard ratio overall mortality top quartile group be 1.99 1.56 3.14 10 year follow up 1.87 1.22 2.88 overall follow up duration . compare low decrease trajectory adjusted hazard ratio worsen heart failure high decrease trajectory be 1.37 1.10 1.71 5 year follow up 1.78 1.10 2.88 10 year follow up 1.67 1.04 2.68 overall follow up duration . adjusted hazard ratio overall mortality be 2.16 1.39 3.35 10 year follow up 2.23 1.46 3.40 overall follow up duration . conclusion follow up high baseline level tyg index high decrease trajectory be independently associate long term worsen heart failure increase risk overall mortality .	Cardiovascular diabetology	21/03/2025
10.1136/gutjnl-2024-334466	rectal diclofenac versus indomethacin prevention post ercp pancreatitis	Kang X, Xia M, Wang J, Wang X, Luo H, Qin W, Liang Z, Zhao G, Yang L, Sun H, Tao J, Ning B, Zhong L, Zhang R, Ma X, Zhao J, Yue L, Jin H, Kang C, Ren G, Liang S, Wang H, Wang L, Nie Y, Wu K, Fan DM, Pan Y	background recent meta analysis suggest diclofenac may be superior to indomethacin prevent post endoscopic retrograde cholangiopancreatography ercp pancreatitis pep . aim study be to compare efficacy 100   mg rectal indomethacin versus diclofenac pep incidence . design multicentre double blind randomise control trial be conduct nine tertiary centre china . patient low high risk pep native papilla be randomly allocate 1:1 to receive 100   mg diclofenac 100   mg indomethacin rectally ercp . primary outcome be occurrence pep define cotton consensus . intention treat principle be conduct analysis . result trial be terminate early futility predetermine first interim analysis . june 2023 may 2024 1204 patient be randomise diclofenac group n=600 indomethacin group n=604 . baseline characteristic be balance . primary outcome occur 53 patient 8.8 600 patient allocate diclofenac group 37 patient 6.1 604 patient allocate indomethacin group relative risk 1.44 95 ci 0.96 2.16 p=0.074 . pep occur 35 14.2 247 high risk patient diclofenac group 26 9.8 266 high risk patient indomethacin group p=0.124 . pep incidence be also comparable low risk patient two group 18/353 5.1 vs 11/338 3.3 p=0.227 . other ercp relate complication do not differ two group . conclusion pre procedure 100   mg rectal diclofenac be not superior same dose rectal indomethacin regard prevent pep . finding support current clinical practice guideline 100   mg indomethacin diclofenac pep prophylaxis patient contraindication . trial registration number clinicaltrials.gov nct05947461 .	Gut	20/03/2025
10.1016/j.eururo.2025.02.020	european association urology guidelines renal cell carcinoma 2025	Bex A, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U, Dabestani S, Hora M, Klatte T, Kuusk T, Lund L, Marconi L, Palumbo C, Pignot G, Powles T, Schouten N, Tran M, Volpe A, Bedke J	background objective european association urology eau renal cell carcinoma rcc guideline panel have update evidence base guideline recommendation management rcc . here present summary 2025 rcc guideline update standardised methodology to provide reproducible evidence management rcc . method 2025 update literature search be perform cover period may 1 2023 may 1 2024 use medline embase cochrane libraries . data search focus meta analysis systematic review randomise control trial rcts retrospective control comparator arm study . evidence be synthesise outline eau guideline . key finding limitation clinical practise recommendation be update chapter rcc guideline basis structured literature search . study include be predominantly retrospective matched unmatched cohort base single- multi institutional datum . several prospective study rct provide datum result recommendation base high level evidence . specifically update include new recommendation stereotactic body radiotherapy localised rcc adjuvant therapy systemic therapy clear cell rcc late line other subtype new chapter hereditary rcc . conclusions clinical implication 2025 rcc guideline have be update multidisciplinary panel expert use methodological standard to provide contemporary evidence base management rcc .	European urology	10/03/2025
10.1038/s41586-025-08727-3	histological signature map anti fibrotic factor mouse human lung .	Guo JL, Griffin M, Yoon JK, Lopez DM, Zhu Y, Lu JM, Mikos G, Parker JBL, Mascharak S, Brenac C, Guardino NJ, Abbas DB, Li DJ, Valencia C, Liang NE, Januszyk M, Chang HY, Wan DC, Desai TJ, Longaker MT	fibrosi replacement healthy tissue collagen rich matrix can occur follow injury almost organ(1,2 . mouse lung follow stereotyped sequence fibrogenesis resolution bleomycin injury(3 reason that profile post injury histological stage could uncover pro fibrotic versus anti fibrotic feature functional value human fibrosis . here quantify spatiotemporally resolve matrix transformation integration multi omic datum . first chart stepwise trajectory matrix aberration versus resolution derive high dimensional set histological fibre feature denote reversible transition uniform to disorder histological architecture . single cell sequence trajectory identify temporally enriched x27;ecm secreting&#x27 csmd1 express x27;pro resolving&#x27 cd248 express fibroblast respective post injury stage . visium base spatial analysis far suggest divergent matrix architecture spatial transcriptional neighbourhood fibroblast subtype identify distinct fibrotic versus non fibrotic biomolecular milieu . critically pro resolve fibroblast instillation help to ameliorate fibrosis vivo . furthermore fibroblast neighbourhood associate factor serpine2 pi16 functionally modulate human lung fibrosis ex vivo . spatial phenotyping idiopathic pulmonary fibrosis protein level additionally uncover analogous fibroblast subtype neighbourhood human disease . collectively finding establish atlas pro- anti fibrotic factor underlie lung matrix architecture implicate fibroblast associate biological feature modulate fibrotic progression versus resolution .	Nature	19/03/2025
No	cross cultural psychometric evaluation dutch mcgill qol questionnaire	De Vrieze T, Coeck D, Verbelen H, Devoogdt N, Tjalma W, Gebruers N	aim study assess cross cultural psychometric property dutch mqol breast cancer patient . method 26 patient be recruit antwerp university hospital . eligible patient fill mqol different moment time order to evaluate clinimetric property . to determine validity mqol be correlate eortc qlq c30 . internal consistency be analyse use cronbach&#x27;s test ret reliability be determine icc . statistical responsiveness s.e.m mdc be calculate . result strong correlation be find x27;qol score&#x27 mqol domain x27;existential well- being&#x27 eortc qlq c30 r = 0.72 . excellent test ret reliability icc 1,1 be demonstrate intraclass coefficient range 0.82 0.92 . mdc total score only 1.22 12 be see need to detect factual change patients&#x27 qol. psychometric property dutch mqol be find comparable property original questionnaire . conclusion dutch version mqol be valid reliable questionnaire breast cancer patient show statistical responsiveness . strong to excellent reliability version mqol be useful clinical as well scientific setting .	Facts, views &amp; vision in ObGyn	01/12/2016
10.1093/procel/pwaf025	single nucleus transcriptomics decodes link aging lumbar disc	Wang M, He Z, Wang A, Sun S, Li J, Liu F, Li C, Yang C, Lei J, Yu Y, Ma S, Wang S, Zhang W, Yu Z, Liu GH, Qu J	lumbar disc ld herniation aging be prevalent condition can result substantial morbidity . study aim to clarify mechanism connect ld aging herniation particularly focus cellular senescence molecular alteration nucleus pulposus np . perform detailed analysis np sample diverse cohort include individual vary age diagnose ld herniation . methodology combine histological assessment single nucleus rna sequence to identify phenotypic molecular change relate np aging herniation . discover that cellular senescence decrease nucleus pulposus progenitor cell nppc be central process . additionally find age relate increase nfat1 expression promote nppc senescence contribute aging herniation ld . research offer fresh insight ld aging associated pathology potentially guide development new therapeutic strategy to target root cause ld herniation aging .	Protein &amp; cell	22/03/2025
10.1126/science.ado8680	apoplastic barrier be essential nodule formation nitrogen fixation	Shen D, Micic N, Venado RE, Bjarnholt N, Crocoll C, Persson DP, Samwald S, Kopriva S, Westhoff P, Metzger S, Neumann U, Nakano RT, Marín Arancibia M, Andersen TG	establishment apoplastic root barrier know casparian strip occur early root development . legume area overlap nitrogen fix nodule formation raise possibility that nodulation barrier formation be connect . nodule also contain casparian strip yet case role be unknown . establish mutant defective barrier lotus japonicus . reveal that effective apoplastic blockage endodermis be important root shoot signal underlie nodulation . finding far reveal that nodule genetic machinery casparian strip formation be share root . apoplastic blockage control metabolic source sink status require nitrogen fixation . identify casparian strip model system to study spatially constrain symbiotic plant microbe relationship .	Science (New York, N.Y.)	21/03/2025
10.1016/j.cell.2025.02.015	growth maternal intestine reproduction .	Ameku T, Laddach A, Beckwith H, Milona A, Rogers LS, Schwayer C, Nye E, Tough IR, Thoumas JL, Gautam UK, Wang YF, Jha S, Castano-Medina A, Amourda C, Vaelli PM, Gevers S, Irvine EE, Meyer L, Andrew I, Choi KL, Patel B, Francis AJ, Studd C, Game L, Young G, Murphy KG, Owen B, Withers DJ, Rodriguez-Colman M, Cox HM, Liberali P, Schwarzer M, Leulier F, Pachnis V, Bellono NW, Miguel-Aliaga I	organ many female animal be remodel reproduction . use mouse intestine striking tractable model organ resizing find that reproductive remodeling be anticipatory distinct diet- microbiota induce resizing . reproductive remodeling involve partially irreversible elongation small intestine fully reversible growth epithelial villi associate expansion isthmus progenitor accelerate enterocyte migration . identify induction sglt3a transporter subset enterocyte early reproductive hallmark . electrophysiological genetic interrogation indicate that sglt3a do not sustain digestive function enterocyte health rather detect proton sodium to extrinsically support expansion adjacent fgfbp1 positive isthmus progenitor promote villus growth . finding reveal unanticipated specificity physiological organ remodeling . suggest that organ- state specific growth program could be leveraged to improve pregnancy outcome prevent maladaptive consequence such growth .	Cell	14/03/2025
10.1016/j.annonc.2025.03.007	impact immunological context outcome solid cancer patient	Mubarak O, Middleton G	introduction outcomes genotype match targeted therapy solid cancer patient be heterogeneous have exceptional response other primary progression . review explore immunobiological feature may underlie differential response . method conduct literature review study assess impact immune context follow search web science medline embase . relevant outcome include response progression free survival overall survival . datum be extract multivariate analysis univariate analysis directly kaplan meier curve . meta analysis be perform where three more study analyse same immune factor same cancer type . remain study be analyse descriptively . result adjuvant set assessment immune context do not highlight group fail to derive benefit use dabrafenib trametinib resection brafv600e melanoma differential gene expression exceptional responder show enrichment gene associate immune activation . brafv600e colorectal cancer patient high cytolytic score benefit addition mek inhibition whereas low score fare well . high pd l1 expression be predictive inferior outcome egfr alk g12c tyrosine kinase inhibitor . egfr mutant patient high cd8 + t cell pd l1 positivity have very poor outcome . stromal tumour infiltrate lymphocyte predict efficacy stromal poor tumour her-2 + breast cancer treat short course adjuvant trastuzumab . high immune metagene single immune gene expression be predictive benefit chemotherapy plus trastuzumab not chemotherapy alone . addition pertuzumab lapatanib appear to be beneficial immune non enriched microenvironment . high mhci be negatively high mhcii positively predictive outcome trastuzumab base therapy . conclusion knowledge be first review assess immunological context biomarker targeted therapy . result review represent important resource to aid future translational study advance stratified precision medicine oncology .	Annals of oncology : official journal of the European Society for Medical	19/03/2025
10.1038/s41392-025-02191-1	intranasal prime boost rna vaccination elicit potent t cell response lung	Li H, Hu Y, Li J, He J, Yu G, Wang J, Lin X	rapid success rna vaccine prevent sars cov-2 have spark interest use cancer immunotherapy . although many cancer originate mucosal tissue current rna cancer vaccine be mainly administer non mucosally . here develop non invasive intranasal cancer vaccine utilize circular rna encapsulate lipid nanoparticle to induce localized mucosal immune response . strategy elicit potent anti tumor t cell response preclinical lung cancer model while mitigate systemic adverse effect commonly associate intravenous rna vaccination . specifically type 1 conventional dendritic cell be indispensable t cell prime post vaccination alveolar macrophage type 1 conventional dendritic cell boost antigen specific t cell response lung tissue . moreover vaccination facilitate expansion endogenous adoptive transfer antigen specific t cell result robust anti tumor efficacy . single cell rna sequence reveal that vaccination reprogram endogenous t cell enhance cytotoxicity induce memory like phenotype . additionally intranasal vaccine can modulate response car t cell to augment therapeutic efficacy tumor cell express specific tumor associate antigen . collectively intranasal rna vaccine strategy represent novel promising approach develop rna vaccine target mucosal malignancy .	Signal transduction and targeted therapy	24/03/2025
10.1186/s12967-024-05972-4	association adjustable dietary factor periodontitis nhanes	Chen L, Zhao R, Zhang Y	background periodontitis be major cause tooth loss adult one most common non communicable disease . clinically periodontitis impairs oral health associate various systemic disease . maintain healthy diet be consider risk reduction periodontitis . to explore causal effect dietary datum periodontitis mendelian randomization mr analysis . method total 11,704 participant 21 dietary variable nhanes be random forest to rank importance predict periodontitis . datum be genome wide association study gwas database to estimate causal relationship diet datum periodontitis . two sample mr analysis be conduct use inverse variance weight   ivw method . result mr show alcohol consumption sugar intake increase risk chronic periodontitis odd ratio or 2.768 95 ci 1.03e   +   00 7.42e   +   00 2.123 95 ci 1.06e   +   00 4.26e   +   00 respectively . vitamin mineral include folic acid folate magnesium vitamin a vitamin e vitamin c calcium vitamin d zinc be not causally associate chronic periodontitis . alcohol consumption great 2.5 drink day sugar intake more 4.88   g increase risk periodontitis calculate relative risk 1.33 1.61 respectively . conclusion be suggest to drink alcohol less 2.5 drink day consume sugar less 4.88   g day to avoid alcohol sugar consumption promote development periodontitis . establish dietary pattern conducive periodontal health may be focus further clinical research .	Journal of translational medicine	20/03/2025
10.1210/clinem/dgaf191	testosterone male bone health puzzle interactions .	Tenuta M, Hasenmajer V, Gianfrilli D, Isidori AM	sex steroid be pivotal skeletal development maintenance life . testosterone primarily drive male cortical bone growth periosteal expansion particularly puberty while estradiol be essential trabecular bone formation inhibit resorption . conversion testosterone dihydrotestosterone estradiol transport protein somatotropic axis non androgenic function testis underscore intricate interplay protect male bone health . clinical model include estrogen resistance aromatase deficiency complete androgen insensitivity syndrome highlight estradiol&#x27;s critical role maintain male bone integrity . use aromatase inhibitor androgen deprivation therapy reveal adverse effect estrogen androgen blockade often result significant bone loss . gender affirm hormone therapy provide further insight testosterone&#x27;s influence cortical bone development maintenance role sex steroid adulthood . review dig link male hypogonadism osteoporosis emphasize testosterone replacement therapy trt finding major trial include t trial bone t4bone traverse fracture . while trt have be show to improve bone mineral density bmd effect fracture risk remain inconclusive . unexpected finding traverse fracture trial highlight importance caution confirm that anti resorptive therapy remain first line treatment male osteoporosis . investigate synergistic effect combine trt anti resorptive therapy impact therapeutic timing peak bone mass accrual role confounder fracture risk be promise area future research to optimize male skeletal health .	The Journal of clinical endocrinology and metabolism	22/03/2025
10.1126/sciadv.adt2117	cd38 mediate metabolic reprogramme promote stability suppressive	Sarkar I, Basak D, Ghosh P, Gautam A, Bhoumik A, Singh P, Kar A, Mahanti S, Chowdhury S, Chakraborty L, Mondal S, Mukherjee R, Mehrotra S, Majumder S, Sengupta S, Paul S, Chatterjee S	tumor microenvironment tme regulatory t cell t(regs adapt metabolism to thrive low glucose high lactate condition mechanism remain unclear . study identify cd38 key regulator adaptation deplete nicotinamide adenine dinucleotide oxidize form nad(+ redirect lactate derive pyruvate phosphoenolpyruvate bypass tricarboxylic acid tca cycle . prevent accumulation α ketoglutarate destabilize t(reg induce hypermethylation foxp3 locus . restore nad(+ nicotinamide mononucleotide reverse adaptation push t(reg back tca cycle reduce suppressive function . yumm1.7 melanoma bear mouse small molecule cd38 inhibition selectively destabilize intratumoral t(reg spark robust antitumor immunity . finding reveal that target cd38 nad(+ axis disrupt t(reg metabolic adaptation offer strategy to enhance antitumor response .	Science advances	21/03/2025
10.1038/s41422-025-01095-7	molecular mechanism arrestin biased agonism neurotensin receptor 1	Sun D, Li X, Yuan Q, Wang Y, Shi P, Zhang H, Wang T, Sun W, Ling S, Liu Y, Lai J, Xie W, Yin W, Liu L, Xu HE, Tian C	biased allosteric modulator bam g protein couple receptor gpcr have be forefront drug discovery owe potential to selectively stimulate therapeutically relevant signaling avoid target side effect . although structure gpcr complex g protein grk bam bind state have recently be resolve reveal that bam can induce biased signal directly modulate interaction gpcr two transducer bam bind gpcr arrestin complex structure have yet be determine limit understanding full pharmacological profile bam . herein develop chemical protein synthesis strategy to generate neurotensin receptor 1 ntsr1 define hexa phosphorylation c terminus resolve high resolution cryo em structure 2.65 2.88   å ntsr1 complex β arrestin1 bam sbi-553 . structure reveal unique quot;loop engagement&quot configuration β arrestin1 coupling ntsr1 presence sbi-553 markedly different typical quot;core engagement&quot configuration observe absence bam . configuration be characterize engagement intracellular loop 3 ntsr1 cavity central crest β arrestin1 represent previously unobserved arrestin selective conformation gpcr . finding fill critical knowledge gap regard regulation gpcr arrestin interaction bias signal bam would advance development safe more efficacious gpcr target therapeutic .	Cell research	21/03/2025
10.1038/s41467-025-58107-8	microbiota indole-3 propionic acid heart axis mediate protection	Huang R, Shen ZY, Huang D, Zhao SH, Dan LX, Wu P, Tang QZ, Ma ZG	anti program death 1 αpd1 immune checkpoint blockade be use combination cancer treatment associate cardiovascular toxicity . leflunomide lef can suppress growth several tumor mitigate cardiac remodeling mouse . however role lef αpd1 induced cardiotoxicity remain unclear . here report that lef treatment inhibit αpd1 related cardiotoxicity compromise efficacy αpd1 mediated immunotherapy . lef change community structure gut microbiota αpd1 treat melanoma bear mouse . moreover mouse receive microbiota transplant lef+αpd1 treat melanoma bear mouse have well cardiac function compare mouse receive transplant αpd1 treat mouse . mechanistically analyze metabolomic identify indole-3 propionic acid ipa protect cardiac dysfunction αpd1 treat mouse . ipa can directly bind aryl hydrocarbon receptor promote phosphoinositide 3 kinase expression thus curtail cardiomyocyte response immune injury . finding reveal that lef mitigate αpd1 induced cardiac toxicity melanoma bear mouse modulation microbiota ipa heart axis .	Nature communications	19/03/2025
10.1126/sciadv.ads5458	sip2 be master transcription factor plasmodium merozoite formation .	Nishi T, Kaneko I, Yuda M	malaria one most serious infectious disease worldwide be cause proliferation plasmodium parasite repeat cycle intraerythrocytic development . parasite replicate schizogony host erythrocyte produce multiple progeny merozoite invade new erythrocyte . although merozoite formation be most crucial step malaria pathogenesis molecular mechanism remain unclear . sip2 be ap2 transcription factor express schizogony be particularly conserve erythrocyte infect apicomplexan parasite . here reveal that sip2 plasmodium berghei pbsip2 function master transcription factor merozoite formation . conditional disruption pbsip2 result developmental arrest merozoite formation notable down regulation merozoite relate gene . chip seq show that pbsip2 comprehensively activate merozoite relate gene bind to previously report cis regulatory element merozoite invasion relate gene include bipartite motif tgcan(4 6)gtgca . collectively result indicate that sip2 be transcription factor establish erythrocyte infectivity may have evolutionary origin common ancestor erythrocyte infect apicomplexan parasite .	Science advances	21/03/2025
10.1007/s11883-025-01290-2	manage dyslipidemia chronic kidney disease implication cardiovascular	Theofilis P, Vlachakis PK, Karakasis P, Kalaitzidis RG	purpose review review aim to address complex relationship dyslipidemia chronic kidney disease ckd emphasize dual role drive cardiovascular disease cvd risk contribute ckd progression . explore pathophysiological mechanism highlight recent biomarker discovery evaluate contemporary emerge lipid lower therapy tailor ckd patient . recent finding recent study have highlight inadequacy traditional lipid marker like ldl c reflect cardiovascular risk ckd . novel biomarker such remnant cholesterol lipoprotein(a demonstrate strong association adverse outcome . emerge lipid lower agent include bempedoic acid pemafibrate pcsk9 inhibitor show promise risk reduction especially non dialysis dependent ckd . however evidence remain limited advanced stage ckd dialysis patient . furthermore alteration lipid metabolism such dysfunctional hdl triglyceride rich lipoprotein be now recognize significant contributor cvd renal damage ckd population . dyslipidemia be pivotal modifiable risk factor ckd exacerbate cardiovascular risk disease progression . while statin remain cornerstone therapy early moderate ckd efficacy diminish advanced stage . advent novel therapeutic option deep understanding dyslipidemia&#x27;s pathophysiology hold potential improve outcome . future research should prioritize personalize approach focus unique metabolic derangement ckd advance treatment high risk dialysis dependent patient .	Current atherosclerosis reports	21/03/2025
10.1111/jcmm.70434	machine learning base glycolipid metabolism gene signature predict prognosis	Zhu L, Liang F, Han X, Ye B, Xue L	use machine learning approach develop validate novel prognostic model oesophageal squamous cell carcinoma escc base glycolipid metabolism relate gene . integrated analysis tcga geo dataset establish robust 15 gene signature effectively stratify patient distinct risk group . signature demonstrate superior prognostic value reveal significant association immune infiltration pattern . high risk patient exhibit reduce immune cell infiltration particularly b cell nk cell alongside increase tumour purity . single cell rna sequence analysis uncover unique cellular composition pattern enhance interaction intensity high risk group especially epithelial smooth muscle cell . functional validation confirm mecp2 promising therapeutic target knockdown significantly inhibit tumour progression   vitro   vivo . drug sensitivity analysis identify specific therapeutic agent show potential efficacy high risk patient . study provide practical prognostic tool novel insight relationship glycolipid metabolism tumour immunity escc offer potential strategy personalise treatment .	Journal of cellular and molecular medicine	01/03/2025
10.1038/s41591-025-03570-5	optimal dietary pattern healthy aging .	Tessier AJ, Wang F, Korat AA, Eliassen AH, Chavarro J, Grodstein F, Li J, Liang L, Willett WC, Sun Q, Stampfer MJ, Hu FB, Guasch-Ferré M	global population age be critical to identify diet prevent noncommunicable disease optimally promote healthy aging . here use longitudinal questionnaire datum nurses&#x27 health study 1986 2016 health professionals follow study 1986 2016 examine association long term adherence eight dietary pattern ultraprocesse food consumption healthy aging as assess accord measure cognitive physical mental health as well live 70 year age free chronic disease . to 30 year follow up 9,771 9.3 105,015 participant 66 woman mean age   =   53 year s.d .   =   8) achieve healthy aging . dietary pattern high adherence be associate great odd healthy aging domain . odd ratio highest quintile versus low range 1.45 95 confidence interval ci   =   1.35 1.57 healthful plant base diet 1.86 95 ci   =   1.71 2.01 alternative healthy eating index . when age threshold healthy aging be shift 75 year alternative healthy eating index diet show strong association healthy aging odd ratio 2.24 95 ci   =   2.01 2.50 . high intake fruit vegetable whole grain unsaturated fat nut legume low fat dairy product be link great odd healthy aging whereas high intake trans fat sodium sugary beverage red processed meat be inversely associate . finding suggest that dietary pattern rich plant base food moderate inclusion healthy animal base food may enhance overall healthy aging guide future dietary guideline .	Nature medicine	24/03/2025
10.1016/j.kint.2025.01.011	podocyte aging diabetic kidney disease .	Li L, Liu Y	podocyte injury cause series cellular change include hypertrophy dedifferentiation senescence apoptosis detachment . although evidence suggest pivotal role podocyte senescence diabetic kidney disease exact trigger underlying mechanism remain elusive . study li et   al . uncover gpr124 g protein couple receptor protect podocyte senescence inhibit focal adhesion kinase . finding underscore that gpr124 focal adhesion kinase axis could be novel target diabetic kidney disease therapy .	Kidney international	01/04/2025
10.1038/s42255-025-01234-9	vestibular neuron link motion sickness behavioural thermoregulation	Tu L, Fang X, Yang Y, Yu M, Liu H, Liu H, Yin N, Bean JC, Conde KM, Wang M, Li Y, Ginnard OZ, Liu Q, Shi Y, Han J, Zhu Y, Fukuda M, Tong Q, Arenkiel B, Xue M, He Y, Wang C, Xu Y	motion sickness be associate thermoregulation metabolic control underlying neural circuitry remain largely unknown . here show that neuron medial vestibular nuclei parvocellular part mvepc mediate hypothermic response induce motion . reactivation motion sensitive mvepc neuron recapitulates motion sickness mouse . show that motion activate neuron mvepc be glutamatergic mvepc(glu optogenetic stimulation mvepc(glu neuron mimic motion induce hypothermia signal lateral parabrachial nucleus lpbn . acute inhibition mvepc lpbn circuitry abrogate motion induce hypothermia . finally show that chronic inhibition mvepc(glu neuron prevent diet induce obesity improve glucose homeostasis suppress food intake . overall finding highlight mvepc(glu neuron potential target motion sickness treatment obesity control .	Nature metabolism	21/03/2025
10.1186/s12933-025-02688-7	explore impact metabolic comorbiditie epicardial adipose tissue	Menghoum N, Badii MC, Leroy M, Parra M, Roy C, Lejeune S, Vancraeynest D, Pasquet A, Brito D, Casadei B, Depoix C, Filippatos G, Gruson D, Edelmann F, Ferreira VM, Lhommel R, Mahmod M, Neubauer S, Persu A, Piechnik S, Hellenkamp K, Ikonomidis I, Krakowiak B, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Gerber BL, Balligand JL, Beauloye C, Pouleur AC	background heart failure hf preserve ejection fraction hfpef be increasingly prevalent worldwide aging comorbiditie . epicardial adipose tissue eat favor diabete obesity be show to contribute hfpef pathophysiology be emerge therapeutic target . study explore relationship ventricular eat measure cardiovascular magnetic resonance cmr metabolic factor image characteristic control pre hf patient hfpef patient . method patient belgian cohort enrol december 2015 june 2017 be categorize hf stage pre hf n   =   16 hfpef n   =   104 compare match control n   =   26 to pre hf n   =   191 beta3 lvh cohort . biventricular eat volume be measure end diastolic short axis cine stack . belgian cohort association eat hf stage various biological imaging marker be explore . clinical endpoint be composite mortality first hf hospitalization hfpef group . result eat significantly differ group high value hfpef patient compare pre hf control 72.4   ±   20.8ml m(2)vs . 55.0   ±   11.8ml m(2 48   ±   8.9ml m(2 p   lt   0.001 belgian cohort to pre hf 52.0   ±   15.0 ml m(2 p   lt   0.001 beta3 lvh cohort . subsequent analysis focus belgian cohort . contrast atrial fibrillation diabete prevalence body mass index bmi do not differ pre hf hfpef patient . multivariable logistic regression random forest classification identify eat n terminal pro b type natriuretic peptide nt probnp h(2)fpef score strong marker hfpef status . eat be significantly correlate h(2)fpef score r   =   0.41 p   =   0.003 bmi r   =   0.30 p   lt   0.001 high sensitive troponin t r   =   0.41 p   lt   0.001 nt probnp r   =   0.37 p   lt   0.001 soluble suppression tumorigenicity-2 sst2 r   =   0.30 p   lt   0.001 e e&#x27 ratio r   =   0.33 p   lt   0.001 leave ventricular global longitudinal strain r   =   0.35 p   lt   0.001 . hfpef patient diabetes ischemic cardiomyopathy elevated sst2 be independently associate elevated eat . contrast diabete bmi increase eat be not associate prognosis . conclusion eat assess cmr be significantly high hfpef patient compare control pre hf patient irrespective diabete bmi . eat be moderately associate hfpef status . hfpef patient elevated eat exhibit marked diabetic ischemic inflammatory profile highlight potential role drug target eat . trial registration characterization heart failure preserved ejection fraction assessment efficacy mirabegron new beta3 adrenergic receptor prevention heart failure beta3_lvh . trial registration number clinicaltrials.gov . identifier nct03197350 nct02599480 .	Cardiovascular diabetology	22/03/2025
10.1038/s41467-025-58074-0	smoking aggravate neovascular age relate macular degeneration	He K, Dong X, Yang T, Li Z, Liu Y, He J, Wu M, Wei-Zhang S, Kaysar P, Cui B, Yao X, Zhang L, Zhou W, Xu H, Wei J, Liu Q, Hu J, Wang X, Yan H	age relate macular degeneration amd be prevalent neuroinflammation condition lead cause irreversible blindness elderly population . smoke significantly increase amd risk mechanism remain unclear . here investigate role sema4d plexinb1 axis progression amd sema4d plexinb1 be highly activate smoking . use patient derive sample mouse model discover that smoking increase presence sema4d surface cd8(+ t cell migrate choroidal neovascularization cnv lesion cxcl12 cxcr4 axis interact receptor plexinb1 choroidal pericyte . lead ror2 mediate plexinb1 phosphorylation pericyte activation thereby disrupt vascular homeostasis promote neovascularization . inhibition sema4d reduce cnv improve benefit anti vegf treatment . conclusion study unveil molecular mechanism smoking exacerbate amd pathology present potential therapeutic strategy target sema4d to augment current amd treatment .	Nature communications	22/03/2025
10.1038/s41419-025-07498-z	histone lactylation enhance gclc expression thus promote chemoresistance	Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, Mu L, Luo X, Qin J	colorectal cancer stem cell ccsc play critical role mediating chemoresistance . lactylation be post translational modification induce lactate regulate gene expression . however whether lactylation affect chemoresistance ccsc remain unknown . here demonstrate that histone lactylation enhance ccsc chemoresistance vitro vivo . furthermore finding show that p300 catalyze lactylation histone h4 k12 whereas hdac1 facilitate delactylation ccsc . notably lactylation h4k12 h4k12la upregulate gclc expression inhibit ferroptosis ccsc inhibition p300 ldha decrease h4k12la level thereby increase chemosensitivity ccsc . additionally gclc inhibitor bso promote ferroptosis sensitize ccsc oxaliplatin . take together finding suggest that histone lactylation upregulate gclc to inhibit ferroptosis signal thus enhance ccsc chemoresistance . finding provide new insight relationship cellular metabolism chemoresistance suggest potential therapeutic strategy target p300 ldha gclc . show that histone h4k12 lactylation promote chemoresistance cscs . p300 catalyze lactylation histone h4 k12 hdac1 inhibit histone lactylation same site . h4k12la cscs regulate expression ferroptosis relate gene gclc thereby inhibit ferroptosis lead chemoresistance . target p300 ldha gclc may be overcome tumor chemoresistance .	Cell death &amp; disease	20/03/2025
10.1016/j.ccell.2025.02.024	pai-1 drive sfrp2(high cancer associate fibroblast hijack abscopal effect	Zhang YP, Guo ZQ, Cai XT, Rong ZX, Fang Y, Chen JQ, Zhuang KM, Ruan MJ, Ma SC, Lin LY, Han DD, Li YS, Wang YY, Wang J, Cao CH, Tang XR, Xie QK, Chen Y, Lin Y, Tan JL, Yu ZH, Wu ZN, Wei W, Zheng DY, Zeng YJ, Ruan YC, Xu ZP, Gu JZ, Xiao LS, Liu L, Guan J, Bai X, Wu DH, Dong ZY	abscopal effect radioimmunotherapy wherein tumor shrinkage occur irradiated field be therapeutically promising clinically rare . mechanism underlie effect remain elusive . here   vivo genome wide crispr screen identify sfrp2 potential stromal regulator abscopal effect . sfrp2 exhibit cancer associate fibroblast caf)-specific expression radioimmunotherapy mediate upregulation unirradiated tumor . conditional sfrp2 knockout cafs boost abscopal effect rewire vascular immune microenvironment to promote cd8(+ t   cell recruitment unirradiated tumor .   vivo lineage tracing reveal that elevate sfrp2 correlate radioimmunotherapy drive pericyte lineage commitment . serum proteomic reveal that irradiate tumor secrete pai-1 trigger distant tumor pericyte cell fate transition sfrp2(high caf lrp1 p65 axis . pharmacologically block sfrp2 pai-1 enhance abscopal effect humanize patient derive xenograft model . finding collectively illustrate that pai-1 induce sfrp2(high caf serve critical stromal regulator to hijack abscopal effect provide promise target enhance radioimmunotherapy effectiveness .	Cancer cell	12/03/2025
10.1016/j.jprot.2021.104190	chronic restraint stress induce change colonic homeostasis relate index	Li CC, Gan L, Tan Y, Yan MZ, Liu XM, Chang Q, Pan RL	chronic stressor represent risk factor etiology exacerbation several gastrointestinal disease . goal present study be to examine whether chronic restraint stress crs could initiate aggravate colonic inflammation integrity damage metabolic disturbance rat . firstly increase inflammatory cytokine interferon γ ifn γ tumor necrosis factor α(tnf α interleukin-10(il-10 decrease tight junction tj protein occludin zonula occludins-1 zo-1 rat colon be observe . secondly untargete metabolomic base ultra performance liquid chromatography couple quadrupole time flight mass uplc q tof ms reveal that trp metabolism be most prominently affect . thirdly quantification trp metabolite prominence ultrafast liquid chromatography couple qtrap 5500 mass uflc qtrap-5500 ms show that trp kynurenine kyn kynurenic acid ka 3 hydroxykynurenine 3 hk be significantly increase . same time 5 hydroxytryptamine 5 ht be unchanged 5 hydroxyindolacetic acid 5 hiaa be significantly decrease colon crs rat . besides trp metabolic enzyme change be same trend correspond metabolite . thus datum show that crs could initiate colonic inflammation integrity damage colonic metabolism disturbance especially trp kyn metabolism pathway rat may provide experimental background future research stress relate gastrointestinal dysfunction . significance chronic exposure psychological stress could induce metabolic imbalance body stressful life event be intimately correlate frequent relapse patient intestinal disorder . present study show that chronic restraint stress crs could initiate aggravate colonic inflammation integrity damage metabolic disturbance especially tryptophan kynurenine metabolism rat . tryptophan kynurenine pathway may be involve initiation development disease induce chronic stress . research may shed light future research stress relate gastrointestinal dysfunction .	Journal of proteomics	30/05/2021
10.1136/gutjnl-2024-334516	dietary whey protein protect crohn&#x27;s disease orchestrate	Su R, Wen W, Jin Y, Cao Z, Feng Z, Chen J, Lu Y, Zhou G, Dong C, Gao S, Li X, Zhang H, Chao K, Lan P, Wu X, Philips A, Li K, Gao X, Zhang F, Zuo T	background gut microbiome diet be important factor pathogenesis management crohn&#x27;s disease cd . however role gut phageome dietary influence be unknown . objective aim to explore effect diet gut phageome bacteriome interaction link cd protection . design recruit cd patient healthy subject n=140 conduct multiomics investigation include pair ileal mucosa phageome bacteriome profiling dietary survey phenome interrogation . screen effect diet gut phageome bacteriome as well epidemiological association cd risk . underlie mechanism be explore target phage bacteria monoculture coculture vitro two mouse model vivo . result dietary screening human whey protein wp consumption be find to profoundly impact gut phageome bacteriome more pronounced phageome be associate low cd risk . indeed wp reshape gut phageome can causally attenuate intestinal inflammation as show faecal phageome versus bacteriome transplantation wp consume versus wp non consuming mouse recipient mouse . mechanistically wp induce phage newly isolate phage akkzt003p herein lysis mucin forage bacterium akkermansia muciniphila unleash symbiotic bacterium streptococcus thermophilus to counteract intestinal inflammation . conclusion study chart importance cross kingdom interaction gut phage bacteria mediate dietary effect cd protection . importantly uncover beneficial dietary wp keystone phage akkzt003p probiotic s. thermophilus can be use cd management future .	Gut	23/03/2025
10.1056/NEJMoa2414482	tezepelumab adults severe chronic rhinosinusitis nasal polyps .	Lipworth BJ, Han JK, Desrosiers M, Hopkins C, Lee SE, Mullol J, Pfaar O, Li T, Chen C, Almqvist G, Margolis MK, McLaren J, Jagadeesh S, MacKay J, Megally A, Hellqvist Å, Mankad VS, Bahadori L, Ponnarambil SS	background treatment tezepelumab have be effective sinonasal symptom patient severe uncontrolled asthma history chronic rhinosinusitis nasal polyp efficacy safety adult severe uncontrolled chronic rhinosinusitis nasal polyp be unknown . method randomly assign adult physician diagnose symptomatic severe chronic rhinosinusitis nasal polyp to receive standard care tezepelumab dose 210 mg placebo subcutaneously 4 week 52 week . coprimary end point be change baseline total nasal polyp score range 0 to 4 nostril high score indicate great severity mean nasal congestion score range 0 to 3 high score indicate great severity week 52 . key secondary end point assess overall population be loss smell score total score sinonasal outcome test snot-22 range 0 to 110 high score indicate great severity lund mackay score range 0 to 24 high score indicate great severity total symptom score range 0 to 24 high score indicate great severity first decision to treat nasal polyp surgery use systemic glucocorticoid therapy assess time event analysis individual composite . result total 203 patient be assign to receive tezepelumab 205 to receive placebo . week 52 patient receive tezepelumab have significant improvement total nasal polyp score mean difference vs. placebo -2.07 95 confidence interval ci -2.39 to -1.74 mean nasal congestion score -1.03 95 ci -1.20 -0.86 p&lt;0.001 score . tezepelumab significantly improve loss smell score mean difference vs. placebo -1.00 95 ci -1.18 -0.83 snot-22 total score -27.26 95 ci -32.32 -22.21 lund mackay score -5.72 95 ci -6.39 -5.06 total symptom score -6.89 95 ci -8.02 -5.76 p&lt;0.001   score . surgery nasal polyp be indicate significantly few patient tezepelumab group 0.5 placebo group 22.1 hazard ratio 0.02 95 ci 0.00 to 0.09 be significantly less use systemic glucocorticoid tezepelumab 5.2 placebo 18.3 hazard ratio 0.12 95 ci 0.04 0.27 p&lt;0.001 time event analysis . conclusion tezepelumab therapy lead significantly great reduction size nasal polyp severity nasal congestion sinonasal symptom use nasal polyp surgery systemic glucocorticoid placebo adult severe uncontrolled chronic rhinosinusitis nasal polyp . fund astrazeneca amgen waypoint clinicaltrials.gov number nct04851964 . .	The New England journal of medicine	01/03/2025
10.1158/0008-5472.CAN-24-3180	slc3a2 mediated lysine uptake cancer cells restricts t cell activity	Chang Y, Wang N, Li S, Zhang J, Rao Y, Xu Z, Li L, Wu H, Chen J, Lin Y, Huang X, Liu P, Zhang J, Liao Y, Lin C, Huang C, Xia N	abnormal amino acid metabolism support cancer cell proliferation invasion immune evasion hepatocellular carcinoma hcc . previous research explore amino acid metabolism hcc have primarily focus how metabolic reprogramme impact tumor cell . here focus role amino acid metabolism dysregulation crosstalk hcc t cell . hcc cell disrupt lysine uptake t cell lead impaired t cell immunity . lysine deprivation decrease stat3 level t cell inhibit t cell proliferation effector function ultimately promote tumor progression . mechanistically hcc cell outcompete t cell lysine express high level lysine transporter slc3a2 . clinically elevated slc3a2 expression correlate poor survival be link dysregulate t cell functional gene signature hcc patient . furthermore multikinase inhibitor lenvatinib induce c myc slc3a2 regulatory axis limit efficacy lenvatinib treatment . lysine supplementation enhance tumor sensitivity combined treatment lenvatinib anti pd-1 immunotherapy . finding suggest that lysine supplementation be potential therapeutic strategy treat hcc enhance sensitivity hcc tyrosine kinase inhibitor immune checkpoint blockade .	Cancer research	24/03/2025
10.1186/s12933-025-02625-8	piezo1 deletion mitigate diabetic cardiomyopathy maintain mitochondrial	Niu W, Liu X, Deng B, Hong T, Wang C, Yan Y, Liu J, Jiang Y, Li J	objective increase evidence highlight critical role piezo1 cardiovascular disease expression upregulate diabetic heart . however involvement piezo1 pathogenesis diabetic cardiomyopathy dcm remain unclear . study aim to elucidate regulatory role piezo1 mitochondrial dynamic context dcm to investigate underlie mechanism . method construct cardiac specific knockout piezo1 piezo1(∆myh6 mouse . type 1 diabetes be induce use streptozotocin stz injection while type 2 diabete be establish high fat diet combine stz . echocardiography assess left ventricular function histological evaluation use masson stain to examine cardiac pathology piezo1(fl fl control piezo1(∆myh6 control piezo1(fl fl diabetic piezo1(∆myh6 diabetic mouse . mitochondrial function include oxygen specie level mitochondrial morphology respiration rate be also assess . result finding reveal that piezo1 expression be upregulate myocardium diabetic mouse high glucose treat cell . cardiac specific knockout piezo1 improve cardiac dysfunction ameliorate cardiac fibrosis diabetic mouse . moreover piezo1 deficiency also attenuate mitochondrial impairment . piezo1(fl fl diabetic mouse exhibit increase calpain activity excessive mitochondrial fission mediate drp1 obvious reduced fusion however piezo1 deficiency restore calpain level mitochondrial dysfunction . observation be also corroborate h9c2 cell neonatal mouse cardiomyocyte . cardiac specific knockout piezo1 increase phosphorylation drp1 erk1/2 vivo vitro . piezo1 knockout treatment inhibitor improve mitochondrial function . conclusion study provide first evidence that piezo1 be elevate dcm modulation mitochondrial dynamic be reverse piezo1 deficiency . thus piezo1 inhibition may provide promising therapeutic strategy treatment dcm .	Cardiovascular diabetology	20/03/2025
10.1053/j.gastro.2025.02.036	perforin generate cd8(+ t cells exacerbates ibd induced depression	Huang S, Pan L, Pang S, Guo H, Li M, Tian Y, Shi W, Liu B, Wang S, Fan Z, Zong Y, Tian D, Zhang D	background amp aims approximately 25.2 inflammatory bowel disease ibd patient suffer psychological disorder particularly depression . recent study have indicate close relationship intestinal immunity brain disorder . method perform transcriptome analysis immunofluorescence stain colonic sample ibd patient . role perforin generate colonic cd8(+ t cell ibd induce depression be investigate dss- cd8(+ t cell transfer induce colitis use prf1 egfp reporter prf1 knockout mouse . result study reveal significant correlation depressive symptom severity perforin production cd8(+ t cell ibd patient mouse colitis . moreover perforin deficiency cd8(+ t cell mitigate inflammation depressive like behavior mouse colitis . mechanistically perforin granzyme b be find to stimulate expression cxcl9 colonic epithelial cell . cxcl9 be show to be release circulation to enter hippocampus where induce endoplasmic reticulum er stress hippocampal neuron cxcr3 hspa5 axis . cascade event subsequently be find to exacerbate depression . neutralize cxcl9 vivo alleviate depression have effect colitis mouse . conclusion perforin generate colonic cd8(+ t cell promote intestinal epithelial cell cxcl9 production lead neuronal er stress hippocampus induce depression ibd .	Gastroenterology	20/03/2025
10.1038/s41596-025-01145-9	spatially resolve genome wide joint profiling epigenome transcriptome	Li H, Bao S, Farzad N, Qin X, Fung AA, Zhang D, Bai Z, Tao B, Fan R	epigenome cell be tightly correlate gene transcription control cell identity diverse biological activity . recent advance spatial technology have improve understanding tissue heterogeneity analyze transcriptomic epigenomic spatial information preserve have be mainly restrict one molecular layer time . here present procedure two spatially resolve sequence method spatial atac rna seq spatial cut&amp;tag rna seq that co profile transcriptome epigenome genome wide . method transcriptomic readout be generate tissue fixation permeabilization situ reverse transcription . spatial atac rna seq tn5 transposase be use to probe accessible chromatin spatial cut&amp;tag rna seq tissue be incubate primary antibody target histone modification follow protein a fuse tn5 induce tagmentation . method leverage microfluidic device deliver two set oligonucleotide barcode to generate two dimensional mosaic tissue pixel near single cell resolution . spatial atac rna seq spatial cut&amp;tag rna seq library can be generate 3 5 d allow researcher to simultaneously investigate transcriptomic landscape epigenomic landscape intact tissue section . protocol be extension previous spatially resolve epigenome sequence protocol provide opportunity multimodal profiling .	Nature protocols	21/03/2025
10.1126/science.adt7570	hippocampal encoding memory human infant .	Yates TS, Fel J, Choi D, Trach JE, Behm L, Ellis CT, Turk-Browne NB	human lack memory specific event first few year life . investigate mechanistic basis infantile amnesia scan brain awake infant functional magnetic resonance imaging while perform subsequent memory task . great activity hippocampus viewing previously unseen photograph be relate late memory base look behavior begin 1 year age suggest that capacity to encode individual memory come online infancy . availability encode mechanism episodic memory period human life be later lose autobiographical record imply that postencode mechanism whereby memory infancy become inaccessible retrieval may be more responsible infantile amnesia .	Science (New York, N.Y.)	21/03/2025
10.1126/sciimmunol.adk7429	dysregulation γδ intraepithelial lymphocyte precede crohn&#x27;s disease like	Xu W, Golovchenko NB, Martínez-Vargas IU, Fong A, Rout P, Achi S, Bucar EB, Hsieh JJ, Vidmar KJ, Zhang L, Polydorides AD, Prinz I, Kollias G, Frey MR, Pizarro TT, Verzi MP, Edelblum KL	intraepithelial lymphocyte express γδ t cell receptor γδ iels provide immunosurveillance intestinal barrier be reduce patient active crohn&#x27;s disease cd . here report underappreciated role γδ iels maintain immunological tolerance onset progression cd like ileitis use tnf(δare/+ mouse . find that tnf induce down regulation epithelial hepatocyte nuclear factor 4 gamma butyrophilin be follow loss ileal vγ7 iels impaired barrier surveillance histological onset disease . reduction immunoregulatory cd39(+ γδ iels coincide influx immature peripheral cd39(neg γδ t cell epithelium lead expansion induced iels whereas early depletion γδ iels correlate accelerated onset ileal inflammation . finding identify multiple layer γδ iel dysregulation ileitis development indicate that loss steady state immunoregulatory γδ iels may contribute initiation ileal cd .	Science immunology	21/03/2025
10.1172/JCI184021	tp53 mutation tet2 deficiency cooperate to drive leukemogenesis	Zhang P, Whipp EC, Skuli SJ, Gharghabi M, Saygin C, Sher SA, Carroll M, Pan X, Eisenmann ED, Lai TH, Harrington BK, Chan WK, Youssef Y, Chen B, Penson A, Lewis AM, Castro CR, Fox N, Cihan A, Le Luduec JB, DeWolf S, Kauffman T, Mims AS, Canfield D, Phillips H, Williams KE, Shaffer J, Lozanski A, Doong TJ, Lozanski G, Mao C, Walker CJ, Blachly JS, Daniyan AF, Alinari L, Baiocchi RA, Yang Y, Grieselhuber NR, Campbell MJ, Baker SD, Blaser BW, Abdel-Wahab O, Lapalombella R	mutation deletion tp53 be associate adverse outcome patient myeloid malignancy develop improved therapy tp53 mutant leukemias be urgent need . here identify mutation tet2 most common co occurring mutation tp53 mutant acute myeloid leukemia aml patient . mouse combine hematopoietic specific deletion tet2 tp53 result enhanced self renewal compare deletion gene alone . tp53 tet2 double knockout mouse develop serially transplantable aml . mouse aml patient combine tet2 tp53 alteration upregulate innate immune signal malignant granulocyte monocyte progenitor gmps have leukemia initiate capacity . a20 govern leukemic maintenance trigger aberrant non canonical nf κb signal . mouse tp53 tet2 loss have expansion monocytic myeloid derive suppressor cell mdsc impair t cell proliferation activation . moreover mouse aml patient combine tp53 tet2 alteration display increase expression tigit ligand cd155 malignant cell . tigit blocking antibodie augment nk cell mediate killing tp53 tet2 double mutant aml cell reduce leukemic burden prolonged survival tp53 tet2 double knockout mouse . finding uncover leukemia promote link tet2 tp53 mutation highlight therapeutic strategy to overcome immunosuppressive bone marrow environment adverse subtype aml .	The Journal of clinical investigation	20/03/2025
10.1186/s12933-025-02684-x	impact glycemic control metric short- long term mortality	Yu Q, Fu Q, Ma X, Wang H, Xia Y, Chen Y, Li P, Li Y, Wu Y	background glycemic control be critical manage transcatheter aortic valve replacement tavr patient especially intensive care unit icu . emerge metric such hemoglobin glycation index hgi stress hyperglycemia ratio shr glycemic variability gv offer advanced insight glucose metabolism . however prognostic implication short- long term outcome post tavr remain underexplored . method retrospective cohort study analyze 3342 icu admit tavr patient mimic iv database . patient be stratify tertile hgi shr gv level . survival analyse include kaplan‒meier curve cox proportional hazard model restrict cubic spline rcs be use to assess association glycemic control metric 30 day 365 day cause mortality patient . sensitivity analysis subgroup assessment external validation be also perform to verify study finding . result follow up 1.6 6.9 patient experience 30 day 365 day mortality tavr respectively . fully adjust cox regression model low hgi hr 1.48 95 ci 1.05 2.09 p   =   0.025 high shr hr 1.63 95 ci 1.15 2.32 p   =   0.006 be most significantly associate increase risk 365 day mortality . high shr be also significantly associate increase risk 30 day mortality patient hr 2.92 95 ci 1.32 6.45 p   =   0.008 . lower hr 0.59 95 ci 0.38 0.92 p   =   0.019 high gv level hr 1.43 95 ci 1.06 1.93 p   =   0.020 be associate risk 365 day mortality . conclusion critically ill tavr patient glycemic control metric be closely associate long term cause mortality . hgi shr gv provide prognostic insight clinical outcome surpass conventional glucose measurement . finding highlight importance personalized glycemic management strategy improve tavr patient outcome .	Cardiovascular diabetology	22/03/2025
10.1002/advs.202413209	target copa enhance erdafitinib sensitivity fgfr altered bladder cancer .	Zhao H, Gao X, Jiang Y, Yu Y, Wang L, Sun J, Wang M, Xiong X, Huang C, Zhang H, Jiang G	fibroblast growth factor receptor fgfr family aberration be common urothelial cancer . fgfr tyrosine kinase inhibitor erdafitinib have be approve locally advanced metastatic urothelial cancer fgfr2/3 alteration . despite initial efficacy erdafitinib resistance can not be avoid . molecular mechanism underlie erdafitinib resistance have not be well investigate . here genome wide crispr screen be perform coatomer protein complex subunit α copa be identify key target to enhance erdafitinib sensitivity . functionally deficiency copa reduce proliferation fgfr alter bladder cancer cell upon erdafitinib treatment . mechanistically copa knockout increase degradation leucine rich pentatricopeptide repeat contain lrpprc protein lead reduce inhibitor dna bind 3 id3 mrna stability m6a dependent manner . collectively finding reveal novel mechanism erdafitinib resistance provide potential therapeutic target fgfr alter bladder cancer .	Advanced science (Weinheim, Baden-Wurttemberg, Germany)	20/03/2025
10.1016/j.jhep.2025.03.008	effect albumin treatment duration response rate outcome patient	Schleicher EM, Karbannek H, Weinmann-Menke J, Galle PR, Stallmach A, Gairing SJ, Zipprich A, Ripoll C, Labenz C	background aim guideline recommend volume expansion albumin 48 hour patient cirrhosis acute kidney injury aki to correct hypovolemia rule prerenal aki . recent update acute disease quality initiative adqi)-international club ascites ica consensus guideline suggest shorten duration 24 hour primarily base expert opinion . study aim to evaluate response rate albumin treatment 24 48 hour to compare assess prognostic significance three different definition response albumin therapy . methods datum 127 prospectively recruit patient cirrhosis aki two german center be analyze . examine three response definition 24 48 hour 1 serum creatinine scr decrease gt 0.3 mg dl 2 scr decrease gt;25 3 scr decrease at least one aki stage . follow up be prolong liver transplantation death hemodialysis hd . result overall 30 54 patient respond albumin treatment depend definition response rate be balance aki stage . notably relevant number patient respond 48 hour do not respond first 24 hour . additional response albumin second 24 hour be 38 24 25 definition 1 2 3 respectively . response accord definition 3 be associate well hd- transplantation free survival . conclusion substantial proportion patient require 48 hour to respond albumin treatment . shorten time albumin therapy may lead overtreatment terlipressin . impact implication study provide valuable insight optimal duration albumin treatment patient cirrhosis acute kidney injury aki challenge recent recommendation shorten treatment period albumin . furthermore optimal definition response albumin reduction at least one aki stage have be assess . result study be highly clinically relevant since shorten albumin therapy may lead overtreatment terlipressin evidence to support choice definition response albumin be lack . clinician can use finding to predict treatment outcome well avoid fluid overload improve patient prognosis while also consider potential risk early intervention terlipressin .	Journal of hepatology	19/03/2025
10.1001/jama.2025.0068	unified approach health data exchange report us dhhs .	Abbasi AB, Layden J, Gordon W, Gregurick S, DeLew N, Grossman J, Bierman AS, Monarez S, Curtis LH, Viall AH, Rocca M, Rivera DR, Marston H, Mugge A, Smith SR, Bent K, Macrae J, Sheehy A, Wegrzyn RD, Valdez RB, Johnson C, Bush L, Blum J, Cohen MK, Bertagnolli MM, Califf RM, Tripathi M	importance health information technology such electronic health record ehrs have be widely adopt yet access exchange datum fragmented us health care system remain challenge . to unlock potential ehr datum to improve patient health public health health care be essential to streamline exchange health datum . leader us department health human services dhhs describe how dhhs have implement fundamental building block to achieve vision . observation across dhhs have implement 3 foundational building block call 2016 21st century cures act to create unified approach secure high quality timely exchange health datum health care system . united states core data interoperability provide minimum baseline datum element must be available federally regulated health information technology system such certify ehr . datum element now must be accessible use fast healthcare interoperability resources secure flexible open industry standard health datum exchange . trusted exchange framework common agreement provide network to securely exchange health datum country . 3 building block united states core data interoperability fast healthcare interoperability resources trusted exchange framework common agreement be now place thank diligent public private sector work 2 administration . dhhs be work to refine building block increase adoption regulatory authority grant public private partnership . conclusion relevance technological building block describe article be create unified approach health datum exchange patient access clinical care quality improvement scientific research public health other use health datum . collaboration public nonprofit private sector be need to maximize potential . unlock potential health datum building block be foundation 21st century digital health care system will improve experience patient clinician result well health outcome .	JAMA	25/03/2025
10.1038/s41586-025-08873-8	structure mechanism human mitochondrial pyruvate carrier .	Liang J, Shi J, Song A, Lu M, Zhang K, Xu M, Huang G, Lu P, Wu X, Ma D	mitochondrial pyruvate carrier mpc be mitochondrial inner membrane protein complex essential uptake pyruvate matrix primary carbon source tricarboxylic acid tca cycle(1,2 . here report six cryo em structure human mpc three different state three structure obtain different condition intermembrane space ims)-open state high resolution 3.2 å structure pyruvate treat mpc occluded state 3.7 å two structure matrix face state bind inhibitor uk5099 inhibitory nanobody matrix side 3.2 å 3.0 å respectively . mpc be assign heterodimer consisting mpc1 mpc2 transmembrane domain adopt pseudo c2 symmetry . approximate rigid body movement occur ims open state occluded state while structural change primarily matrix side facilitate transition occluded state matrix face state reveal alternate access mechanism pyruvate transport . uk5099 bind structure inhibitor fit well interact extensively pocket open matrix side . finding provide important insight mechanism underlie mpc mediate substrate transport recognition inhibition uk5099 will facilitate future drug development target mpc .	Nature	18/03/2025
10.1002/cac2.70021	immunosuppressive jag2(+ tumor associate neutrophil hamper pd-1 blockade	Wang C, Yang M, Zhong Y, Cao K, Wang X, Zhang C, Wang Y, He M, Lu J, Zhang G, Huang Y, Liu H	background tumor associate neutrophil tans play critical role modulate immune response exhibit significant heterogeneity . previous study demonstrate that jagged canonical notch ligand 2 jag2)(+ tan be associate immunosuppressive microenvironment high grade serous ovarian cancer hgsoc underlying mechanism remain unclear . study aim to elucidate role jag2(+ tan tumor immunosuppressive microenvironment hgsoc . methods hgsoc sample be collect 274 sample constitute two independent cohort training validation cohort additional 30 sample utilize to establish patient derive tumor organoid pdtos . characterize number phenotype jag2(+ tan multiplex immunohistochemistry flow cytometry single cell rna sequence scrna seq . investigate biological function jag2 immune evasion use vitro co culture system flow cytometry tumor bear mouse model pdto . result jag2(+ tan express elevated level immunosuppressive molecule include program cell death ligand 1 cd14 have independent prognostic value overall survival patient hgsoc . scrna seq analysis reveal that jag2(+ tan exhibit terminally mature phenotype . infiltration jag2(+ tan be positively correlate abundance effector regulatory t cell etregs . interaction jag2(+ tans skewed cd4(+ t cell etreg phenotype process be suppress notch inhibitor ly3039478 induce recombinant jagged2 . furthermore demonstrate that jag2(+ tan enhance notch signaling activation ultimately promote recombination signal bind protein immunoglobulin kappa j region rbpj)-induce differentiation naïve cd4(+ t cell etregs . clinically jag2(+ tan could serve biomarker assess immunotherapy resistance various solid tumor . pharmacological target notch signal ly3039478 jag2 neutralization antibodie enhance efficacy program cell death protein 1 pd-1 monoclonal antibodie mabs xenograft pdto model . conclusion emergence jag2(+ tan be crucial differentiation etregs trigger immune evasion resistance anti pd-1 therapy . inhibit notch signal ly3039478 jag2 neutralization antibody may overcome anti pd-1 resistance hgsoc .	Cancer communications (London, England)	22/03/2025
10.1038/s41477-025-01949-3	cell wall associate kinase phosphorylate nlr immune receptor negatively	Zhong C, Li W, Zhang X, Zhang D, Wen Z, Song W, Jiang Z, Gao Z, Guo H, Bi G, Liu Z, Li D, Dinesh-Kumar SP, Zhang Y	plant deploy intracellular nucleotide bind leucine rich repeat nlrs to detect pathogen effector initiate immune response . although activation mechanism plant nlrs forming resistosome have be elucidate whether nlr resistosome assembly be regulate fine tune immunity remain enigmatic . here use antiviral coil coil nucleotide bind site leucine rich repeat barley stripe resistance 1 bsr1 model demonstrate that bsr1 be phosphorylate . use proximity labelling approach identify wall associate kinase like protein 20 wakl20 negatively regulate bsr1 mediate immune response directly phosphorylate ser470 residue nb arc domain bsr1 . mechanistically ser470 phosphorylation result steric clash intramolecular domain bsr1 thereby compromise bsr1 oligomerization . phosphorylation site be conserve multiple plant nlrs result show that wakl20 participate other nlr mediate immune response besides bsr1 . together data reveal phosphorylation mechanism modulate plant resistosome assembly provide new insight nlr mediate plant immunity .	Nature plants	01/03/2025
10.1111/codi.70046	alcohol consumption risk early onset colorectal cancer systematic	Huang S, Yu L, Xiong F, Zhang B, Ruan S	aim exist evidence have show positive association alcohol consumption increase risk colorectal cancer crc . however evidence be primarily base study crc age role alcohol early onset colorectal cancer eocrc remain to be determine . aim study be to investigate association increase incidence eocrc alcohol consumption . method systematically search pubmed embase cochrane web science june 2024 study evaluate association alcohol intake eocrc risk report specific result e.g. relative risk hazard ratio correspond 95 ci . base vary design include study corresponding effect value be extract categorize high alcohol consumption low alcohol consumption group random effect model be adopt to estimate pooled effect size analysis . furthermore subgroup analysis publication bias assessment be conduct . result three cohort study eight case control study be eligible include . result be pool meta analysis yield heighten risk eocrc increase alcohol intake   =   1.56 95 ci 1.28 1.89 i(2   =   89.3 . subgroup analysis significant difference be find association alcohol consumption risk develop eocrc gender location tumour site . result sensitivity analysis publication bias indicate that conclusion be robust . conclusion meta analysis provide possible evidence association alcohol consumption risk eocrc . more research be need future to confirm finding .	Colorectal disease : the official journal of the Association of Coloproctology of	01/03/2025
10.1016/j.lanepe.2024.101183	pfmg2025 integrate genomic medicine national healthcare system		integrate genomic medicine healthcare system be health policy challenge requires continuously transfer scientific advance clinic ensure equal access patient . france be one first country to integrate genome sequencing clinical practice nationwide level ambition to provide more accurate diagnostic personalized treatment . since 2016 french government have invest € 239 m 2025 french genomic medicine initiative pfmg2025 have so far focused patient rare disease rd cancer genetic predisposition cgp cancer . pfmg2025 have address numerous challenge to set operational organizational framework . december 31st 2023 12,737 result be return prescriber rd cgp patient median delivery time 202 day diagnostic yield 30.6 3109 cancer patient median delivery time 45 day . pfmg2025&#x27;s future priority encompass ensure economic sustainability strengthen link research empower patient practitioner foster collaboration european partner . funding december 31st 2023 € 239 m have be invest french government .	The Lancet regional health. Europe	01/03/2025
10.1016/S2215-0366(25)00028-8	clinical cost effectiveness lithium versus quetiapine augmentation	Cleare AJ, Kerr-Gaffney J, Goldsmith K, Zenasni Z, Yaziji N, Jin H, Colasanti A, Geddes JR, Kessler D, McAllister-Williams RH, Young AH, Barrera A, Marwood L, Taylor RW, Tee H	background lithium quetiapine be first line augmentation option treatment resistant depression however few study have compare directly none long 8 week . aim to assess whether quetiapine augmentation therapy be more clinically effective cost effective lithium patient treatment resistant depression 12 month . method do pragmatic open label parallel group randomise control superiority trial six national health service trust england . eligible participant be adult aged ≥18 year current episode major depressive disorder meet dsm-5 criterion score 14 high 17 item hamilton depression rating scale screen have respond inadequately two more therapeutic antidepressant trial . exclusion criterion include have diagnosis bipolar disorder current psychosis . participant be randomly assign 1:1 decision to prescribe lithium quetiapine stratify site depression severity treatment resistance use block randomisation randomly vary block size . randomisation pre prescribing safety check be undertake standard care proceed trial medication initiation . coprimary outcome be depressive symptom severity 12 month measure weekly use quick inventory depressive symptomatology time cause treatment discontinuation . economic analysis compare cost effectiveness two treatment nhs personal social service perspective societal perspective . primary analysis be do intention treat population include randomly assign participant . people live experience be involve trial . trial be complete register international standard randomised controlled trial registry isrctn16387615 . finding dec 5 2016 july 26 2021 212 participant 97 46 male gender 115 54 female gender be randomly assign decision to prescribe quetiapine n=107 lithium n=105 . mean age participant be 42·4 year sd 14·0 year 188 89 212 participant be white seven 3 be mixed ethnicity nine 4 participant be asian four 2 be black three 1 be other ethnicity ethnicity be not record one 1 participant . participant quetiapine group have significantly low overall burden depressive symptom severity than participant lithium group area group difference curve -68·36 95 ci -129·95 to -6·76 p=0·0296 . time discontinuation do not significantly differ two group . quetiapine be more cost effective lithium . 32 serious adverse event be record 18 participant one be deem possibly relate trial medication female participant lithium group . most common serious adverse event be overdose occur three 3 107 participant quetiapine group seven event three 3 105 participant lithium group five event . interpretation result trial suggest that quetiapine be more clinically effective lithium first line augmentation option reduce symptom depression long term management treatment resistant depression be probably more cost effective lithium . funding national institute health care research health technology assessment programme .	The lancet. Psychiatry	01/04/2025
10.5414/CP204738	sodium zirconium cyclosilicate associate adverse event analysis	Lin Y, Hong Q	purpose study aim to investigate adverse drug event ade signal associate potassium ion bind agent sodium zirconium cyclosilicate szc)use united states food drug administration&#x27;s adverse event report system faer provide insight safe clinical application . material method adverse reaction relate szc be retrieve faer database cover period may 2018 september 2023 . analysis utilize several statistical method include reporting odd ratio ror medicine healthcare regulatory agency mhra bayesian confidence propagation neural network bcpnn multi item gamma poisson shrinker mgps method proportioanl imbalance approach . result total 35 positive ade signal be identify 1,069 ade report where szc be primary suspect . signal encompass 10 different system organ class soc . conclusion study successfully identify analyze ade signal faer database contribute valuable insight evaluate rationality safety clinical medication practice involve szc .	International journal of clinical pharmacology and therapeutics	21/03/2025
10.1097/HEP.0000000000001313	high level hepatitis b surface antigen associate delayed development	Tseng TC, Hosaka T, Pan MH, Liu CJ, Suzuki F, Chen CJ, Su TH, Kumada H, Yang WT, Yang HC, Liu CH, Chen PJ, Yang HI, Kao JH	background active viral replication patient chronic hbv infection be major risk factor hepatocellular carcinoma hcc . however hcc risk highly viremic patient such immune tolerant patient remain unclear . study aim to investigate relationship viral factor hcc risk patient chronic hbv infection focus immune tolerant patient . patient method total 6,139 non cirrhotic taiwanese patient chronic hbv infection be enrol comprise 2,666 patient eradicate b study 3,473 patient reveal hbv study . primary endpoint be hcc development . relationship viral factor hcc risk hbeag positive hbeag negative patient be analyze separately . result median 21.7 year follow up 547 patient develop hcc . relationship viral factor hcc risk vary depend hbeag status . hcc risk increase viral load plateaue ≥5 log10 iu ml hbeag negative patient while show limited correlation hbeag positive patient . conversely hbsag level be positively associate hcc risk hbeag negative patient negatively associate hbeag positive patient . further investigation focus hbeag positive immune tolerant patient show that hbsag level ≥10,000   iu ml vs. lt;10,000   iu ml be associate delay hcc development be validate internally various subgroup analysis externally independent japanese cohort . conclusion predictive role hbv dna hbsag level hcc development differ hbeag negative hbeag positive patient . particularly immune tolerant patient hbsag level ≥10,000   iu ml show delay development hcc suggest hbsag biomarker to define genuine immune tolerant patient .	Hepatology (Baltimore, Md.)	20/03/2025
10.1093/bjs/znaf057	impact pd1 blockade add neoadjuvant chemoradiotherapy rectal cancer	Pang K, Liu X, Yao H, Lin G, Kong Y, Li A, Han J, Wu G, Wang X, Ye Y, Zhang J, Chen G, Wu A, Xiao Y, Yang Y, Zhang Z	background addition pd1 blockade neoadjuvant chemoradiotherapy crt have be show to significantly increase pcr rate locally advanced rectal cancer larc . yet impact total mesorectal excision tme remain unknown . method post hoc analysis randomized polarstar trial enrol patient larc eight major colorectal cancer centre beijing to compare neoadjuvant crt plus pd1 blockade crt alone be undertake . patient receive one three combination neoadjuvant treatment tme surgery crt plus concurrent pd1 blockade concurrent group crt plus sequential pd1 blockade sequential group crt alone control group . several parameter relate tme surgery be study . result concurrent group sequential group control group 52 46 45 patient respectively be include analysis . proportion patient undergo sphincter save plus one stage anastomosis surgery be 92 48 52 96 44 46 87 39 45 respectively . proportion patient stoma be 21 11 52 17 8 46 11 5 45 respectively . grade 3/4 surgical complication rate be 4 2 52 7 3 46 4 2 45 respectively . significant difference be observe sequential group control group respect proportion patient trg0 37 versus 18 respectively p = 0.040 ypt0 be ypn0 39 versus 20 respectively p = 0.046 low neoadjuvant rectal nar score 54 versus 31 respectively p = 0.025 . conclusion neoadjuvant crt plus pd1 blockade enhance pathological tumour regression be beneficial successful implementation tme patient larc . validation large sample size be warrant .	The British journal of surgery	04/03/2025
10.1038/s41586-025-08728-2	regulated somatic hypermutation enhance antibody affinity maturation .	Merkenschlager J, Pyo AGT, Silva Santos GS, Schaefer-Babajew D, Cipolla M, Hartweger H, Gitlin AD, Wingreen NS, Nussenzweig MC	germinal centre be specialized microenvironment where b   cell undergo affinity maturation . b   cell express antibody affinity be improve somatic hypermutation be select expansion limit number t   follicular helper cell . cell division be accompany mutation immunoglobulin gene be believe to be fix rate 1   ×   10(-3 base pair cell division(1 . as mutagenesis be random probability acquire deleterious mutation outweigh probability acquire affinity enhance mutation . effect might be heighten even become counterproductive b   cell express high affinity antibodie undergo great number cell divisions(2 . here experimentally examine theoretical model explain how affinity maturation could be optimize vary rate somatic hypermutation such that cell express high affinity antibodie divide more mutate less division . datum obtain mouse immunize sars cov-2 vaccine   model antigen align theoretical model show that cell produce high affinity antibodie shorten g0 g1 phase cell cycle reduce mutation rate . propose that mechanism safeguard high affinity b   cell lineage enhance outcome antibody affinity maturation .	Nature	19/03/2025
10.1016/j.ahj.2025.03.013	hyperoxemic oxygen therapy patients acute anterior myocardial infarction	Zeymer U, Hassinger F, Bramlage P, Schäfer A, Westermann D, Thiele H	background patient acute anterior st elevation myocardial infarction stemi be high risk death heart failure hf despite treatment primary percutaneous coronary intervention pci . adjunctive therapy hyperoxemic supersaturated oxygen sso2 follow pci reduce infarct size previous randomized trial none trial be power clinical endpoint . aim hot aami trial evaluate whether hyperoxemic supersaturated oxygen sso2 therapy follow pci reduce risk death heart failure . method hot aami be multicenter 1:1 randomize open label study 50 site germany . patient present anterior stemi undergo successful pci left anterior descend artery be randomize to receive sso2 therapy top standard care standard care alone . primary endpoint be composite cause mortality unplanned heart failure hospital admission outpatient visit heart failure require intravenous diuretic therapy 12 48 month follow up . secondary endpoint include cardiovascular mortality recurrent myocardial infarction stroke quality life . sample size calculation hot aami trial be base detect relative reduction 25 primary composite endpoint . control group yearly event rate 16 be expect comprise mortality 7 hospitalization heart failure 5 acute heart failure require outpatient treatment 4 . study be design to detect 25 relative difference two sided significance level 0.05 80 power require total 393 event therefore 1266 patient will be enrol . conclusion hot aami trial be first trial power to determine whether sso2 therapy administer immediately post pci improve death heart failure outcome patient anterior stemi . trial registration hot aami clinicaltrials.gov nct06742684 .	American heart journal	21/03/2025
10.1136/thorax-2024-221825	use inhaled corticosteroid bronchiectasis datum european	Pollock J, Polverino E, Dhar R, Dimakou K, Traversi L, Bossios A, Haworth C, Loebinger MR, De Soyza A, Vendrell M, Burgel PR, Mertsch P, McDonnell MJ, Skgrat S, Maiz-Carro L, Sibila O, van der Eerden M, Kauppi P, Hill AT, Wilson R, Milenkovic B, Menéndez R, Murris M, Crichton ML, Borecki S, Obradovic D, Irfan M, Eshenkulova V, Nowinski A, Amorim A, Torres A, Lorent N, Welte T, Blasi F, Van Braeckel E, Altenburg J, Shteinberg M, Boersma W, Elborn JS, Aliberti S, Ringshausen FC, Goeminne P, Chalmers JD	introduction current bronchiectasis guideline advise use inhaled corticosteroid ics except patient associated asthma allergic bronchopulmonary aspergillosis abpa and/or chronic obstructive pulmonary disease copd . study aim to describe use ics patient bronchiectasis europe . method patient bronchiectasis be enrol european bronchiectasis registry 2015 2022 . patient be group ics user non user baseline clinical characteristic associate ics use be investigate . patient be follow clinical outcome exacerbation hospitalisation mortality to 5 year . evaluate if elevated blood eosinophil count laboratory upper limit normal modify effect ics exacerbation . result 19   324 patient be include analysis 10   109 52.3 be record be prescribe ics baseline . exclusion patient history asthma copd and/or abpa 3174/9715 32.7 patient bronchiectasis be prescribe ics . frequency ics use varied country range 17 to 85 include patient . ics user have more severe disease significantly bad lung function high bronchiectasis severity index score more frequent exacerbation baseline p&lt;0.0001 . overall ics user do not have reduce risk exacerbation hospitalisation follow up significant reduction exacerbation frequency be observe subgroup ics user elevated blood eosinophil count relative risk 0.70 95 ci 0.59 0.84 p&lt;0.001 . conclusion ics use be common bronchiectasis include not currently recommend ics accord bronchiectasis guideline . ics use may be associate reduce exacerbation frequency patient elevated blood eosinophil .	Thorax	23/03/2025
10.1016/j.cell.2025.02.016	jumbo phage killer immune system target early infection nucleus form	Yuping L, Guan L, Becher I, Makarova KS, Cao X, Hareendranath S, Guan J, Stein F, Yang S, Boergel A, Lapouge K, Remans K, Agard D, Savitski M, Typas A, Koonin EV, Feng Y, Bondy-Denomy J	jumbo bacteriophage ϕkz like family assemble lipid base early phage infection epi vesicle proteinaceous nucleus like structure infection . structure protect phage nuclease may create selective pressure immunity mechanism target specific phage family . here identify quot;jumbo phage killer&quot juk two component immune system terminate infection ϕkz like phage suppress expression early phage gene prevent phage dna replication phage nucleus assembly while save cell . juka formerly yaaw rapidly sense epi vesicle bind early express phage protein gp241 then directly recruit jukb. jukb effector structurally resemble pore form toxin destabilize epi vesicle . functional anti-ϕkz juka homolog be find bacterial phyla associate diverse effector . finding reveal widespread defense system specifically target early event execute ϕkz like jumbo phage prior phage nucleus assembly .	Cell	18/03/2025
10.1099/ijsem.0.002654	stackebrandtia solo sp . nov . novel actinobacterium isolate soil	Liu MJ, Jin CZ, Park DJ, Asem MD, Xiao M, Salam N, Li WJ, Kim CJ	aerobic actinobacterium strain an130378(t be isolate soil sample collect korea subject taxonomic investigation use polyphasic approach . phylogenetic analysis base 16s rrna gene sequence datum show strain an130378(t be member genus stackebrandtia sequence similarity 97.3   stackebrandtia albiflava yim 45751(t 97.1   stackebrandtia endophytica yim 64602(t . whole cell hydrolysate contain meso diaminopimelic acid diagnostic diamino acid galactose glucose xylose . major menaquinone be mk-11(h4 mk-10(h4 mk-11(h6 while major fatty acid be identify iso c15     0 anteiso c17     0 anteiso c15     0 iso c17     0 sum feature 3 c16     1ω6c and/or c16     1ω7c . polar lipid be identify diphosphatidylglycerol phosphatidylethanolamine phosphatidylglycerol phosphatidylmethylethanolamine unidentified aminophospholipid four unidentified glycolipid three unidentified phospholipid two unidentified polar lipid . g+c   content genomic dna be determined to be 67.7   mol% . chemotaxonomic genotypic datum indicate that strain belong genus stackebrandtia . basis morphological chemotaxonomic datum phylogenetic analysis strain an130378(t be consider to represent novel specie genus stackebrandtia name stackebrandtia solo sp . nov . be propose . type strain be an130378(t (= dsm 103573(t)=kctc 39809(t .	International journal of systematic and evolutionary microbiology	01/04/2018
10.1186/s12943-025-02290-1	egfr mediate local invasiveness response cetuximab head neck	Zhou J, He M, Zhao Q, Shi E, Wang H, Ponkshe V, Song J, Wu Z, Ji D, Kranz G, Tscherne A, Schwenk-Zieger S, Razak NA, Hess J, Belka C, Zitzelsberger H, Ourailidis I, Stögbauer F, Boxberg M, Budczies J, Reichel CA, Canis M, Baumeister P, Wang H, Unger K, Mock A, Gires O	background recurrent metastatic head neck squamous cell carcinoma r m hnscc be severe frequently lethal condition . oncogene addiction epidermal growth factor receptor egfr be hallmark hnscc clinical efficacy egfr target therapy remain low . understand molecular network govern egfr drive progression be paramount exploration co)-treatment target predictive marker . method perform function base mapping differentially express gene egfr mediate local invasion fdegs use photoconvertible tracer rna sequence rna seq cellular 3d model . result upon alignment public single cell rna seq scrna seq dataset hnscc specific regulon gene regulatory network local invasion invgrn be infer gene expression datum be overrepresente bud tumor . invgrn comprise central hubs inhibin subunit beta alpha inhba snail family transcriptional repressor 2 snai2 druggable fdegs integrin subunit beta 4 itgb4 laminin 5 lamb3 lamc2 sphingosine kinase 1 sphk1 . blockade inhba repress local invasion be revert activin a laminin 5 sphingosine-1 phosphate demonstrate functional interconnectivity invgrn . epithelial mesenchymal transition emt malignant cell invgrn be induce newly define egfr activity subtype prognostic value be promote amphiregulin areg epiregulin ereg . importantly co inhibition sphk1 show synthetic effect cetuximab mediate invasion blockade high expression select fdegs be associate response cetuximab patient derive xenotransplantation pdx r m hnscc patient . conclusion describe actionable network egfr mediate local invasion define druggable effector predictive potential regard response r m hnscc cetuximab .	Molecular cancer	22/03/2025
10.1016/j.jad.2025.03.100	association rar prevalence prognosis depression a	Zhu XF, Hu YQ, Long ZW, Cao MZ	background depression have become significant public health issue . red blood cell distribution width albumin ratio rar be regard reliable marker inflammation nutritional status association remain unknown . therefore study aim to evaluate association rar depression . method 28,737 participant be include national health nutrition examination survey 2005 2018 . weighted multivariate logistic regression cox regression explore relationship rar prevalence mortality depression . restrict cubic spline rcs detect nonlinear relationship threshold effect . stratified analysis explore potential interaction variable . result cross sectional study 2519 participant 7.67   have depression . weighted multivariate logistic regression show rar be independently associate depression   =   1.26 95   ci   =   1.12 1.42 p   lt   0.001 . cohort study be 301 case cause mortality 9.94   depression population include 77 case cardiovascular mortality 2.66   . weight multivariate cox regression analysis present that rar be relate high cause mortality hr   =   1.98 95   ci   =   1.62 2.42 p   lt   0.001 cardiovascular mortality hr   =   1.73 95   ci   =   1.19 2.51 p   =   0.004 depression population . subgroup analysis show that rar be consistently relate prevalence mortality depression subgroup p   lt   0.05 . rcs reveal that relationship rar depression be nonlinear p nonlinear   =   0.011 while association rar cause mortality be linear p nonlinear   =   0.245 . conclusion rar be significantly associate prevalence prognosis depression . nevertheless more investigation be require to elucidate underlying process .	Journal of affective disorders	21/03/2025
10.1038/s41467-025-58146-1	solid like condensation morf8 inhibit rna edit heat stress	Wu J, Wang Y, Chen H, Xu T, Yang W, Fang X	heat stress inhibit photosynthesis efficiency thereby suppress plant growth crop yield . however mechanism underlie inhibition be not fully understand . here report that multiple organellar rna editing factor 8 morf8 form condensate solid like property chloroplast upon heat stress . vitro datum show that morf8 condensation be intrinsically heat dependent primarily determine idr intrinsically disorder region . purification characterization morf8 condensate show that numerous editing factor include ppr protein morf be partition . provide genetic biochemical evidence that morf8 condensation inhibit chloroplast rna editing . agreement find that heat stress morf8 condensation lead reduced editing rnas encode nadh dehydrogenase like ndh complex impair ndh activity photosynthesis efficiency . finding uncover morf8 putative chloroplastic thermosensor mediate photosynthesis inhibition heat highlight functional significance solid material property biomolecular condensate .	Nature communications	21/03/2025
10.1001/jamanetworkopen.2025.1421	seven vs fourteen days antibiotics gram negative bloodstream infection a	Lee TC, Prosty CJ, Fralick M, Huttner A, McDonald EG, Molina J, Paul M, Pinto R, Rishu A, von Dach E, Yahav D, Fowler R, Daneman N	importance gram negative bloodstream infection be common cause hospitalization . 2 week duration antibiotic therapy have be commonly use short duration may have similar outcome . objectives to assess whether 7 day antibiotic therapy be noninferior 14 day . data source start 2022 individual patient data meta analysis pubmed cochrane central register controlled trials web science be search to identify additional eligible randomized clinical trial rcts conduct may 1 2022 november 30 2024 . study selection rct involve primarily adult be hospitalize time gram negative bloodstream infection be allocate 7 14 day antibiotic therapy . study be independently review 2 investigator . data extraction synthesis prisma guideline be follow . datum be extract 2 investigator . unpublished datum be obtain directly study author . risk bias certainty evidence be assess duplicate use cochrane risk bias tool version 2 grading recommendations assessment development evaluation approach . datum be pool separate random effect meta analysis intention treat itt protocol pp population . noninformative prior probability be use effect evidence base weakly informative prior probability be use heterogeneity . risk ratio rrs 95 credible interval cris probability noninferiority be calculate use prespecified upper bind 1.25 less . main outcomes measures ninety day cause mortality . result four eligible rct contribute 3729 patient itt population 1912 woman 51.3 median age range 67 79 year 3126 pp population . itt analysis 90 day 226 patient 12.8 receive 7 day antibiotic die compare 253 13.7 receive 14 day correspond rr 90 day mortality 0.91 95 cri 0.69 1.22 97.8 probability noninferiority . pp analysis rr be 0.93 95 cri 0.68 1.32 correspond 95.1 probability noninferiority . conclusion relevance systematic review meta analysis patient gram negative bloodstream infection adequate source control 7 day antibiotic therapy have high probability be noninferior 14 day . finding support short duration antibiotic therapy appropriately select patient like include rct .	JAMA network open	03/03/2025
